Publications

Publications published since 2000 from OUS - Department of Haematology

772 publications found

Publications 2019

  1. Andersen MF, Holme PA, Tjønnfjord GE (2019)
    Surgical procedures in patients with severe haemophilia 1997–2014
    Tidsskr Nor Laegeforen, 139 (8)
    DOI 10.4045/tidsskr.18.0592, PubMed 31062561
  2. Andersen MLF, Holme PA, Tjonnfjord GE (2019)
    Surgical intervention in patients with severe bleeding disorder 1997-2014
    Tidsskr. Nor. Laegeforen., 139 (8), 709-712
  3. Atukunda P, Muhoozi GKM, van den Broek TJ, Kort R, Diep LM, Kaaya AN, Iversen PO, Westerberg AC (2019)
    Child development, growth and microbiota: follow-up of a randomized education trial in Uganda
    J Glob Health, 9 (1), 010431
    DOI 10.7189/jogh-09-010431, PubMed 31131103
  4. Beitland S, Wimmer H, Lorentsen T, Jacobsen D, Draegni T, Brunborg C, Kløw NE, Sandset PM, Sunde K (2019)
    Venous thromboembolism in the critically ill: A prospective observational study of occurrence, risk factors and outcome
    Acta Anaesthesiol Scand, 63 (5), 630-638
    DOI 10.1111/aas.13316, PubMed 30623406
  5. Berentsen S, Röth A, Randen U, Jilma B, Tjønnfjord GE (2019)
    Cold agglutinin disease: current challenges and future prospects
    J Blood Med, 10, 93-103
    DOI 10.2147/JBM.S177621, PubMed 31114413
  6. Birgegard G, Samuelsson J, Ahlstrand E, Ejerblad E, Enevold C, Ghanima W, Hasselbalch H, Nielsen CH, Knutsen H, Pedersen OB, Sørensen A, Andreasson B (2019)
    Inflammatory functional iron deficiency common in myelofibrosis, contributes to anaemia and impairs quality of life. From the Nordic MPN study Group
    Eur J Haematol, 102 (3), 235-240
    DOI 10.1111/ejh.13198, PubMed 30472746
  7. Blakstad EW, Korpela K, Lee S, Nakstad B, Moltu SJ, Strømmen K, Rønnestad AE, Brække K, Iversen PO, de Vos WM, Drevon CA (2019)
    Enhanced nutrient supply and intestinal microbiota development in very low birth weight infants
    Pediatr Res (in press)
    DOI 10.1038/s41390-019-0412-x, PubMed 31086354
  8. Chellappa S, Kushekhar K, Munthe LA, Tjønnfjord GE, Aandahl EM, Okkenhaug K, Taskén K (2019)
    The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function
    J Immunol, 202 (5), 1397-1405
    DOI 10.4049/jimmunol.1701703, PubMed 30692213
  9. Chowdary P, Carcao M, Holme PA, Jiménez-Yuste V, Lentz SR, Møss J, Poulsen LH, Shen C, Tosetto A, Wheeler A, Santagostino E (2019)
    Fixed doses of N8-GP prophylaxis maintain moderate-to-mild factor VIII levels in the majority of patients with severe hemophilia A
    Res Pract Thromb Haemost, 3 (3), 542-554
    DOI 10.1002/rth2.12220, PubMed 31294338
  10. Cremers EMP, de Witte T, de Wreede L, Eikema DJ, Koster L, van Biezen A, Finke J, Socié G, Beelen D, Maertens J, Nagler A, Kobbe G, Ziagkos D, Itälä-Remes M, Gedde-Dahl T, Sierra J, Niederwieser D, Ljungman P, Beguin Y, Ozkurt ZN, Anagnostopoulos A, Jindra P, Robin M, Kröger N (2019)
    A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation
    Leuk Lymphoma
    DOI 10.1080/10428194.2019.1594215, PubMed 30997844
  11. Curry N, Albayrak C, Escobar M, Andre Holme P, Kearney S, Klamroth R, Misgav M, Négrier C, Wheeler A, Santagostino E, Shima M, Landorph A, Tønder SM, Lentz SR (2019)
    Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)
    Haemophilia, 25 (3), 373-381
    DOI 10.1111/hae.13712, PubMed 30817066
  12. Dahm AEA, Jacobsen EM, Wik HS, Jacobsen AF, Mollnes TE, Kanse SM, Sandset PM (2019)
    Elevated Complement C3 and C4 Levels are Associated with Postnatal Pregnancy-Related Venous Thrombosis
    Thromb Haemost (in press)
    DOI 10.1055/s-0039-1692426, PubMed 31254974
  13. Eilertsen AL, Dahm AEA, Høibraaten E, Lofthus CM, Mowinckel MC, Sandset PM (2019)
    Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment
    Blood Coagul Fibrinolysis, 30 (1), 17-23
    DOI 10.1097/MBC.0000000000000784, PubMed 30507711
  14. El-Serafi I, Loy O, Zhao Y, Oerther S, Mattsson J (2019)
    Pre-formulation investigations for establishing a protocol for treosulfan handling and activation
    Pharm Dev Technol, 24 (5), 639-648
    DOI 10.1080/10837450.2018.1551903, PubMed 30474459
  15. Engeseth M, Enden T, Andersen MH, Sandset PM, Wik HS (2019)
    Does the Villalta scale capture the essence of post-thrombotic syndrome? A qualitative study of patient experience and expert opinion
    J Thromb Haemost (in press)
    DOI 10.1111/jth.14557, PubMed 31265193
  16. Garabet L, Ghanima W, Hellum M, Sandset PM, Bussel JB, Tran H, Henriksson CE (2019)
    Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists
    Platelets, 1-7 (in press)
    DOI 10.1080/09537104.2019.1639655, PubMed 31280643
  17. Garabet L, Ghanima W, Rangberg A, Teruel-Montoya R, Martinez C, Lozano ML, Nystrand CF, Bussel JB, Sandset PM, Jonassen CM (2019)
    Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists
    Platelets, 1-8
    DOI 10.1080/09537104.2019.1585527, PubMed 30885035
  18. Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos MV, Lonial S, Joao C, Anderson KC, García-Sanz R, Riva E, Du J, van de Donk N, Berdeja JG, Terpos E, Zamagni E, Kyle RA, San Miguel J, Goldschmidt H, Giralt S, Kumar S, Raje N, Ludwig H, Ocio E, Schots R, Einsele H et al. (2019)
    International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
    Lancet Oncol, 20 (6), e302-e312
    DOI 10.1016/S1470-2045(19)30309-2, PubMed 31162104
  19. Ifversen M, Turkiewicz D, Marquart HV, Winiarski J, Buechner J, Mellgren K, Arvidson J, Rascon J, Körgvee LT, Madsen HO, Abrahamsson J, Lund B, Jonsson OG, Heilmann C, Heyman M, Schmiegelow K, Vettenranta K (2019)
    Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experience
    Br J Haematol, 184 (6), 982-993
    DOI 10.1111/bjh.15761, PubMed 30680711
  20. Jarvis KB, Tveiterås M, de Lange C, Ruud E (2019)
    Central venous line-related thromboembolism is common in children with non-high-risk acute lymphoblastic leukaemia
    Acta Paediatr, 108 (6), 1167-1168
    DOI 10.1111/apa.14757, PubMed 30786076
  21. Jønsson V, Awan H, Jones ND, Johannesen TB, Steig BÁ, Andosdottir G, Tjønnfjord GE (2019)
    Inheritance of Susceptibility to Malignant Blood Disorders
    Sci Rep, 9 (1), 2444
    DOI 10.1038/s41598-019-38879-y, PubMed 30792429
  22. Küpers LK, Monnereau C, Sharp GC, Yousefi P, Salas LA, Ghantous A, Page CM, Reese SE, Wilcox AJ, Czamara D, Starling AP, Novoloaca A, Lent S, Roy R, Hoyo C, Breton CV, Allard C, Just AC, Bakulski KM, Holloway JW, Everson TM, Xu CJ, Huang RC, van der Plaat DA, Wielscher M et al. (2019)
    Meta-analysis of epigenome-wide association studies in neonates reveals widespread differential DNA methylation associated with birthweight
    Nat Commun, 10 (1), 1893
    DOI 10.1038/s41467-019-09671-3, PubMed 31015461
  23. Lenartova A, Randen U, Johannesen TB, Tjønnfjord GE (2019)
    Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway
    Cancer Epidemiol, 60, 128-133
    DOI 10.1016/j.canep.2019.04.002, PubMed 30986631
  24. Lien K, Johansen B, Veierød MB, Haslestad AS, Bøhn SK, Melsom MN, Kardel KR, Iversen PO (2019)
    Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis/chronic fatigue syndrome
    Physiol Rep, 7 (11), e14138
    DOI 10.14814/phy2.14138, PubMed 31161646
  25. Ljungkvist M, Strandberg K, Berntorp E, Chaireti R, Holme PA, Larsen OH, Lassila R, Jouppila A, Szanto T, Zetterberg E (2019)
    Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study
    Haemophilia, 25 (2), 334-342
    DOI 10.1111/hae.13640, PubMed 30715788
  26. Luhr M, Torgersen ML, Szalai P, Hashim A, Brech A, Staerk J, Engedal N (2019)
    The kinase PERK and the transcription factor ATF4 play distinct and essential roles in autophagy resulting from tunicamycin-induced ER stress
    J Biol Chem, 294 (20), 8197-8217
    DOI 10.1074/jbc.RA118.002829, PubMed 30926605
  27. Pearson ADJ, Scobie N, Norga K, Ligas F, Chiodin D, Burke A, Minard-Colin V, Adamson P, Marshall LV, Balakumaran A, Benettaib B, Bhargava P, Bollard CM, Bolotin E, Bomken S, Buechner J, Burkhardt B, Caron H, Copland C, Demolis P, Egorov A, Farhan M, Zugmaier G, Gross T, Horton-Taylor D et al. (2019)
    ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children
    Eur J Cancer, 110, 74-85
    DOI 10.1016/j.ejca.2019.01.013, PubMed 30772656
  28. Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O'Gorman P, Sonneveld P, Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T, Zaki M, Anderson K, Dimopoulos M et al. (2019)
    Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
    Lancet Oncol, 20 (6), 781-794
    DOI 10.1016/S1470-2045(19)30152-4, PubMed 31097405
  29. Sandset PM, Dahm AEA (2019)
    Is venous thromboembolism a problem in patients with cancer in palliative care?
    Lancet Haematol, 6 (2), e61-e62
    DOI 10.1016/S2352-3026(18)30218-7, PubMed 30709433
  30. Schultz NH, Holme PA, Henriksson CE, Mowinckel MC, Sandset PM, Bratseth V, Jacobsen EM (2019)
    The influence of rivaroxaban on markers of fibrinolysis and endothelial cell activation/injury in patients with venous thrombosis
    Thromb Res, 177, 154-156
    DOI 10.1016/j.thromres.2019.03.010, PubMed 30903875
  31. Skretting G, Andersen E, Myklebust CF, Sandset PM, Tinholt M, Iversen N, Stavik B (2019)
    Transcription factor FOXP3: A repressor of the TFPI gene?
    J Cell Biochem, 120 (8), 12924-12936
    DOI 10.1002/jcb.28563, PubMed 30861202
  32. Søraas A, Matsuyama M, de Lima M, Wald D, Buechner J, Gedde-Dahl T, Søraas CL, Chen B, Ferrucci L, Dahl JA, Horvath S, Matsuyama S (2019)
    Epigenetic age is a cell-intrinsic property in transplanted human hematopoietic cells
    Aging Cell, 18 (2), e12897
    DOI 10.1111/acel.12897, PubMed 30712319
  33. Saad A, Lamb L, Wang T, Hemmer MT, Spellman S, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Agrawal V, Aljurf M, Beitinjaneh AM, Bhatt VR, Buchbinder D, Byrne M, Cahn JY, Cairo M, Castillo P, Chhabra S, Diaz MA, Farhan S, Floisand Y, Frangoul HA, Gadalla SM, Gajewski J et al. (2019)
    Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation
    Biol Blood Marrow Transplant (in press)
    DOI 10.1016/j.bbmt.2019.05.007, PubMed 31085303
  34. Torkildsen S, Gorunova L, Heim S, Tjønnfjord GE, Spetalen S, Risberg B, Tran HTT, Panagopoulos I (2019)
    Molecular Genetic Characterization of Acute Myeloid Leukemia With Trisomy 4 as the Sole Chromosome Abnormality
    Cancer Genomics Proteomics, 16 (3), 175-178
    DOI 10.21873/cgp.20123, PubMed 31018948
  35. Wiktor-Jedrzejczak W, Drozd-Sokolowska J, Eikema DJ, Hoek J, Potter M, Wulf G, Sellner L, Ljungman P, Chevallier P, Volin L, Koc Y, Martin S, Bunjes D, Rovira M, Itälä-Remes M, Foá R, Deconinck E, Gedde-Dahl T, Cornelissen J, Collin M, Brecht A, Patel A, de Groot M, Reményi P, Nagler A et al. (2019)
    EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)
    Bone Marrow Transplant (in press)
    DOI 10.1038/s41409-019-0448-x, PubMed 30664723
  36. Zhang B, Ayuda-Durán P, Piechaczyk L, Fløisand Y, Safont MM, Karlsen IT, Fandalyuk Z, Tadele D, van Mierlo P, Rowe AD, Robertson JM, Gjertsen BT, McCormack E, Enserink JM (2019)
    GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells
    Haematologica, 104 (5), e229
    DOI 10.3324/haematol.2019.220533, PubMed 31040234

Publications 2018

  1. Anastasopoulou S, Eriksson MA, Heyman M, Wang C, Niinimäki R, Mikkel S, Vaitkevičienė GE, Johannsdottir IM, Myrberg IH, Jonsson OG, Als-Nielsen B, Schmiegelow K, Banerjee J, Harila-Saari A, Ranta S (2018)
    Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease
    Pediatr Blood Cancer, 66 (5), e27594
    DOI 10.1002/pbc.27594, PubMed 30592147
  2. Andersen E, Chollet ME, Myklebust CF, Pinotti M, Bernardi F, Chuansumrit A, Skarpen E, Sandset PM, Skretting G (2018)
    Activation of Endoplasmic Reticulum Stress and Unfolded Protein Response in Congenital Factor VII Deficiency
    Thromb Haemost, 118 (4), 664-675
    DOI 10.1055/s-0038-1637690, PubMed 29618153
  3. Bhamra JS, Iversen PO, Titze TK, Tjønnfjord GE, Akkök ÇA (2018)
    A Case of Posttransfusion Purpura with Severe Refractory Thrombocytopenia but No Cutaneous Manifestations
    Case Rep Hematol, 2018, 8187659
    DOI 10.1155/2018/8187659, PubMed 30510818
  4. Bruserud Ø, Melve GK, Gedde-Dahl T, Tvedt THA (2018)
    Immunological heterogeneity of healthy peripheral blood stem cell donors - preharvesting donor characteristics, additional heterogeneity induced by granulocyte colony-stimulating factor and possible importance for outcome after allotransplantation
    Expert Rev Hematol, 11 (10), 757-759
    DOI 10.1080/17474086.2018.1511420, PubMed 30126308
  5. Chortatos A, Iversen PO, Haugen M, Eberhard-Gran M, Bjelland EK, Veierød MB (2018)
    Nausea and vomiting in pregnancy - association with pelvic girdle pain during pregnancy and 4-6 months post-partum
    BMC Pregnancy Childbirth, 18 (1), 137
    DOI 10.1186/s12884-018-1764-7, PubMed 29739355
  6. Danylesko I, Bukauskas A, Paulson M, Peceliunas V, Gedde-Dahl D Y T, Shimoni A, Shouval R, Griskevicius L, Floisand Y, Nagler A (2018)
    Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease
    Bone Marrow Transplant, 54 (7), 987-993
    DOI 10.1038/s41409-018-0364-5, PubMed 30356163
  7. Diep PP, Melberg HO, Brinch L, Buechner J, Fløisand Y, Gedde-Dahl T, Loge JH, Tjønnfjord GE, Ruud E (2018)
    Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway
    Bone Marrow Transplant, 53 (5), 657-660
    DOI 10.1038/s41409-018-0091-y, PubMed 29358600
  8. Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R et al. (2018)
    Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
    Lancet, 393 (10168), 253-264
    DOI 10.1016/S0140-6736(18)33003-4, PubMed 30545780
  9. Enden T, Bernklev T, Jelsness-Jorgensen LP, Amdal CD (2018)
    Patients know their own health best
    Tidsskr. Nor. Laegeforen., 138 (8), 716-718
  10. Etscheid M, Subramaniam S, Lochnit G, Zabczyk M, Undas A, Lang IM, Hanschmann KM, Kanse SM (2018)
    Altered structure and function of fibrinogen after cleavage by Factor VII Activating Protease (FSAP)
    Biochim Biophys Acta Mol Basis Dis, 1864 (10), 3397-3406
    DOI 10.1016/j.bbadis.2018.07.030, PubMed 30076961
  11. Fløisand Y, Lazarevic VL, Maertens J, Mattsson J, Shah NN, Zachée P, Taylor A, Akbari M, Quadri S, Parfionovas A, Chen YB (2018)
    Safety and Effectiveness of Vedolizumab in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Retrospective Record Review
    Biol Blood Marrow Transplant, 25 (4), 720-727
    DOI 10.1016/j.bbmt.2018.11.013, PubMed 30468919
  12. Fronas SG, Wik HS, Dahm AEA, Jørgensen CT, Gleditsch J, Raouf N, Klok FA, Ghanima W (2018)
    Safety of D-dimer testing as a stand-alone test for the exclusion of deep vein thrombosis as compared with other strategies
    J Thromb Haemost, 16 (12), 2471-2481
    DOI 10.1111/jth.14314, PubMed 30303610
  13. Gamage TH, Gunnes G, Lee RH, Louch WE, Holmgren A, Bruton JD, Lengle E, Kolstad TRS, Revold T, Amundsen SS, Dalen KT, Holme PA, Tjønnfjord GE, Christensen G, Westerblad H, Klungland A, Bergmeier W, Misceo D, Frengen E (2018)
    STIM1 R304W causes muscle degeneration and impaired platelet activation in mice
    Cell Calcium, 76, 87-100
    DOI 10.1016/j.ceca.2018.10.001, PubMed 30390422
  14. Gravensteen IK, Jacobsen EM, Sandset PM, Helgadottir LB, Rådestad I, Sandvik L, Ekeberg Ø (2018)
    Anxiety, depression and relationship satisfaction in the pregnancy following stillbirth and after the birth of a live-born baby: a prospective study
    BMC Pregnancy Childbirth, 18 (1), 41
    DOI 10.1186/s12884-018-1666-8, PubMed 29361916
  15. Habberstad AH, Tran HTT, Randen U, Spetalen S, Dybedal I, Tjønnfjord GE, Dahm AEA (2018)
    Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report
    J Med Case Rep, 12 (1), 105
    DOI 10.1186/s13256-018-1663-6, PubMed 29685167
  16. Hermansen JU, Tjønnfjord GE, Munthe LA, Taskén K, Skånland SS (2018)
    Cryopreservation of primary B cells minimally influences their signaling responses
    Sci Rep, 8 (1), 17651
    DOI 10.1038/s41598-018-36121-9, PubMed 30518828
  17. Hjorthaug HS, Gervin K, Mowinckel P, Munthe-Kaas MC (2018)
    Exploring the influence from whole blood DNA extraction methods on Infinium 450K DNA methylation
    PLoS One, 13 (12), e0208699
    DOI 10.1371/journal.pone.0208699, PubMed 30540848
  18. Holme PA, Tjønnfjord GE (2018)
    Continuous infusion of simoctocog alfa in haemophilia A patients undergoing surgeries
    Haemophilia, 25 (1), 54-59
    DOI 10.1111/hae.13625, PubMed 30394617
  19. Hope S, Nordstrom M, Retterstol K, Iversen PO, Kolset SO (2018)
    The right to a health promoting diet for people with intellectual disabilities
    Tidsskr. Nor. Laegeforen., 138 (2), 122-123
  20. Kolset SO, Nordstrøm M, Hope S, Retterstøl K, Iversen PO (2018)
    Securing rights and nutritional health for persons with intellectual disabilities - a pressing challenge
    Food Nutr Res, 62
    DOI 10.29219/fnr.v62.1268, PubMed 29899685
  21. Korpela K, Blakstad EW, Moltu SJ, Strømmen K, Nakstad B, Rønnestad AE, Brække K, Iversen PO, Drevon CA, de Vos W (2018)
    Intestinal microbiota development and gestational age in preterm neonates
    Sci Rep, 8 (1), 2453
    DOI 10.1038/s41598-018-20827-x, PubMed 29410448
  22. Kostovski E, Frigato E, Savikj M, Dahm A, Sandset PM, Mowinckel MC, Skretting G, Østerud B, Bertolucci C, Iversen PO (2018)
    Normalization of disrupted clock gene expression in males with tetraplegia: a crossover randomized placebo-controlled trial of melatonin supplementation
    Spinal Cord, 56 (11), 1076-1083
    DOI 10.1038/s41393-018-0176-x, PubMed 29985456
  23. Kverneland M, Molteberg E, Iversen PO, Veierød MB, Taubøll E, Selmer KK, Nakken KO (2018)
    Effect of modified Atkins diet in adults with drug-resistant focal epilepsy: A randomized clinical trial
    Epilepsia, 59 (8), 1567-1576
    DOI 10.1111/epi.14457, PubMed 29901816
  24. Lindgren M, Samuelsson J, Nilsson L, Knutsen H, Ghanima W, Westin J, Johansson PL, Andréasson B (2018)
    Genetic variation in IL28B (IFNL3) and response to interferon-alpha treatment in myeloproliferative neoplasms
    Eur J Haematol, 100 (5), 419-425
    DOI 10.1111/ejh.13034, PubMed 29369421
  25. Lorentino F, Labopin M, Bernardi M, Ciceri F, Socié G, Cornelissen JJ, Esteve J, Ruggeri A, Volin L, Yacoub-Agha I, Craddock C, Passweg J, Blaise D, Gedde-Dahl T, Poiani M, Fegueux N, Mohty M, Nagler A, Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2018)
    Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission
    Am J Hematol, 93 (10), 1236-1244
    DOI 10.1002/ajh.25231, PubMed 30058714
  26. Lundell LS, Savikj M, Kostovski E, Iversen PO, Zierath JR, Krook A, Chibalin AV, Widegren U (2018)
    Protein translation, proteolysis and autophagy in human skeletal muscle atrophy after spinal cord injury
    Acta Physiol (Oxf), 223 (3), e13051
    DOI 10.1111/apha.13051, PubMed 29423932
  27. McLornan DP, Szydlo R, Robin M, van Biezen A, Koster L, Blok HJP, Van Lint MT, Finke J, Vitek A, Carlson K, Griskevicius L, Holler E, Itälä-Remes M, Schaap M, Socié G, Bay JO, Beguin Y, Bruno B, Cornelissen JJ, Gedde-Dahl T, Ljungman P, Rubio MT, Yakoub-Agha I, Klyuchnikov E, Olavarria E et al. (2018)
    Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT
    Br J Haematol, 182 (3), 418-422
    DOI 10.1111/bjh.15407, PubMed 29808926
  28. Muhoozi GKM, Atukunda P, Skaare AB, Willumsen T, Diep LM, Westerberg AC, Iversen PO (2018)
    Effects of nutrition and hygiene education on oral health and growth among toddlers in rural Uganda: follow-up of a cluster-randomised controlled trial
    Trop Med Int Health, 23 (4), 391-404
    DOI 10.1111/tmi.13036, PubMed 29381827
  29. Myhrvold IK, Cremaschi A, Hermansen JU, Tjønnfjord GE, Munthe LA, Taskén K, Skånland SS (2018)
    Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia
    Oncotarget, 9 (10), 9273-9284
    DOI 10.18632/oncotarget.23949, PubMed 29507689
  30. Nahalomo A, Iversen PO, Rukundo PM, Kaaya A, Kikafunda J, Eide WB, Marais M, Wamala E, Kabahenda M (2018)
    Realization of the right to adequate food and the nutritional status of land evictees: a case for mothers/caregivers and their children in rural Central Uganda
    BMC Int Health Hum Rights, 18 (1), 21
    DOI 10.1186/s12914-018-0162-6, PubMed 29793472
  31. Navarro-Fernández J, Eugenia de la Morena-Barrio M, Martínez-Alonso E, Dybedal I, Toderici M, Bohdan N, Miñano A, Heimdal K, Abildgaard U, Martínez-Menárguez JÁ, Corral J, Vicente V (2018)
    Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family
    Oncotarget, 9 (69), 33202-33214
    DOI 10.18632/oncotarget.26059, PubMed 30237862
  32. Nesvold MB, Jensen JL, Hove LH, Singh PB, Young A, Palm Ø, Andersen LF, Carlsen MH, Iversen PO (2018)
    Dietary Intake, Body Composition, and Oral Health Parameters among Female Patients with Primary Sjögren's Syndrome
    Nutrients, 10 (7)
    DOI 10.3390/nu10070866, PubMed 29973575
  33. Ngari MM, Iversen PO, Thitiri J, Mwalekwa L, Timbwa M, Fegan GW, Berkley JA (2018)
    Linear growth following complicated severe malnutrition: 1-year follow-up cohort of Kenyan children
    Arch Dis Child, 104 (3), 229-235
    DOI 10.1136/archdischild-2018-315641, PubMed 30266874
  34. Ngari MM, Mwalekwa L, Timbwa M, Hamid F, Ali R, Iversen PO, Fegan GW, Berkley JA (2018)
    Changes in susceptibility to life-threatening infections after treatment for complicated severe malnutrition in Kenya
    Am J Clin Nutr, 107 (4), 626-634
    DOI 10.1093/ajcn/nqy007, PubMed 29635501
  35. Olsson M, Stanne TM, Pedersen A, Lorentzen E, Kara E, Martinez-Palacian A, Rønnow Sand NP, Jacobsen AF, Sandset PM, Sidelmann JJ, Engström G, Melander O, Kanse SM, Jern C (2018)
    Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity
    J Thromb Haemost, 16 (10), 2024-2034
    DOI 10.1111/jth.14258, PubMed 30070759
  36. Panagopoulos I, Gorunova L, Jacobsen EM, Andersen K, Micci F, Heim S (2018)
    RUNX1-PDCD6 fusion resulting from a novel t(5;21)(p15;q22) chromosome translocation in myelodysplastic syndrome secondary to chronic lymphocytic leukemia
    PLoS One, 13 (4), e0196181
    DOI 10.1371/journal.pone.0196181, PubMed 29672642
  37. Pathak M, Diep PP, Lai X, Brinch L, Ruud E, Drolsum L (2018)
    Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation
    Bone Marrow Transplant, 53 (7), 863-872
    DOI 10.1038/s41409-018-0090-z, PubMed 29382955
  38. Qvigstad C, Tait RC, Rauchensteiner S, Berntorp E, de Moerloose P, Schutgens RE, Holme PA, ADVANCE Working Group (2018)
    The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment
    Medicine (Baltimore), 97 (39), e12551
    DOI 10.1097/MD.0000000000012551, PubMed 30278553
  39. Reikvam H, Skavland J, Gullaksen SE, Hovland R, Gedde-Dahl T, Bruserud Ø, Gjertsen BT (2018)
    Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation
    Case Rep Hematol, 2018, 2045985
    DOI 10.1155/2018/2045985, PubMed 30345125
  40. Reiterer V, Figueras-Puig C, Le Guerroue F, Confalonieri S, Vecchi M, Jalapothu D, Kanse SM, Deshaies RJ, Di Fiore PP, Behrends C, Farhan H (2018)
    The pseudophosphatase STYX targets the F-box of FBXW7 and inhibits SCFFBXW7 function
    EMBO J, 37 (6)
    DOI 10.15252/embj.201899170, PubMed 29545456
  41. Rogne M, Svaerd O, Madsen-Østerbye J, Hashim A, Tjønnfjord GE, Staerk J (2018)
    Cytokinesis arrest and multiple centrosomes in B cell chronic lymphocytic leukaemia
    J Cell Mol Med, 22 (5), 2846-2855
    DOI 10.1111/jcmm.13579, PubMed 29516674
  42. Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Gantenbein AR, Kurth T, Lampl C, Lidegaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Paemeleire K, Sandset PM, Terwindt GM, Vetvik KG, Martelletti P, European Headache Federation (EHF), the European Society of Contraception and Reproductive Health (ESCRH) (2018)
    Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)
    J Headache Pain, 19 (1), 76
    DOI 10.1186/s10194-018-0896-5, PubMed 30171365
  43. Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Kurth T, Lampl C, Lidegaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Sandset PM, Martelletti P, European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC) (2018)
    Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
    J Headache Pain, 19 (1), 81
    DOI 10.1186/s10194-018-0912-9, PubMed 30203397
  44. Savikj M, Ruby MA, Kostovski E, Iversen PO, Zierath JR, Krook A, Widegren U (2018)
    Retained differentiation capacity of human skeletal muscle satellite cells from spinal cord-injured individuals
    Physiol Rep, 6 (12), e13739
    DOI 10.14814/phy2.13739, PubMed 29906337
  45. Schultz NH, Holme PA, Bjørnsen S, Henriksson CE, Sandset PM, Jacobsen EM (2018)
    The impact of rivaroxaban on primary hemostasis in patients with venous thrombosis
    Platelets, 1-5 (in press)
    DOI 10.1080/09537104.2018.1557618, PubMed 30569801
  46. Schultz NH, Lundblad R, Holme PA (2018)
    Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series
    J Med Case Rep, 12 (1), 138
    DOI 10.1186/s13256-018-1660-9, PubMed 29764497
  47. Schwab C, Gabrysch A, Olbrich P, Patiño V, Warnatz K, Wolff D, Hoshino A, Kobayashi M, Imai K, Takagi M, Dybedal I, Haddock JA, Sansom DM, Lucena JM, Seidl M, Schmitt-Graeff A, Reiser V, Emmerich F, Frede N, Bulashevska A, Salzer U, Schubert D, Hayakawa S, Okada S, Kanariou M et al. (2018)
    Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects
    J Allergy Clin Immunol, 142 (6), 1932-1946
    DOI 10.1016/j.jaci.2018.02.055, PubMed 29729943
  48. Shapiro AD, Nakar C, Parker JM, Albert GR, Moran JE, Thibaudeau K, Thukral N, Hardesty BM, Laurin P, Sandset PM (2018)
    Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency
    Blood, 131 (12), 1301-1310
    DOI 10.1182/blood-2017-09-806729, PubMed 29321155
  49. Sioud M, Westby P, Vasovic V, Fløisand Y, Peng Q (2018)
    Development of a new high-affinity human antibody with antitumor activity against solid and blood malignancies
    FASEB J, 32 (9), 5063-5077
    DOI 10.1096/fj.201701544R, PubMed 29913558
  50. Skaarud KJ, Hjermstad MJ, Bye A, Veierød MB, Gudmundstuen AM, Lundin KEA, Distante S, Brinch L, Tjønnfjord GE, Iversen PO (2018)
    Effects of individualized nutrition after allogeneic hematopoietic stem cell transplantation following myeloablative conditioning; a randomized controlled trial
    Clin Nutr ESPEN, 28, 59-66
    DOI 10.1016/j.clnesp.2018.08.002, PubMed 30390894
  51. Subramaniam S, Kanse SM, Kothari H, Reinhardt C, Fletcher C (2018)
    Post-transcriptional, post-translational and pharmacological regulation of tissue factor pathway inhibitor
    Blood Coagul Fibrinolysis, 29 (8), 668-682
    DOI 10.1097/MBC.0000000000000775, PubMed 30439766
  52. Tangen JM, Tjønnfjord GE, Gulbrandsen N, Gedde-Dahl T, Stormorken E, Anderson K, Vo CD, Schjesvold FH, For Oslo Myeloma Center (2018)
    Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001-2010: a retrospective, population based analysis
    BMC Cancer, 18 (1), 801
    DOI 10.1186/s12885-018-4722-x, PubMed 30089450
  53. Tavoly M, Wik HS, Sirnes PA, Jelsness-Jørgensen LP, Ghanima JP, Klok FA, Sandset PM, Ghanima W (2018)
    The impact of post-pulmonary embolism syndrome and its possible determinants
    Thromb Res, 171, 84-91
    DOI 10.1016/j.thromres.2018.09.048, PubMed 30267974
  54. Tinholt M, Garred Ø, Borgen E, Beraki E, Schlichting E, Kristensen V, Sahlberg KK, Iversen N (2018)
    Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study
    J Thromb Haemost, 16 (7), 1347-1356
    DOI 10.1111/jth.14151, PubMed 29766637
  55. Tulstrup M, Grosjean M, Nielsen SN, Grell K, Wolthers BO, Wegener PS, Jonsson OG, Lund B, Harila-Saari A, Abrahamsson J, Vaitkeviciene G, Pruunsild K, Toft N, Holm M, Hulegårdh E, Liestøl S, Griskevicius L, Punab M, Wang J, Carroll WL, Zhang Z, Dalgaard MD, Gupta R, Nersting J, Schmiegelow K (2018)
    NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia
    Leukemia, 32 (12), 2527-2535
    DOI 10.1038/s41375-018-0245-3, PubMed 30201983
  56. Utne KK, Dahm A, Wik HS, Jelsness-Jørgensen LP, Sandset PM, Ghanima W (2018)
    Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome
    Thromb Res, 163, 6-11
    DOI 10.1016/j.thromres.2018.01.013, PubMed 29324334
  57. Zhang B, Durán PA, Piechaczyk L, Fløisand Y, Safont MMS, Karlsen IT, Fandalyuk Z, Tadele D, Mierlo PV, Rowe AD, Robertson JM, Gjertsen BT, McCormack E, Enserink JM, Bjørn Tore Gjertsen Group, Emmet McCormack Group (2018)
    GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells
    Haematologica (in press)
    DOI 10.3324/haematol.2018.189399, PubMed 29748445

Publications 2017

  1. Andresen MS, Ali HO, Myklebust CF, Sandset PM, Stavik B, Iversen N, Skretting G (2017)
    Estrogen induced expression of tissue factor pathway inhibitor-2 in MCF7 cells involves lysine-specific demethylase 1
    Mol Cell Endocrinol, 443, 80-88
    DOI 10.1016/j.mce.2017.01.016, PubMed 28088469
  2. Berentsen S, Randen U, Oksman M, Birgens H, Tvedt THA, Dalgaard J, Galteland E, Haukås E, Brudevold R, Sørbø JH, Næss IA, Malecka A, Tjønnfjord GE (2017)
    Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial
    Blood, 130 (4), 537-541
    DOI 10.1182/blood-2017-04-778175, PubMed 28533306
  3. Berntorp E, Dargaud Y, Hart D, Lobet S, Mancuso ME, d'Oiron R, Perry D, Pollard D, van den Berg M, Blatný J, Chambost H, Doria AS, Holme PA, Kaczmarek R, Mantovani L, McLaughlin P, Nanayakkara L, Petrini P, Sannié T, Laane E, Maia R, Dettoraki A, Farrell A, Halimeh S, Raza S et al. (2017)
    The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany
    Eur J Haematol, 98 Suppl 85, 1-15
    DOI 10.1111/ejh.12828, PubMed 28101938
  4. Byskov K, Boettger T, Ruehle PF, Nielsen NV, Etscheid M, Kanse SM (2017)
    Factor VII activating protease (FSAP) regulates the expression of inflammatory genes in vascular smooth muscle and endothelial cells
    Atherosclerosis, 265, 133-139
    DOI 10.1016/j.atherosclerosis.2017.08.029, PubMed 28881271
  5. Canaani J, Beohou E, Labopin M, Socié G, Huynh A, Volin L, Cornelissen J, Milpied N, Gedde-Dahl T, Deconinck E, Fegueux N, Blaise D, Mohty M, Nagler A (2017)
    Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT
    Am J Hematol, 92 (4), 344-350
    DOI 10.1002/ajh.24640, PubMed 28052366
  6. Canaani J, Labopin M, Socie G, Nihtinen A, Huynh A, Cornelissen J, Deconinck E, Gedde-Dahl T, Forcade E, Chevallier P, Bourhis JH, Blaise D, Mohty M, Nagler A (2017)
    Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT
    Am. J. Hematol., 92 (7), 653-659
  7. Chollet ME, Andersen E, Skarpen E, Myklebust CF, Koehler C, Morth JP, Chuansumrit A, Pinotti M, Bernardi F, Thiede B, Sandset PM, Skretting G (2017)
    Factor VII deficiency: Unveiling the cellular and molecular mechanisms underlying three model alterations of the enzyme catalytic domain
    Biochim Biophys Acta Mol Basis Dis, 1864 (3), 660-667
    DOI 10.1016/j.bbadis.2017.12.016, PubMed 29246447
  8. Cui XY, Skretting G, Tinholt M, Stavik B, Dahm AEA, Sahlberg KK, Kanse S, Iversen N, Sandset PM (2017)
    A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7
    Thromb Res, 157, 111-116
    DOI 10.1016/j.thromres.2017.07.013, PubMed 28734156
  9. Espada S, Stavik B, Holm S, Sagen EL, Bjerkeli V, Skjelland M, Dahl TB, Espevik T, Kanse S, Sandset PM, Skretting G, Halvorsen B (2017)
    Tissue factor pathway inhibitor attenuates ER stress-induced inflammation in human M2-polarized macrophages
    Biochem Biophys Res Commun, 491 (2), 442-448
    DOI 10.1016/j.bbrc.2017.07.070, PubMed 28712870
  10. Garabet L, Ghanima W, Monceyron Jonassen C, Skov V, Holst R, Mowinckel MC, C Hasselbalch H, A Kruse T, Thomassen M, Liebman H, Bussel JB, Sandset PM (2017)
    Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia
    Platelets, 30 (2), 206-212
    DOI 10.1080/09537104.2017.1394451, PubMed 29215956
  11. Ghanima W, Wik HS, Tavoly M, Enden T, Jelsness-Jørgensen LP (2017)
    Late consequences of venous thromboembolism: Measuring quality of life after deep vein thrombosis and pulmonary embolism
    Thromb Res, 164, 170-176
    DOI 10.1016/j.thromres.2017.07.025, PubMed 28760416
  12. Gjevestad GO, Ottestad I, Biong AS, Iversen PO, Retterstøl K, Raastad T, Skålhegg BS, Ulven SM, Holven KB (2017)
    Consumption of protein-enriched milk has minor effects on inflammation in older adults-A 12-week double-blind randomized controlled trial
    Mech Ageing Dev, 162, 1-8
    DOI 10.1016/j.mad.2017.01.011, PubMed 28163108
  13. Grasso S, Neumann A, Lang IM, Etscheid M, von Köckritz-Blickwede M, Kanse SM (2017)
    Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs)
    Thromb Res, 161, 36-42
    DOI 10.1016/j.thromres.2017.11.012, PubMed 29178989
  14. Gravensteen IK (2017)
    Author's reply re: Healthcare utilisation, induced labour and caesarean section in the pregnancy after stillbirth: a prospective study
    BJOG, 125 (1), 92
    DOI 10.1111/1471-0528.14787, PubMed 28791796
  15. Gravensteen IK, Jacobsen EM, Sandset PM, Helgadottir LB, Rådestad I, Sandvik L, Ekeberg Ø (2017)
    Healthcare utilisation, induced labour and caesarean section in the pregnancy after stillbirth: a prospective study
    BJOG, 125 (2), 202-210
    DOI 10.1111/1471-0528.14750, PubMed 28516500
  16. Gullaksen SE, Skavland J, Gavasso S, Tosevski V, Warzocha K, Dumrese C, Ferrant A, Gedde-Dahl T, Hellmann A, Janssen J, Labar B, Lang A, Majeed W, Mihaylov G, Stentoft J, Stenke L, Thaler J, Thielen N, Verhoef G, Voglova J, Ossenkoppele G, Hochhaus A, Hjorth-Hansen H, Mustjoki S, Sopper S et al. (2017)
    Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib
    Haematologica, 102 (8), 1361-1367
    DOI 10.3324/haematol.2017.167080, PubMed 28522574
  17. Gustavsen A, Skattum L, Bergseth G, Lorentzen B, Floisand Y, Bosnes V, Mollnes TE, Barratt-Due A (2017)
    Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome: A case report
    Medicine (Baltimore), 96 (11), e6338
    DOI 10.1097/MD.0000000000006338, PubMed 28296762
  18. Herold J, Nowak S, Kostin S, Daniel JM, Francke A, Subramaniam S, Braun-Dullaeus RC, Kanse SM (2017)
    Factor VII activating protease (FSAP) influences vascular remodeling in the mouse hind limb ischemia model
    Am J Transl Res, 9 (6), 3084-3095
    PubMed 28670395
  19. Holme PA, Tjønnfjord GE, Batorova A (2017)
    Continuous infusion of coagulation factor concentrates during intensive treatment
    Haemophilia, 24 (1), 24-32
    DOI 10.1111/hae.13331, PubMed 28873263
  20. Johannsdottir IM, Loge JH, Kiserud CE, Karlstad Ø, Skurtveit S (2017)
    Increased prescription rates of anxiolytics and hypnotics to survivors of cancer in childhood, adolescence, and young adulthood-A population-based study
    Pediatr Blood Cancer, 65 (2)
    DOI 10.1002/pbc.26860, PubMed 29077266
  21. Klohe K, Prazeres da Costa C, Lien N, Holmboe-Ottesen G, Rychlik M, Haavardsson I, Stordalen G, Singh S, Engebretsen I, Iversen PO, Winkler AS (2017)
    Nutrition – A global challenge for health
    Tidsskr Nor Laegeforen, 137 (23-24)
    DOI 10.4045/tidsskr.17.0679, PubMed 29231665
  22. Komperød MJ, Sommer C, Mellin-Olsen T, Iversen PO, Røseth AG, Valeur J (2017)
    Persistent symptoms in patients with Crohn's disease in remission: An exploratory study on the role of diet
    Scand J Gastroenterol, 53 (5), 573-578
    DOI 10.1080/00365521.2017.1397736, PubMed 29168412
  23. Krishnan K, Jusufovic M, Sandset PM, Sandset EC (2017)
    Antiplatelet Therapy in Noncardioembolic Stroke: A Review of Current Evidence
    Semin Neurol, 37 (3), 366-375
    DOI 10.1055/s-0037-1603469, PubMed 28759917
  24. Lazarevic VL, Labopin M, Depei W, Yakoub-Agha I, Huynh A, Ljungman P, Schaap N, Cornelissen JJ, Maillard N, Pioltelli P, Gedde-Dahl T, Lenhoff S, Houhou M, Esteve J, Mohty M, Nagler A (2017)
    Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)
    Am J Hematol, 93 (1), 31-39
    DOI 10.1002/ajh.24928, PubMed 28971504
  25. Małecka A, Trøen G, Tierens A, Østlie I, Małecki J, Randen U, Wang J, Berentsen S, Tjønnfjord GE, Delabie JMA (2017)
    Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease
    Br J Haematol, 183 (5), 838-842
    DOI 10.1111/bjh.15063, PubMed 29265349
  26. Muhoozi GKM, Atukunda P, Diep LM, Mwadime R, Kaaya AN, Skaare AB, Willumsen T, Westerberg AC, Iversen PO (2017)
    Nutrition, hygiene, and stimulation education to improve growth, cognitive, language, and motor development among infants in Uganda: A cluster-randomized trial
    Matern Child Nutr, 14 (2), e12527
    DOI 10.1111/mcn.12527, PubMed 28925580
  27. Ngari MM, Thitiri J, Mwalekwa L, Timbwa M, Iversen PO, Fegan GW, Berkley JA (2017)
    The impact of rickets on growth and morbidity during recovery among children with complicated severe acute malnutrition in Kenya: A cohort study
    Matern Child Nutr, 14 (2), e12569
    DOI 10.1111/mcn.12569, PubMed 29178404
  28. Olsen MB, Hildrestrand GA, Scheffler K, Vinge LE, Alfsnes K, Palibrk V, Wang J, Neurauter CG, Luna L, Johansen J, Øgaard JDS, Ohm IK, Slupphaug G, Kuśnierczyk A, Fiane AE, Brorson SH, Zhang L, Gullestad L, Louch WE, Iversen PO, Østlie I, Klungland A, Christensen G, Sjaastad I, Sætrom P et al. (2017)
    NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial Rupture
    Cell Rep, 18 (1), 82-92
    DOI 10.1016/j.celrep.2016.12.009, PubMed 28052262
  29. Osooli M, Steen Carlsson K, Baghaei F, Holmström M, Rauchensteiner S, Holme PA, Hvitfeldt L, Astermark J, Berntorp E (2017)
    The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register
    Haemophilia, 23 (3), e180-e187
    DOI 10.1111/hae.13231, PubMed 28393468
  30. Ottestad I, Løvstad AT, Gjevestad GO, Hamarsland H, Šaltytė Benth J, Andersen LF, Bye A, Biong AS, Retterstøl K, Iversen PO, Raastad T, Ulven SM, Holven KB (2017)
    Intake of a Protein-Enriched Milk and Effects on Muscle Mass and Strength. A 12-Week Randomized Placebo Controlled Trial among Community-Dwelling Older Adults
    J Nutr Health Aging, 21 (10), 1160-1169
    DOI 10.1007/s12603-016-0856-1, PubMed 29188875
  31. Pahnke S, Larfors G, Axdorph-Nygell U, Fischer-Nielsen A, Haastrup E, Heldal D, Itälä-Remes M, Johansson JE, Kauppila M, Lenhoff S, Ljungman P, Niittyvuopio R, Sandstedt A, Hägglund H (2017)
    Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors
    J Clin Apher, 33 (3), 226-235
    DOI 10.1002/jca.21576, PubMed 28833474
  32. Panagopoulos I, Gorunova L, Torkildsen S, Tierens A, Heim S, Micci F (2017)
    FAM53B truncation caused by t(10;19)(q26;q13) chromosome translocation in acute lymphoblastic leukemia
    Oncol Lett, 13 (4), 2216-2220
    DOI 10.3892/ol.2017.5705, PubMed 28454383
  33. Panagopoulos I, Gorunova L, Torkildsen S, Tjønnfjord GE, Micci F, Heim S (2017)
    DEK-NUP214-Fusion Identified by RNA-Sequencing of an Acute Myeloid Leukemia with t(9;12)(q34;q15)
    Cancer Genomics Proteomics, 14 (6), 437-443
    DOI 10.21873/cgp.20053, PubMed 29109093
  34. Prebensen C, Trøseid M, Ueland T, Dahm A, Sandset PM, Aaberge I, Waalen K, Dyrhol-Riise AM, Taskén K, Kvale D (2017)
    Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
    PLoS One, 12 (5), e0176527
    DOI 10.1371/journal.pone.0176527, PubMed 28464042
  35. Retterstøl K, Narverud I, Selmer R, Berge KE, Osnes IV, Ulven SM, Halvorsen B, Aukrust P, Holven KB, Iversen PO (2017)
    Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics
    Lipids Health Dis, 16 (1), 115
    DOI 10.1186/s12944-017-0511-9, PubMed 28606150
  36. Ringdén O, Labopin M, Sadeghi B, Mailhol A, Beelen D, Fløisand Y, Ghavamzadeh A, Finke J, Ehninger G, Volin L, Socié G, Kröger N, Stuhler G, Ganser A, Schmid C, Giebel S, Mohty M, Nagler A (2017)
    What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?
    J Intern Med, 283 (2), 166-177
    DOI 10.1111/joim.12695, PubMed 29027756
  37. Robin M, Porcher R, Zinke-Cerwenka W, van Biezen A, Volin L, Mufti G, Craddock C, Finke J, Richard C, Passweg J, Peniket A, Maertens J, Sucak G, Gedde-Dahl T, Vitek A, Nagler A, Blaise D, Beelen D, Maillard N, Schwerdtfeger R, de Witte T, Kroger N (2017)
    Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
    Bone Marrow Transplant, 52 (7), 1081
    DOI 10.1038/bmt.2017.86, PubMed 28677682
  38. Rørholt M, Ghanima W, Farkas DK, Nørgaard M (2017)
    Risk of cardiovascular events and pulmonary hypertension following splenectomy - a Danish population-based cohort study from 1996-2012
    Haematologica, 102 (8), 1333-1341
    DOI 10.3324/haematol.2016.157008, PubMed 28572164
  39. Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Kurth T, Lampl C, Lidegaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Sandset PM, Martelletti P, European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC) (2017)
    Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
    J Headache Pain, 18 (1), 108
    DOI 10.1186/s10194-017-0815-1, PubMed 29086160
  40. Sagedal S, Sandvik L, Klingenberg O, Sandset PM (2017)
    β-Thromboglobulin may not reflect platelet activation during haemodialysis with the HeprAN membrane
    Scand J Clin Lab Invest, 77 (8), 679-684
    DOI 10.1080/00365513.2017.1397288, PubMed 29117741
  41. Schultz NH, Tran HTT, Bjørnsen S, Henriksson CE, Sandset PM, Holme PA (2017)
    The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
    Thromb J, 15, 6
    DOI 10.1186/s12959-017-0129-1, PubMed 28239301
  42. Schultz NH, Tran HTT, Bjørnsen S, Henriksson CE, Sandset PM, Holme PA (2017)
    The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII in apixaban-treated patients in vitro
    Res Pract Thromb Haemost, 1 (1), 49-56
    DOI 10.1002/rth2.12015, PubMed 30046673
  43. Server A, Bargalló N, Fløisand Y, Sponheim J, Graus F, Hald JK (2017)
    Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation
    Neuroradiology, 59 (2), 105-126
    DOI 10.1007/s00234-017-1804-4, PubMed 28255902
  44. Slack J, Albert MH, Balashov D, Belohradsky BH, Bertaina A, Bleesing J, Booth C, Buechner J, Buckley RH, Ouachée-Chardin M, Deripapa E, Drabko K, Eapen M, Feuchtinger T, Finocchi A, Gaspar HB, Ghosh S, Gillio A, Gonzalez-Granado LI, Grunebaum E, Güngör T, Heilmann C, Helminen M, Higuchi K, Imai K et al. (2017)
    Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders
    J Allergy Clin Immunol, 141 (1), 322-328.e10
    DOI 10.1016/j.jaci.2017.02.036, PubMed 28392333
  45. Sperling C, Maitz MF, Grasso S, Werner C, Kanse SM (2017)
    A Positively Charged Surface Triggers Coagulation Activation Through Factor VII Activating Protease (FSAP)
    ACS Appl Mater Interfaces, 9 (46), 40107-40116
    DOI 10.1021/acsami.7b14281, PubMed 29091393
  46. Stavik B, Holm S, Espada S, Iversen N, Sporsheim B, Bjerkeli V, Dahl TB, Sandset PM, Skjelland M, Espevik T, Skretting G, Halvorsen B (2017)
    Increased expression of TFPI in human carotid stenosis
    Thromb Res, 155, 31-37
    DOI 10.1016/j.thromres.2017.04.024, PubMed 28482260
  47. Steffensen IL, Frølich W, Dahl KH, Iversen PO, Lyche JL, Lillegaard ITL, Alexander J (2017)
    Benefit and risk assessment of increasing potassium intake by replacement of sodium chloride with potassium chloride in industrial food products in Norway
    Food Chem Toxicol, 111, 329-340
    DOI 10.1016/j.fct.2017.11.044, PubMed 29175183
  48. Strømmen K, Haag A, Moltu SJ, Veierød MB, Blakstad EW, Nakstad B, Almaas AN, Brække K, Rønnestad AE, Daniel H, Drevon CA, Iversen PO (2017)
    Enhanced nutrient supply to very low birth weight infants is associated with higher blood amino acid concentrations and improved growth
    Clin Nutr ESPEN, 18, 16-22
    DOI 10.1016/j.clnesp.2017.01.003, PubMed 29132733
  49. Tikkinen KAO, Craigie S, Agarwal A, Siemieniuk RAC, Cartwright R, Violette PD, Novara G, Naspro R, Agbassi C, Ali B, Imam M, Ismaila N, Kam D, Gould MK, Sandset PM, Guyatt GH (2017)
    Procedure-specific Risks of Thrombosis and Bleeding in Urological Non-cancer Surgery: Systematic Review and Meta-analysis
    Eur Urol, 73 (2), 236-241
    DOI 10.1016/j.eururo.2017.02.025, PubMed 28284738
  50. Tikkinen KAO, Craigie S, Agarwal A, Violette PD, Novara G, Cartwright R, Naspro R, Siemieniuk RAC, Ali B, Eryuzlu L, Geraci J, Winkup J, Yoo D, Gould MK, Sandset PM, Guyatt GH (2017)
    Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis
    Eur Urol, 73 (2), 242-251
    DOI 10.1016/j.eururo.2017.03.008, PubMed 28342641
  51. Tjønnfjord E, Vengen ØA, Berentsen S, Tjønnfjord GE (2017)
    Prophylactic use of eculizumab during surgery in chronic cold agglutinin disease
    BMJ Case Rep, 2017
    DOI 10.1136/bcr-2016-219066, PubMed 28487302
  52. Torkildsen S, Brunetti M, Gorunova L, Spetalen S, Beiske K, Heim S, Panagopoulos I (2017)
    Rearrangement of the Chromatin Organizer Special AT-rich Binding Protein 1 Gene, SATB1, Resulting from a t(3;5)(p24;q14) Chromosomal Translocation in Acute Myeloid Leukemia
    Anticancer Res, 37 (2), 693-698
    DOI 10.21873/anticanres.11365, PubMed 28179318
  53. Vojdeman FJ, Herman SEM, Kirkby N, Wiestner A, van T' Veer MB, Tjønnfjord GE, Itälä-Remes MA, Kimby E, Farooqui MZ, Polliack A, Wu KL, Doorduijn JK, Alemayehu WG, Wittebol S, Kozak T, Walewski J, Abrahamse-Testroote MCJ, van Oers MHJ, Geisler CH, Niemann CU (2017)
    Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia
    Leuk Lymphoma, 58 (10), 2356-2362
    DOI 10.1080/10428194.2017.1285027, PubMed 28278728
  54. Wang D, Fløisand Y, Myklebust CV, Bürgler S, Parente-Ribes A, Hofgaard PO, Bogen B, Taskén K, Tjønnfjord GE, Schjesvold F, Dalgaard J, Tveita A, Munthe LA (2017)
    Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice
    Leukemia, 31 (10), 2114-2121
    DOI 10.1038/leu.2017.69, PubMed 28232741
  55. Wik HS, Enden TR, Ghanima W, Engeseth M, Kahn SR, Sandset PM (2017)
    Diagnostic scales for the post-thrombotic syndrome
    Thromb Res, 164, 110-115
    DOI 10.1016/j.thromres.2017.10.022, PubMed 29126608
  56. Wik HS, Ghanima W, Sandset PM, Kahn SR (2017)
    Scoring Systems for Postthrombotic Syndrome
    Semin Thromb Hemost, 43 (5), 500-504
    DOI 10.1055/s-0037-1599142, PubMed 28470653

Publications 2016

  1. Ali HO, Arroyo AB, González-Conejero R, Stavik B, Iversen N, Sandset PM, Martínez C, Skretting G (2016)
    The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulation of tissue factor pathway inhibitor α
    J Thromb Haemost, 14 (6), 1226-37
    DOI 10.1111/jth.13321, PubMed 26999003
  2. Ali HO, Stavik B, Myklebust CF, Andersen E, Dahm AE, Iversen N, Sandset PM, Skretting G (2016)
    Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5'-Flanking Region
    PLoS One, 11 (3), e0152114
    DOI 10.1371/journal.pone.0152114, PubMed 26999742
  3. Barratt-Due A, Fløisand Y, Orrem HL, Kvam AK, Holme PA, Bergseth G, Tjønnfjord GE, Mollnes TE (2016)
    Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
    Rheumatology (Oxford), 55 (7), 1337-9
    DOI 10.1093/rheumatology/kew040, PubMed 27105662
  4. Bates SM, Alonso-Coello P, Tikkinen KA, Ebrahim S, Lopes LC, McDonald SD, Zhou Q, Akl EA, Neumann I, Jacobsen AF, Zhang Y, Santamaría A, Annichino-Bizzacchi JM, Sandset PM, Bitar W, Eckman MH, Guyatt GH (2016)
    Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview
    Thromb Res, 140, 22-9
    DOI 10.1016/j.thromres.2015.12.015, PubMed 27500301
  5. Berger K, Schopohl D, Lowe G, Holme PA, Tait RC, Combescure C, Rauchensteiner S, Klamroth R (2016)
    How to compare cardiovascular disease and risk factors in elderly patients with haemophilia with the general population
    Haemophilia, 22 (5), e406-16
    DOI 10.1111/hae.13069, PubMed 27650262
  6. Biegstraaten M, Cox TM, Belmatoug N, Berger MG, Collin-Histed T, Vom Dahl S, Di Rocco M, Fraga C, Giona F, Giraldo P, Hasanhodzic M, Hughes DA, Iversen PO, Kiewiet AI, Lukina E, Machaczka M, Marinakis T, Mengel E, Pastores GM, Plöckinger U, Rosenbaum H, Serratrice C, Symeonidis A, Szer J, Timmerman J et al. (2016)
    Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease
    Blood Cells Mol Dis, 68, 203-208
    DOI 10.1016/j.bcmd.2016.10.008, PubMed 28274788
  7. Bleker SM, Buchmüller A, Chauleur C, Ní Áinle F, Donnelly J, Verhamme P, Jacobsen AF, Ganzevoort W, Prins M, Beyer-Westendorf J, DeSancho M, Konstantinides S, Pabinger I, Rodger M, Decousus H, Middeldorp S (2016)
    Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses
    Thromb Res, 144, 62-8
    DOI 10.1016/j.thromres.2016.06.001, PubMed 27289488
  8. Broesby-Olsen S, Dybedal I, Gülen T, Kristensen TK, Møller MB, Ackermann L, Sääf M, Karlsson MA, Agertoft L, Brixen K, Hermann P, Stylianou E, Mortz CG, Torfing T, Havelund T, Sander B, Bergström A, Bendix M, Garvey LH, Bjerrum OW, Valent P, Bindslev-Jensen C, Nilsson G, Vestergaard H, Hägglund H (2016)
    Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus
    Acta Derm Venereol, 96 (5), 602-12
    DOI 10.2340/00015555-2325, PubMed 26694951
  9. Bustamante A, Díaz-Fernández B, Giralt D, Boned S, Pagola J, Molina CA, García-Berrocoso T, Kanse SM, Montaner J (2016)
    Factor seven activating protease (FSAP) predicts response to intravenous thrombolysis in acute ischemic stroke
    Int J Stroke, 11 (6), 646-55
    DOI 10.1177/1747493016641949, PubMed 27073188
  10. Bye A, Wesseltoft-Rao N, Iversen PO, Skjegstad G, Holven KB, Ulven S, Hjermstad MJ (2016)
    Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer
    Med Oncol, 33 (6), 54
    DOI 10.1007/s12032-016-0768-2, PubMed 27119533
  11. Cui XY, Tinholt M, Stavik B, Dahm AE, Kanse S, Jin Y, Seidl S, Sahlberg KK, Iversen N, Skretting G, Sandset PM (2016)
    Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer
    J Thromb Haemost, 14 (2), 387-96
    DOI 10.1111/jth.13206, PubMed 26598923
  12. Daniel JM, Reichel CA, Schmidt-Woell T, Dutzmann J, Zuchtriegel G, Krombach F, Herold J, Bauersachs J, Sedding DG, Kanse SM (2016)
    Factor VII-activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation
    J Thromb Haemost, 14 (10), 2058-2067
    DOI 10.1111/jth.13417, PubMed 27431088
  13. Fløisand Y, Lundin KEA, Lazarevic V, Kristiansen JD, Osnes LTN, Tjønnfjord GE, Reims HM, Gedde-Dahl T (2016)
    Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease
    Biol Blood Marrow Transplant, 23 (1), 172-175
    DOI 10.1016/j.bbmt.2016.10.009, PubMed 27777142
  14. Garabet L, Gilboe IM, Mowinckel MC, Jacobsen AF, Mollnes TE, Sandset PM, Jacobsen EM (2016)
    Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus
    Scand J Immunol, 84 (2), 95-9
    DOI 10.1111/sji.12445, PubMed 27135178
  15. Gervin K, Andreassen BK, Hjorthaug HS, Carlsen KCL, Carlsen KH, Undlien DE, Lyle R, Munthe-Kaas MC (2016)
    Intra-individual changes in DNA methylation not mediated by cell-type composition are correlated with aging during childhood
    Clin Epigenetics, 8, 110
    DOI 10.1186/s13148-016-0277-3, PubMed 27785156
  16. Haig Y, Enden T, Grøtta O, Kløw NE, Slagsvold CE, Ghanima W, Sandvik L, Hafsahl G, Holme PA, Holmen LO, Njaaastad AM, Sandbæk G, Sandset PM, CaVenT Study Group (2016)
    Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial
    Lancet Haematol, 3 (2), e64-71
    DOI 10.1016/S2352-3026(15)00248-3, PubMed 26853645
  17. Hjorth-Hansen H, Stentoft J, Richter J, Koskenvesa P, Höglund M, Dreimane A, Porkka K, Gedde-Dahl T, Gjertsen BT, Gruber FX, Stenke L, Eriksson KM, Markevärn B, Lübking A, Vestergaard H, Udby L, Bjerrum OW, Persson I, Mustjoki S, Olsson-Strömberg U (2016)
    Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients
    Leukemia, 30 (9), 1853-60
    DOI 10.1038/leu.2016.121, PubMed 27133821
  18. Holstein K, Batorova A, Carvalho M, Fijnvandraat K, Holme P, Kavakli K, Lambert T, Rocino A, Jiménez-Yuste V, Astermark J, European Haemophilia Therapy Strategy Board (EHTSB) (2016)
    Current view and outcome of ITI therapy - A change over time?
    Thromb Res, 148, 38-44
    DOI 10.1016/j.thromres.2016.10.015, PubMed 27770665
  19. Ilander M, Olsson-Strömberg U, Schlums H, Guilhot J, Brück O, Lähteenmäki H, Kasanen T, Koskenvesa P, Söderlund S, Höglund M, Markevärn B, Själander A, Lotfi K, Dreimane A, Lübking A, Holm E, Björeman M, Lehmann S, Stenke L, Ohm L, Gedde-Dahl T, Majeed W, Ehrencrona H, Koskela S, Saussele S et al. (2016)
    Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
    Leukemia, 31 (5), 1108-1116
    DOI 10.1038/leu.2016.360, PubMed 27890936
  20. James PD, Mahlangu J, Bidlingmaier C, Mingot-Castellano ME, Chitlur M, Fogarty PF, Cuker A, Mancuso ME, Holme PA, Grabell J, Satkunam N, Hopman WM, Mathew P, Global Emerging HEmostasis Experts Panel (GEHEP) (2016)
    Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study
    Haemophilia, 22 (6), 912-918
    DOI 10.1111/hae.13089, PubMed 27868369
  21. Johannsdottir IM, Karlstad Ø, Loge JH, Fosså SD, Kiserud C, Skurtveit S (2016)
    Prescriptions of Antidepressants to Survivors of Cancer in Childhood, Adolescence, and Young Adulthood: A Population-Based Study
    J Adolesc Young Adult Oncol, 6 (1), 120-126
    DOI 10.1089/jayao.2016.0041, PubMed 27841952
  22. Junge G, Machein U (2016)
    Comment on: Real-life effectiveness of canakinumab in cryoprin-associated periodic syndrome
    Rheumatology (Oxford), 55 (7), 1340-1
    DOI 10.1093/rheumatology/kew234, PubMed 27190226
  23. Kaur P, Bergrem A, Gerlyng P, Reims HM, Leh S, Valeur J (2016)
    A methadone user with anaemia, skeletal pain and altered appearance
    Tidsskr Nor Laegeforen, 136 (10), 925-9
    DOI 10.4045/tidsskr.15.0692, PubMed 27272371
  24. Koenecke C, Heim D, van Biezen A, Heuser M, Aljurf M, Kyrcz-Krzemien S, Volin L, de Souza CA, Gedde-Dahl T, Sengeloev H, Schanz U, Komarnicki M, Arroyo CH, Tholouli E, Gluckman E, Esquirol A, Yakoub-Agha I, Gürman G, Olavarria E, Kröger N (2016)
    Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party
    Bone Marrow Transplant, 51 (9), 1259-61
    DOI 10.1038/bmt.2016.97, PubMed 27111041
  25. Kontro M, Kumar A, Majumder MM, Eldfors S, Parsons A, Pemovska T, Saarela J, Yadav B, Malani D, Fløisand Y, Höglund M, Remes K, Gjertsen BT, Kallioniemi O, Wennerberg K, Heckman CA, Porkka K (2016)
    HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia
    Leukemia, 31 (2), 301-309
    DOI 10.1038/leu.2016.222, PubMed 27499136
  26. Leiting S, Seidl S, Martinez-Palacian A, Muhl L, Kanse SM (2016)
    Transforming Growth Factor-β (TGF-β) Inhibits the Expression of Factor VII-activating Protease (FSAP) in Hepatocytes
    J Biol Chem, 291 (40), 21020-21028
    DOI 10.1074/jbc.M116.744631, PubMed 27462075
  27. Lenartova A, Johannesen TB, Tjønnfjord GE (2016)
    National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953-2012: a systematic analysis of population-based data
    Cancer Med, 5 (12), 3588-3595
    DOI 10.1002/cam4.849, PubMed 27925456
  28. Małecka A, Trøen G, Tierens A, Østlie I, Małecki J, Randen U, Berentsen S, Tjønnfjord GE, Delabie JM (2016)
    Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity
    Haematologica, 101 (9), e361-4
    DOI 10.3324/haematol.2016.146126, PubMed 27198717
  29. Martin K, Beyer-Westendorf J, Davidson BL, Huisman MV, Sandset PM, Moll S (2016)
    Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
    J Thromb Haemost, 14 (6), 1308-13
    DOI 10.1111/jth.13323, PubMed 27299806
  30. Muhoozi GK, Atukunda P, Mwadime R, Iversen PO, Westerberg AC (2016)
    Nutritional and developmental status among 6- to 8-month-old children in southwestern Uganda: a cross-sectional study
    Food Nutr Res, 60, 30270
    DOI 10.3402/fnr.v60.30270, PubMed 27238555
  31. Mundal L, Veierød MB, Halvorsen T, Holven KB, Ose L, Iversen PO, Tell GS, Leren TP, Retterstøl K (2016)
    Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study
    Eur J Prev Cardiol, 23 (18), 1962-1969
    DOI 10.1177/2047487316666371, PubMed 27558979
  32. Nordheim T, Rustøen T, Iversen PO, Nakstad B (2016)
    Quality of life in parents of preterm infants in a randomized nutritional intervention trial
    Food Nutr Res, 60, 32162
    DOI 10.3402/fnr.v60.32162, PubMed 27839532
  33. Panagopoulos I, Torkildsen S, Gorunova L, Ulvmoen A, Tierens A, Zeller B, Heim S (2016)
    RUNX1 truncation resulting from a cryptic and novel t(6;21)(q25;q22) chromosome translocation in acute myeloid leukemia: A case report
    Oncol Rep, 36 (5), 2481-2488
    DOI 10.3892/or.2016.5119, PubMed 27667292
  34. Robin M, Porcher R, Zinke-Cerwenka W, van Biezen A, Volin L, Mufti G, Craddock C, Finke J, Richard C, Passweg J, Peniket A, Maertens J, Sucak G, Gedde-Dahl T, Vitek A, Nagler A, Blaise D, Beelen D, Maillard N, Schwerdtfeger R, de Witte T, Kroger N (2016)
    Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
    Bone Marrow Transplant, 52 (2), 209-215
    DOI 10.1038/bmt.2016.266, PubMed 27819688
  35. Rukundo PM, Andreassen BA, Kikafunda J, Rukooko B, Oshaug A, Iversen PO (2016)
    Household food insecurity and diet diversity after the major 2010 landslide disaster in Eastern Uganda: a cross-sectional survey
    Br J Nutr, 115 (4), 718-29
    DOI 10.1017/S0007114515004961, PubMed 26777212
  36. Rukundo PM, Oshaug A, Andreassen BA, Kikafunda J, Rukooko B, Iversen PO (2016)
    Food variety consumption and household food insecurity coping strategies after the 2010 landslide disaster - the case of Uganda
    Public Health Nutr, 19 (17), 3197-3209
    DOI 10.1017/S1368980016001397, PubMed 27278061
  37. Skarpengland T, Holm S, Scheffler K, Gregersen I, Dahl TB, Suganthan R, Segers FM, Østlie I, Otten JJ, Luna L, Ketelhuth DF, Lundberg AM, Neurauter CG, Hildrestrand G, Skjelland M, Bjørndal B, Svardal AM, Iversen PO, Hedin U, Nygård S, Olstad OK, Krohg-Sørensen K, Slupphaug G, Eide L, Kuśnierczyk A et al. (2016)
    Neil3-dependent base excision repair regulates lipid metabolism and prevents atherosclerosis in Apoe-deficient mice
    Sci Rep, 6, 28337
    DOI 10.1038/srep28337, PubMed 27328939
  38. Stavik B, Espada S, Cui XY, Iversen N, Holm S, Mowinkel MC, Halvorsen B, Skretting G, Sandset PM (2016)
    EPAS1/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells
    Biochim Biophys Acta, 1862 (4), 670-678
    DOI 10.1016/j.bbadis.2016.01.017, PubMed 26826018
  39. Tavoly M, Utne KK, Jelsness-Jørgensen LP, Wik HS, Klok FA, Sandset PM, Ghanima W (2016)
    Health-related quality of life after pulmonary embolism: a cross-sectional study
    BMJ Open, 6 (11), e013086
    DOI 10.1136/bmjopen-2016-013086, PubMed 27810979
  40. Tekpli X, Urbanucci A, Hashim A, Vågbø CB, Lyle R, Kringen MK, Staff AC, Dybedal I, Mills IG, Klungland A, Staerk J (2016)
    Changes of 5-hydroxymethylcytosine distribution during myeloid and lymphoid differentiation of CD34+ cells
    Epigenetics Chromatin, 9, 21
    DOI 10.1186/s13072-016-0070-8, PubMed 27252783
  41. Tinholt M, Sandset PM, Iversen N (2016)
    Polymorphisms of the coagulation system and risk of cancer
    Thromb Res, 140 Suppl 1, S49-54
    DOI 10.1016/S0049-3848(16)30098-6, PubMed 27067978
  42. Tinholt M, Sandset PM, Mowinckel MC, Garred Ø, Sahlberg KK, Kristensen VN, Børresen-Dale AL, Jacobsen AF, Skretting G, Iversen N (2016)
    Determinants of acquired activated protein C resistance and D-dimer in breast cancer
    Thromb Res, 145, 78-83
    DOI 10.1016/j.thromres.2016.08.003, PubMed 27505249
  43. Tiscia GL, Dørum E, Myklebust CF, Grandone E, Sandset PM, Skretting G (2016)
    Functional characterization of annexin A5 gene promoter allelic variants
    Thromb Res, 144, 93-9
    DOI 10.1016/j.thromres.2016.06.009, PubMed 27318245
  44. Torfoss D, Fladhagen T, Holte H, Brinch L, Schjesvold FH, Fløisand Y, Nyquist E, Dalgaard J, Meyer P, Lehmann AK, Hammerstrøm J, Skjelbakken T, Høiby EA, Sandvik L, Kvaløy S (2016)
    Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial
    Clin Microbiol Infect, 23 (3), 179-187
    DOI 10.1016/j.cmi.2016.10.019, PubMed 27793737
  45. Utne KK, Tavoly M, Wik HS, Jelsness-Jørgensen LP, Holst R, Sandset PM, Ghanima W (2016)
    Health-related quality of life after deep vein thrombosis
    Springerplus, 5 (1), 1278
    DOI 10.1186/s40064-016-2949-z, PubMed 27547653
  46. Vandraas K, Tjønnfjord GE, Johannesen TB, Brandal P (2016)
    Persistent bone marrow depression following short-term treatment with temozolomide
    BMJ Case Rep, 2016
    DOI 10.1136/bcr-2016-215797, PubMed 27130558
  47. Vojdeman FJ, Van't Veer MB, Tjønnfjord GE, Itälä-Remes M, Kimby E, Polliack A, Wu KL, Doorduijn JK, Alemayehu WG, Wittebol S, Kozak T, Walewski J, Abrahamse-Testroote MC, van Oers MH, Geisler CH (2016)
    The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia
    Leuk Lymphoma, 58 (3), 594-600
    DOI 10.1080/10428194.2016.1213831, PubMed 27484290
  48. von Krogh AS, Quist-Paulsen P, Waage A, Langseth ØO, Thorstensen K, Brudevold R, Tjønnfjord GE, Largiadèr CR, Lämmle B, Kremer Hovinga JA (2016)
    High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence
    J Thromb Haemost, 14 (1), 73-82
    DOI 10.1111/jth.13186, PubMed 26566785

Publications 2015

  1. Bazarbachi A, Labopin M, Kharfan-Dabaja MA, Schwerdtfeger R, Volin L, Bourhis JH, Socié G, Daguindau E, Gedde-Dahl T, Rambaldi A, Karas M, Schlimok G, Blaise D, Chevallier P, Malard F, Schmid C, Esteve J, Nagler A, Mohty M (2015)
    Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status
    Haematologica, 101 (1), e34-7
    DOI 10.3324/haematol.2015.135681, PubMed 26405153
  2. Beitland S, Sandven I, Kjærvik LK, Sandset PM, Sunde K, Eken T (2015)
    Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis
    Intensive Care Med, 41 (7), 1209-19
    DOI 10.1007/s00134-015-3840-z, PubMed 25971389
  3. Berentsen S, Randen U, Tjønnfjord GE (2015)
    Cold agglutinin-mediated autoimmune hemolytic anemia
    Hematol Oncol Clin North Am, 29 (3), 455-71
    DOI 10.1016/j.hoc.2015.01.002, PubMed 26043385
  4. Berntsen CF, Kristiansen A, Akl EA, Sandset PM, Jacobsen EM, Guyatt G, Vandvik PO (2015)
    Compression Stockings for Preventing the Postthrombotic Syndrome in Patients with Deep Vein Thrombosis
    Am J Med, 129 (4), 447.e1-447.e20
    DOI 10.1016/j.amjmed.2015.11.031, PubMed 26747198
  5. Boon H, Sjögren RJ, Massart J, Egan B, Kostovski E, Iversen PO, Hjeltnes N, Chibalin AV, Widegren U, Zierath JR (2015)
    MicroRNA-208b progressively declines after spinal cord injury in humans and is inversely related to myostatin expression
    Physiol Rep, 3 (11)
    DOI 10.14814/phy2.12622, PubMed 26603456
  6. Bremer S, Fløisand Y, Brinch L, Gedde-Dahl T, Bergan S (2015)
    Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning
    Ther Drug Monit, 37 (4), 493-500
    DOI 10.1097/FTD.0000000000000180, PubMed 25565670
  7. Chollet ME, Skarpen E, Iversen N, Sandset PM, Skretting G (2015)
    The chemical chaperone sodium 4-phenylbutyrate improves the secretion of the protein CA267T mutant in CHO-K1 cells trough the GRASP55 pathway
    Cell Biosci, 5, 57
    DOI 10.1186/s13578-015-0048-4, PubMed 26457178
  8. Chortatos A, Haugen M, Iversen PO, Vikanes Å, Eberhard-Gran M, Bjelland EK, Magnus P, Veierød MB (2015)
    Pregnancy complications and birth outcomes among women experiencing nausea only or nausea and vomiting during pregnancy in the Norwegian Mother and Child Cohort Study
    BMC Pregnancy Childbirth, 15, 138
    DOI 10.1186/s12884-015-0580-6, PubMed 26100060
  9. Chortatos A, Haugen M, Iversen PO, Vikanes Å, Eberhard-Gran M, Bjelland EK, Magnus P, Veierød MB (2015)
    Erratum: Pregnancy complications and birth outcomes among women experiencing nausea only or nausea and vomiting during pregnancy in the Norwegian Mother and Child Cohort Study
    BMC Pregnancy Childbirth, 15, 167
    DOI 10.1186/s12884-015-0596-y, PubMed 26268704
  10. Comerota AJ, Sandset PM, Konstantinides S, de Graaf R, Wakefield TW, Arnoldussen CW, Lam YL, van Gent WB, de Wolf MA, Catarinella FS, Kurstjens RL, Alshabatat A, Wittens CH (2015)
    Theme 4: Invasive management of (recurrent) VTE and PTS
    Thromb Res, 136 Suppl 1, S19-25
    DOI 10.1016/j.thromres.2015.07.037, PubMed 26387732
  11. Craigie S, Tsui JF, Agarwal A, Sandset PM, Guyatt GH, Tikkinen KA (2015)
    Adherence to mechanical thromboprophylaxis after surgery: A systematic review and meta-analysis
    Thromb Res, 136 (4), 723-6
    DOI 10.1016/j.thromres.2015.06.023, PubMed 26140737
  12. Dahm AE, Tiscia G, Holmgren A, Jacobsen AF, Skretting G, Grandone E, Sandset PM (2015)
    Genetic variations in the annexin A5 gene and the risk of pregnancy-related venous thrombosis
    J Thromb Haemost, 13 (3), 409-13
    DOI 10.1111/jth.12817, PubMed 25495894
  13. Eckman MH, Alonso-Coello P, Guyatt GH, Ebrahim S, Tikkinen KA, Lopes LC, Neumann I, McDonald SD, Zhang Y, Zhou Q, Akl EA, Jacobsen AF, Santamaría A, Annichino-Bizzacchi JM, Bitar W, Sandset PM, Bates SM (2015)
    Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities
    Thromb Res, 136 (2), 341-7
    DOI 10.1016/j.thromres.2015.05.020, PubMed 26033397
  14. Fogarty PF, Mancuso ME, Kasthuri R, Bidlingmaier C, Chitlur M, Gomez K, Holme PA, James P, Kruse-Jarres R, Mahlangu J, Mingot-Castellano ME, Soni A, Global Emerging Hemophilia Panel (GEHEP) (2015)
    Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year survey
    Haemophilia, 21 (5), 589-97
    DOI 10.1111/hae.12652, PubMed 25689278
  15. Ghanima W, Khelif A, Waage A, Michel M, Tjønnfjord GE, Romdhan NB, Kahrs J, Darne B, Holme PA, RITP study group (2015)
    Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
    Lancet, 385 (9978), 1653-61
    DOI 10.1016/S0140-6736(14)61495-1, PubMed 25662413
  16. Gimsing P, Hjertner Ø, Abildgaard N, Andersen NF, Dahl TG, Gregersen H, Klausen TW, Mellqvist UH, Linder O, Lindås R, Tøffner Clausen N, Lenhoff S (2015)
    Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial
    Bone Marrow Transplant, 50 (10), 1306-11
    DOI 10.1038/bmt.2015.125, PubMed 26121108
  17. Holme PA, Combescure C, Tait RC, Berntorp E, Rauchensteiner S, de Moerloose P, ADVANCE Working Group (2015)
    Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe
    Haemophilia, 22 (2), 248-255
    DOI 10.1111/hae.12847, PubMed 27880029
  18. Høyvoll LR, Fløisand Y, Orrem HL, Gunnarsson R, Landrø L, Brevig T, Gaustad P, Nordøy I (2015)
    Hemophagocytic lymphohistiocytosis in leprosy
    Lepr Rev, 86 (4), 403-6
    PubMed 26964439
  19. Iversen PO, Dahm A, Skretting G, Mowinckel MC, Stranda A, Østerud B, Sandset PM, Kostovski E (2015)
    Reduced peak, but no diurnal variation, in thrombin generation upon melatonin supplementation in tetraplegia. A randomised, placebo-controlled study
    Thromb Haemost, 114 (5), 964-8
    DOI 10.1160/TH15-05-0396, PubMed 26202881
  20. Iversen PO, Sioud M (2015)
    Engineering therapeutic cancer vaccines that activate antitumor immunity
    Methods Mol Biol, 1218, 263-8
    DOI 10.1007/978-1-4939-1538-5_15, PubMed 25319656
  21. Kostovski E, Dahm AE, Mowinckel MC, Stranda A, Skretting G, Østerud B, Sandset PM, Iversen PO (2015)
    Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin
    Spinal Cord, 53 (4), 285-90
    DOI 10.1038/sc.2014.243, PubMed 25644388
  22. Munthe-Kaas MC, Tierens A, Bechensteen AG, Zeller B (2015)
    Myeloid leukemia of Down syndrome: relation to parvovirus B19 infection and wilms tumor gene (WT1) expression
    J Pediatr Hematol Oncol, 37 (1), e67-8
    DOI 10.1097/MPH.0000000000000093, PubMed 24390447
  23. Narverud I, van Lennep JR, Christensen JJ, Versmissen J, Gran JM, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Ulven SM, Ose L, Veierød MB, Sijbrands E, Retterstøl K, Holven KB (2015)
    Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia
    Atherosclerosis, 243 (1), 155-60
    DOI 10.1016/j.atherosclerosis.2015.09.014, PubMed 26386212
  24. Nissen-Meyer LS, Tjønnfjord GE, Golebiowska E, Kjeldsen-Kragh J, Akkök ÇA (2015)
    Paroxysmal nocturnal haemoglobinuria at Oslo University Hospital 2000-2010
    Tidsskr Nor Laegeforen, 135 (11), 1039-43
    DOI 10.4045/tidsskr.14.0444, PubMed 26080779
  25. Parente-Ribes A, Skånland SS, Bürgler S, Os A, Wang D, Bogen B, Tjønnfjord GE, Taskén K, Munthe LA (2015)
    Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells
    Haematologica, 101 (2), e59-62
    DOI 10.3324/haematol.2015.135590, PubMed 26589914
  26. Rukundo PM, Iversen PO, Andreassen BA, Oshaug A, Kikafunda J, Rukooko B (2015)
    Perceptions on the right to adequate food after a major landslide disaster: a cross-sectional survey of two districts in Uganda
    BMC Int Health Hum Rights, 15, 9
    DOI 10.1186/s12914-015-0047-x, PubMed 25909355
  27. Sandset EC, Jusufovic M, Sandset PM, Bath PM, Berge E, SCAST Study Group (2015)
    Effects of blood pressure-lowering treatment in different subtypes of acute ischemic stroke
    Stroke, 46 (3), 877-9
    DOI 10.1161/STROKEAHA.114.008512, PubMed 25657183
  28. Skuterud Wik H, Flem Jacobsen A, Morten Sandset P (2015)
    Long-term outcome after pregnancy-related venous thrombosis
    Thromb Res, 135 Suppl 1, S1-4
    DOI 10.1016/S0049-3848(15)50430-1, PubMed 25903525
  29. Tangen JM (2015)
    Radiation What it is, what you need to know
    Tidsskr. Nor. Laegeforen., 135 (15), 1387
  30. Tangen JM, Tierens A, Caers J, Binsfeld M, Olstad OK, Trøseid AM, Wang J, Tjønnfjord GE, Hetland G (2015)
    Immunomodulatory effects of the Agaricus blazei Murrill-based mushroom extract AndoSan in patients with multiple myeloma undergoing high dose chemotherapy and autologous stem cell transplantation: a randomized, double blinded clinical study
    Biomed Res Int, 2015, 718539
    DOI 10.1155/2015/718539, PubMed 25664323
  31. Tinholt M, Stavik B, Louch W, Carlson CR, Sletten M, Ruf W, Skretting G, Sandset PM, Iversen N (2015)
    Syndecan-3 and TFPI colocalize on the surface of endothelial-, smooth muscle-, and cancer cells
    PLoS One, 10 (1), e0117404
    DOI 10.1371/journal.pone.0117404, PubMed 25617766
  32. Tinholt M, Vollan HK, Sahlberg KK, Jernström S, Kaveh F, Lingjærde OC, Kåresen R, Sauer T, Kristensen V, Børresen-Dale AL, Sandset PM, Iversen N (2015)
    Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
    Breast Cancer Res, 17, 44
    DOI 10.1186/s13058-015-0548-5, PubMed 25882602
  33. Tjelle TE, Holtung L, Bøhn SK, Aaby K, Thoresen M, Wiik SÅ, Paur I, Karlsen AS, Retterstøl K, Iversen PO, Blomhoff R (2015)
    Polyphenol-rich juices reduce blood pressure measures in a randomised controlled trial in high normal and hypertensive volunteers
    Br J Nutr, 114 (7), 1054-63
    DOI 10.1017/S0007114515000562, PubMed 26227795
  34. Torkildsen S, Gorunova L, Beiske K, Tjønnfjord GE, Heim S, Panagopoulos I (2015)
    Novel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32)
    PLoS One, 10 (7), e0132736
    DOI 10.1371/journal.pone.0132736, PubMed 26186352
  35. Utne KK, Ghanima W, Foyn S, Kahn S, Sandset PM, Wik HS (2015)
    Development and validation of a tool for patient reporting of symptoms and signs of the post-thrombotic syndrome
    Thromb Haemost, 115 (2), 361-7
    DOI 10.1160/TH15-04-0318, PubMed 26422814
  36. Valentino LA, Holme PA (2015)
    Should anti-inhibitor coagulant complex and tranexamic acid be used concomitantly?
    Haemophilia, 21 (6), 709-14
    DOI 10.1111/hae.12723, PubMed 26036756
  37. Wennström L, Edslev PW, Abrahamsson J, Nørgaard JM, Fløisand Y, Forestier E, Gustafsson G, Heldrup J, Hovi L, Jahnukainen K, Jonsson OG, Lausen B, Palle J, Zeller B, Holmberg E, Juliusson G, Stockelberg D, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO), Danish Acute Leukemia Group, Swedish Acute Myeloid Leukemia Group (2015)
    Acute Myeloid Leukemia in Adolescents and Young Adults Treated in Pediatric and Adult Departments in the Nordic Countries
    Pediatr Blood Cancer, 63 (1), 83-92
    DOI 10.1002/pbc.25713, PubMed 26281822
  38. Wesseltoft-Rao N, Hjermstad MJ, Ikdahl T, Dajani O, Ulven SM, Iversen PO, Bye A (2015)
    Comparing two classifications of cancer cachexia and their association with survival in patients with unresected pancreatic cancer
    Nutr Cancer, 67 (3), 472-80
    DOI 10.1080/01635581.2015.1004728, PubMed 25710201
  39. Wik HS, Jacobsen AF, Mowinckel MC, Sandset PM (2015)
    The role of inflammation in post-thrombotic syndrome after pregnancy-related deep vein thrombosis: A population-based, cross-sectional study
    Thromb Res, 138, 16-21
    DOI 10.1016/j.thromres.2015.12.014, PubMed 26826503

Publications 2014

  1. Akkök ÇA, Bergrem A, Tangen JM (2014)
    Hyperleukocytosis
    Tidsskr Nor Laegeforen, 134 (14), 1365
    DOI 10.4045/tidsskr.13.1559, PubMed 25096431
  2. Ali HO, Stavik B, Dørum E, Iversen N, Sandset PM, Skretting G (2014)
    Oestrogen induced downregulation of TFPI expression is mediated by ERα
    Thromb Res, 134 (1), 138-43
    DOI 10.1016/j.thromres.2014.04.004, PubMed 24785473
  3. Bruserud Ø, Tvedt TH, Paulsen PQ, Ahmed AB, Gedde-Dahl T, Tjønnfjord GE, Slåstad H, Heldal D, Reikvam H (2014)
    Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies
    Cancer Immunol Immunother, 63 (8), 757-77
    DOI 10.1007/s00262-014-1578-z, PubMed 24997173
  4. Bürgler S, Gimeno A, Parente-Ribes A, Wang D, Os A, Devereux S, Jebsen P, Bogen B, Tjønnfjord GE, Munthe LA (2014)
    Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism
    J Immunol, 194 (2), 827-35
    DOI 10.4049/jimmunol.1401350, PubMed 25505279
  5. Döhner H, Lübbert M, Fiedler W, Fouillard L, Haaland A, Brandwein JM, Lepretre S, Reman O, Turlure P, Ottmann OG, Müller-Tidow C, Krämer A, Raffoux E, Döhner K, Schlenk RF, Voss F, Taube T, Fritsch H, Maertens J (2014)
    Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
    Blood, 124 (9), 1426-33
    DOI 10.1182/blood-2014-03-560557, PubMed 25006120
  6. Eide NA, Baerland TP, Sauesund E, Lømo J, Lund-Iversen M, Liestøl S (2014)
    Relapse of acute lymphoblastic leukaemia (ALL)
    Acta Ophthalmol, 93 (5), e395-6
    DOI 10.1111/aos.12619, PubMed 25495443
  7. Geisler CH, van T' Veer MB, Jurlander J, Walewski J, Tjønnfjord G, Itälä Remes M, Kimby E, Kozak T, Polliack A, Wu KL, Wittebol S, Abrahamse-Testroote MC, Doorduijn J, Ghidey Alemayehu W, van Oers MH (2014)
    Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL
    Blood, 123 (21), 3255-62
    DOI 10.1182/blood-2014-01-547737, PubMed 24735962
  8. Haig Y, Enden T, Slagsvold CE, Sandvik L, Sandset PM, Kløw NE (2014)
    Residual rates of reflux and obstruction and their correlation to post-thrombotic syndrome in a randomized study on catheter-directed thrombolysis for deep vein thrombosis
    J Vasc Surg Venous Lymphat Disord, 2 (2), 123-30
    DOI 10.1016/j.jvsv.2013.10.054, PubMed 26993176
  9. Hallstensen RF, Bergseth G, Foss S, Jæger S, Gedde-Dahl T, Holt J, Christiansen D, Lau C, Brekke OL, Armstrong E, Stefanovic V, Andersen JT, Sandlie I, Mollnes TE (2014)
    Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn
    Immunobiology, 220 (4), 452-9
    DOI 10.1016/j.imbio.2014.11.003, PubMed 25468724
  10. Hjorth-Hansen H, Stenke L, Söderlund S, Dreimane A, Ehrencrona H, Gedde-Dahl T, Gjertsen BT, Höglund M, Koskenvesa P, Lotfi K, Majeed W, Markevärn B, Ohm L, Olsson-Strömberg U, Remes K, Suominen M, Simonsson B, Porkka K, Mustjoki S, Richter J, Nordic CML Study Group (2014)
    Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)
    Eur J Haematol, 94 (3), 243-50
    DOI 10.1111/ejh.12423, PubMed 25082346
  11. Husøy MA, Brinch L, Tjønnfjord GE, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I, Kolstad A, Akkök ÇA, Rollag H, Gaustad P, Bergan S, Egeland T, Josefsen D, Kvalheim G, Fløisand Y (2014)
    [Allogeneic stem-cell transplantation in adults 1985-2012: results and development]
    Tidsskr Nor Laegeforen, 134 (16), 1569-75
    DOI 10.4045/tidsskr.13.1415, PubMed 25178233
  12. Knudsen E, Carlsen H, Bøyum A, Benestad HB, Iversen PO (2014)
    No major role for the transcription factor NF-κB in bone marrow function during peritonitis in the mouse
    Int J Hematol, 100 (2), 111-8
    DOI 10.1007/s12185-014-1598-7, PubMed 24859830
  13. Kostovski E, Hjeltnes N, Eriksen EF, Kolset SO, Iversen PO (2014)
    Differences in bone mineral density, markers of bone turnover and extracellular matrix and daily life muscular activity among patients with recent motor-incomplete versus motor-complete spinal cord injury
    Calcif Tissue Int, 96 (2), 145-54
    DOI 10.1007/s00223-014-9947-3, PubMed 25539858
  14. Kristiansen A, Brandt L, Agoritsas T, Akl EA, Berge E, Bondi J, Dahm AE, Granan LP, Halvorsen S, Holme PA, Flem Jacobsen A, Jacobsen EM, Neumann I, Sandset PM, Sætre T, Tveit A, Vartdal T, Guyatt G, Vandvik PO (2014)
    Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process
    Chest, 146 (3), 727-734
    DOI 10.1378/chest.13-2828, PubMed 25180723
  15. Kristiansen HA, Spetalen S, Fløisand Y, Heldal D (2014)
    Eltrombopag in Good's Syndrome
    Case Rep Hematol, 2014, 172139
    DOI 10.1155/2014/172139, PubMed 25389501
  16. Kverneland M, Taubøll E, Selmer KK, Iversen PO, Nakken KO (2014)
    Modified Atkins diet may reduce serum concentrations of antiepileptic drugs
    Acta Neurol Scand, 131 (3), 187-90
    DOI 10.1111/ane.12330, PubMed 25312999
  17. Misceo D, Holmgren A, Louch WE, Holme PA, Mizobuchi M, Morales RJ, De Paula AM, Stray-Pedersen A, Lyle R, Dalhus B, Christensen G, Stormorken H, Tjønnfjord GE, Frengen E (2014)
    A dominant STIM1 mutation causes Stormorken syndrome
    Hum Mutat, 35 (5), 556-64
    DOI 10.1002/humu.22544, PubMed 24619930
  18. Moltu SJ, Sachse D, Blakstad EW, Strømmen K, Nakstad B, Almaas AN, Westerberg AC, Rønnestad A, Brække K, Veierød MB, Iversen PO, Rise F, Berg JP, Drevon CA (2014)
    Urinary metabolite profiles in premature infants show early postnatal metabolic adaptation and maturation
    Nutrients, 6 (5), 1913-30
    DOI 10.3390/nu6051913, PubMed 24824288
  19. Mundal L, Sarancic M, Ose L, Iversen PO, Borgan JK, Veierød MB, Leren TP, Retterstøl K (2014)
    Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010
    J Am Heart Assoc, 3 (6), e001236
    DOI 10.1161/JAHA.114.001236, PubMed 25468658
  20. Narverud I, Retterstøl K, Iversen PO, Halvorsen B, Ueland T, Ulven SM, Ose L, Aukrust P, Veierød MB, Holven KB (2014)
    Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review
    Atherosclerosis, 235 (2), 299-309
    DOI 10.1016/j.atherosclerosis.2014.05.917, PubMed 24908240
  21. Panagopoulos I, Torkildsen S, Gorunova L, Tierens A, Tjønnfjord GE, Heim S (2014)
    Comparison between karyotyping-FISH-reverse transcription PCR and RNA-sequencing-fusion gene identification programs in the detection of KAT6A-CREBBP in acute myeloid leukemia
    PLoS One, 9 (5), e96570
    DOI 10.1371/journal.pone.0096570, PubMed 24798186
  22. Pettersson H, Knutsen H, Holmberg E, Andréasson B (2014)
    Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis
    Eur J Haematol, 94 (2), 152-6
    DOI 10.1111/ejh.12410, PubMed 25039361
  23. Pitkänen H, Jouppila A, Mowinckel MC, Lemponen M, Patiwael S, Sandset PM, Lassila R, Brinkman HJ (2014)
    Enhanced thrombin generation and reduced intact protein S in processed solvent detergent plasma
    Thromb Res, 135 (1), 167-74
    DOI 10.1016/j.thromres.2014.10.020, PubMed 25466844
  24. Ruffini PA, Os A, Dolcetti R, Tjønnfjord GE, Munthe LA, Bogen B (2014)
    Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice
    J Transl Med, 12, 207
    DOI 10.1186/1479-5876-12-207, PubMed 25059102
  25. Samarakoon PS, Sorte HS, Kristiansen BE, Skodje T, Sheng Y, Tjønnfjord GE, Stadheim B, Stray-Pedersen A, Rødningen OK, Lyle R (2014)
    Identification of copy number variants from exome sequence data
    BMC Genomics, 15, 661
    DOI 10.1186/1471-2164-15-661, PubMed 25102989
  26. Sandset PM (2014)
    Combined oral contraceptives increase risk of venous thrombosis according to oestrogen dose and type of progestogen
    Evid Based Med, 19 (5), 194
    DOI 10.1136/ebmed-2014-110011, PubMed 24948124
  27. Subramaniam S, Thielmann I, Morowski M, Pragst I, Sandset PM, Nieswandt B, Etscheid M, Kanse SM (2014)
    Defective thrombus formation in mice lacking endogenous factor VII activating protease (FSAP)
    Thromb Haemost, 113 (4), 870-80
    DOI 10.1160/TH14-06-0519, PubMed 25427855
  28. Taraldsrud E, Fevang B, Aukrust P, Beiske KH, Fløisand Y, Frøland S, Rollag H, Olweus J (2014)
    Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9
    Clin Exp Immunol, 175 (3), 439-48
    DOI 10.1111/cei.12239, PubMed 24237110
  29. Tavoly M, Jelsness-Jørgensen LP, Wik HS, Roaldsnes C, Sandset PM, Ghanima W (2014)
    Quality of life after pulmonary embolism: first cross-cultural evaluation of the pulmonary embolism quality-of-life (PEmb-QoL) questionnaire in a Norwegian cohort
    Qual Life Res, 24 (2), 417-25
    DOI 10.1007/s11136-014-0779-4, PubMed 25120017
  30. Tikkinen KA, Agarwal A, Craigie S, Cartwright R, Gould MK, Haukka J, Naspro R, Novara G, Sandset PM, Siemieniuk RA, Violette PD, Guyatt GH (2014)
    Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology
    Syst Rev, 3, 150
    DOI 10.1186/2046-4053-3-150, PubMed 25540016
  31. Tinholt M, Viken MK, Dahm AE, Vollan HK, Sahlberg KK, Garred O, Børresen-Dale AL, Jacobsen AF, Kristensen V, Bukholm I, Kåresen R, Schlichting E, Skretting G, Lie BA, Sandset PM, Iversen N (2014)
    Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
    BMC Cancer, 14, 845
    DOI 10.1186/1471-2407-14-845, PubMed 25407022
  32. Tobiasson M, Dybedahl I, Holm MS, Karimi M, Brandefors L, Garelius H, Grövdal M, Högh-Dufva I, Grønbæk K, Jansson M, Marcher C, Nilsson L, Kittang AO, Porwit A, Saft L, Möllgård L, Hellström-Lindberg E (2014)
    Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial
    Blood Cancer J, 4, e189
    DOI 10.1038/bcj.2014.8, PubMed 24608733
  33. Tran HT, Sørensen B, Bjørnsen S, Pripp AH, Tjønnfjord GE, Andre Holme P (2014)
    Monitoring bypassing agent therapy - a prospective crossover study comparing thromboelastometry and thrombin generation assay
    Haemophilia, 21 (2), 275-83
    DOI 10.1111/hae.12570, PubMed 25521720
  34. Tvedt TH, Holme PA, Bruserud Ø (2014)
    [A man in his 80s with muscle stiffness and skin bleeding]
    Tidsskr Nor Laegeforen, 134 (10), 1058-61
    DOI 10.4045/tidsskr.13.0817, PubMed 24865732
  35. Tveita AA, Schjesvold FH, Sundnes O, Haabeth OA, Haraldsen G, Bogen B (2014)
    Indirect CD4+ T-cell-mediated elimination of MHC II(NEG) tumor cells is spatially restricted and fails to prevent escape of antigen-negative cells
    Eur J Immunol, 44 (9), 2625-37
    DOI 10.1002/eji.201444659, PubMed 24846412
  36. Vangen S, Ellingsen L, Andersgaard AB, Jacobsen AF, Lorentzen B, Nyfløt LT, Rygh AB, Skulstad SM, Tappert C, Øian P (2014)
    Maternal deaths in Norway 2005-2009
    Tidsskr Nor Laegeforen, 134 (8), 836-9
    DOI 10.4045/tidsskr.13.0203, PubMed 24780982
  37. von Krogh AS, Kremer Hovinga JA, Tjønnfjord GE, Ringen IM, Lämmle B, Waage A, Quist-Paulsen P (2014)
    The impact of congenital thrombotic thrombocytopenic purpura on pregnancy complications
    Thromb Haemost, 111 (6), 1180-3
    DOI 10.1160/TH13-08-0713, PubMed 24499950
  38. Woll PS, Kjällquist U, Chowdhury O, Doolittle H, Wedge DC, Thongjuea S, Erlandsson R, Ngara M, Anderson K, Deng Q, Mead AJ, Stenson L, Giustacchini A, Duarte S, Giannoulatou E, Taylor S, Karimi M, Scharenberg C, Mortera-Blanco T, Macaulay IC, Clark SA, Dybedal I, Josefsen D, Fenaux P, Hokland P et al. (2014)
    Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
    Cancer Cell, 25 (6), 794-808
    DOI 10.1016/j.ccr.2014.03.036, PubMed 24835589
  39. Zeidler C, Grote UA, Nickel A, Brand B, Carlsson G, Cortesão E, Dufour C, Duhem C, Notheis G, Papadaki HA, Tamary H, Tjønnfjord GE, Tucci F, Van Droogenbroeck J, Vermylen C, Voglova J, Xicoy B, Welte K (2014)
    Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry
    Haematologica, 99 (8), 1395-402
    DOI 10.3324/haematol.2013.099101, PubMed 24997149

Publications 2013

  1. Cui XY, Skretting G, Jing Y, Sun H, Sandset PM, Sun L (2013)
    Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells
    Blood Cells Mol Dis, 51 (3), 177-84
    DOI 10.1016/j.bcmd.2013.05.003, PubMed 23725749
  2. Dahm A (2013)
    [A. Dahm replies]
    Tidsskr Nor Laegeforen, 133 (16), 1687
    DOI 10.4045/tidsskr.13.1020, PubMed 24005699
  3. Enden T, Kløw NE, Sandset PM (2013)
    Symptom burden and job absenteeism after treatment with additional catheter-directed thrombolysis for deep vein thrombosis
    Patient Relat Outcome Meas, 4, 55-9
    DOI 10.2147/PROM.S47233, PubMed 24082798
  4. Enden T, Resch S, White C, Wik HS, Kløw NE, Sandset PM (2013)
    Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis
    J Thromb Haemost, 11 (6), 1032-42
    DOI 10.1111/jth.12184, PubMed 23452204
  5. Enden T, Wik HS, Kvam AK, Haig Y, Kløw NE, Sandset PM (2013)
    Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study
    BMJ Open, 3 (8), e002984
    DOI 10.1136/bmjopen-2013-002984, PubMed 23988361
  6. Fernandes AM, Herlofsen SR, Karlsen TA, Küchler AM, Fløisand Y, Brinchmann JE (2013)
    Similar properties of chondrocytes from osteoarthritis joints and mesenchymal stem cells from healthy donors for tissue engineering of articular cartilage
    PLoS One, 8 (5), e62994
    DOI 10.1371/journal.pone.0062994, PubMed 23671648
  7. Gerull S, Stern M, Apperley J, Beelen D, Brinch L, Bunjes D, Butler A, Ganser A, Ghavamzadeh A, Koh MB, Komarnicki M, Kröger N, Maertens J, Maschan A, Peters C, Rovira M, Sengeløv H, Socié G, Tischer J, Oneto R, Passweg J, Marsh J (2013)
    Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation
    Haematologica, 98 (11), 1804-9
    DOI 10.3324/haematol.2013.091074, PubMed 23894010
  8. Ghanima W, Atar D, Sandset PM (2013)
    New oral anticoagulants--a review
    Tidsskr Nor Laegeforen, 133 (18), 1940-5
    DOI 10.4045/tidsskr.12.1111, PubMed 24084970
  9. Ghanima W, Knutsen H, Delabie J, Bruserud Ø (2013)
    [Primary myelofibrosis--pathogenesis, diagnosis and treatment]
    Tidsskr Nor Laegeforen, 133 (18), 1946-50
    DOI 10.4045/tidsskr.12.1106, PubMed 24084971
  10. Gravensteen IK, Helgadóttir LB, Jacobsen EM, Rådestad I, Sandset PM, Ekeberg O (2013)
    Women's experiences in relation to stillbirth and risk factors for long-term post-traumatic stress symptoms: a retrospective study
    BMJ Open, 3 (10), e003323
    DOI 10.1136/bmjopen-2013-003323, PubMed 24154514
  11. Grundlingh H, Herselman M, Iversen PO (2013)
    An assessment of the implementation of the National Therapeutic Programme for pregnant women within the City of Cape Town district
    S Afr Med J, 103 (8), 549-51
    DOI 10.7196/samj.6670, PubMed 23885737
  12. Helgadóttir LB, Turowski G, Skjeldestad FE, Jacobsen AF, Sandset PM, Roald B, Jacobsen EM (2013)
    Classification of stillbirths and risk factors by cause of death--a case-control study
    Acta Obstet Gynecol Scand, 92 (3), 325-33
    DOI 10.1111/aogs.12044, PubMed 23157574
  13. Holm AM, Riise GC, Brinch L, Bjørtuft O, Iversen M, Simonsen S, Fløisand Y (2013)
    Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: unresolved questions
    Transplantation, 96 (4), e21-2
    DOI 10.1097/TP.0b013e31829df2c0, PubMed 23958883
  14. Iversen PO, Negaard H, Østenstad B, Sandset PM, Kolset SO (2013)
    Evidence for long-term hypercoagulopathy, but normalization of markers of extracellular matrix turnover, in patients with non-Hodgkin lymphoma
    Leuk Lymphoma, 56 (8), 2479-81
    DOI 10.3109/10428194.2013.803227, PubMed 23656198
  15. Kostovski E, Boon H, Hjeltnes N, Lundell LS, Ahlsén M, Chibalin AV, Krook A, Iversen PO, Widegren U (2013)
    Altered content of AMP-activated protein kinase isoforms in skeletal muscle from spinal cord injured subjects
    Am J Physiol Endocrinol Metab, 305 (9), E1071-80
    DOI 10.1152/ajpendo.00132.2013, PubMed 24022865
  16. Mathijssen NC, Masereeuw R, Holme PA, van Kraaij MG, Laros-van Gorkom BA, Peyvandi F, van Heerde WL (2013)
    Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effect
    Thromb Res, 132 (2), 256-62
    DOI 10.1016/j.thromres.2013.05.027, PubMed 23834817
  17. Mellqvist UH, Gimsing P, Hjertner O, Lenhoff S, Laane E, Remes K, Steingrimsdottir H, Abildgaard N, Ahlberg L, Blimark C, Dahl IM, Forsberg K, Gedde-Dahl T, Gregersen H, Gruber A, Guldbrandsen N, Haukås E, Carlson K, Kvam AK, Nahi H, Lindås R, Andersen NF, Turesson I, Waage A, Westin J et al. (2013)
    Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
    Blood, 121 (23), 4647-54
    DOI 10.1182/blood-2012-11-464503, PubMed 23616624
  18. Moore KL, Kildahl-Andersen O, Kildahl-Andersen R, Tjønnfjord GE (2013)
    Uncommon adverse effect of a common medication
    Tidsskr Nor Laegeforen, 133 (2), 165
    DOI 10.4045/tidsskr.12.0494, PubMed 23344600
  19. Mustjoki S, Richter J, Barbany G, Ehrencrona H, Fioretos T, Gedde-Dahl T, Gjertsen BT, Hovland R, Hernesniemi S, Josefsen D, Koskenvesa P, Dybedal I, Markevärn B, Olofsson T, Olsson-Strömberg U, Rapakko K, Thunberg S, Stenke L, Simonsson B, Porkka K, Hjorth-Hansen H, Nordic CML Study Group (NCMLSG) (2013)
    Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
    Leukemia, 27 (7), 1520-6
    DOI 10.1038/leu.2013.19, PubMed 23328954
  20. Os A, Bürgler S, Ribes AP, Funderud A, Wang D, Thompson KM, Tjønnfjord GE, Bogen B, Munthe LA (2013)
    Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells
    Cell Rep, 4 (3), 566-77
    DOI 10.1016/j.celrep.2013.07.011, PubMed 23933259
  21. Randen U, Tierens AM, Tjønnfjord GE, Delabie J (2013)
    Bone marrow histology in monoclonal B-cell lymphocytosis shows various B-cell infiltration patterns
    Am J Clin Pathol, 139 (3), 390-5
    DOI 10.1309/AJCPPHSUQM8XBJH7, PubMed 23429376
  22. Randen U, Trøen G, Tierens A, Steen C, Warsame A, Beiske K, Tjønnfjord GE, Berentsen S, Delabie J (2013)
    Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma
    Haematologica, 99 (3), 497-504
    DOI 10.3324/haematol.2013.091702, PubMed 24143001
  23. Raps M, Helmerhorst FM, Fleischer K, Dahm AE, Rosendaal FR, Rosing J, Reitsma P, Sandset PM, van Vliet HA (2013)
    The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI
    Thromb Haemost, 109 (4), 606-13
    DOI 10.1160/TH12-10-0771, PubMed 23407778
  24. Sandset PM (2013)
    Mechanisms of hormonal therapy related thrombosis
    Thromb Res, 131 Suppl 1, S4-7
    DOI 10.1016/S0049-3848(13)70009-4, PubMed 23452740
  25. Sandset PM (2013)
    Genotype of proband and thrombophilia screening
    Blood, 122 (15), 2528-9
    DOI 10.1182/blood-2013-08-519801, PubMed 24113791
  26. Schjesvold F, Wiencke K, Tjønnfjord GE (2013)
    [Investigation of anemia]
    Tidsskr Nor Laegeforen, 133 (6), 610
    DOI 10.4045/tidsskr.13.0256, PubMed 23552139
  27. Schjesvold FH (2013)
    [Investigation of amyloidosis]
    Tidsskr Nor Laegeforen, 133 (3), 266
    DOI 10.4045/tidsskr.13.0044, PubMed 23381155
  28. Stavik B, Tinholt M, Sletten M, Skretting G, Sandset PM, Iversen N (2013)
    TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity
    J Hematol Oncol, 6, 5
    DOI 10.1186/1756-8722-6-5, PubMed 23320987
  29. Tran HT, Sørensen B, Rea CJ, Bjørnsen S, Ueland T, Pripp AH, Tjønnfjord GE, Holme PA (2013)
    Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors
    Haemophilia, 20 (3), 369-75
    DOI 10.1111/hae.12318, PubMed 24251535
  30. Tran HT, Tjønnfjord GE, Holme PA (2013)
    Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency
    Haemophilia, 20 (1), 141-6
    DOI 10.1111/hae.12256, PubMed 23992369
  31. van Geffen M, Mathijssen NC, Holme PA, Laros-van Gorkom BA, van Kraaij MG, Masereeuw R, Peyvandi F, van Heerde WL (2013)
    Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients
    Thromb Res, 132 (1), 116-22
    DOI 10.1016/j.thromres.2013.04.021, PubMed 23731565
  32. Vojdeman FJ, Jurlander J, van't Veer M, Itälä-Remes M, Kimby E, Tjønnfjord GE, Walewski J, Kozák T, Polliack A, Montagna M, Regazzi M, Kirkby N, van Oers M, Geisler CH (2013)
    Plasma alemtuzumab levels in patients with chronic lymphocytic leukemia treated with alemtuzumab combined with chemotherapy reflect the efficacy of the treatment: a hypothesis
    Leuk Lymphoma, 54 (4), 790-3
    DOI 10.3109/10428194.2012.720373, PubMed 23025267
  33. Westberg M, Paus AC, Holme PA, Tjønnfjord GE (2013)
    Haemophilic arthropathy: long-term outcomes in 107 primary total knee arthroplasties
    Knee, 21 (1), 147-50
    DOI 10.1016/j.knee.2013.09.010, PubMed 24156923
  34. Whiteley WN, Adams HP, Bath PM, Berge E, Sandset PM, Dennis M, Murray GD, Wong KS, Sandercock PA (2013)
    Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials
    Lancet Neurol, 12 (6), 539-45
    DOI 10.1016/S1474-4422(13)70079-6, PubMed 23642343
  35. Wik HS, Jacobsen AF, Fagerland MW, Sandvik L, Sandset PM (2013)
    Long-term mortality and incidence of cancer after pregnancy-related venous thrombosis: results of a population-based cohort study
    Thromb Res, 131 (6), 497-501
    DOI 10.1016/j.thromres.2013.04.035, PubMed 23726964
  36. Aamodt AH, Sandset PM, Atar D, Tveit A, Russell D (2013)
    [Atrial fibrillation and stroke]
    Tidsskr Nor Laegeforen, 133 (14), 1453-7
    DOI 10.4045/tidsskr.12.0850, PubMed 23929293

Publications 2012

  1. Abildgaard U, Heimdal K (2012)
    Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review
    Eur J Obstet Gynecol Reprod Biol, 166 (2), 117-23
    DOI 10.1016/j.ejogrb.2012.09.026, PubMed 23107053
  2. Akkök CA, Haugaa H, Galgerud A, Brinch L (2012)
    Severe hemolytic transfusion reaction due to anti-A1 following allogeneic stem cell transplantation with minor ABO incompatibility
    Transfus Apher Sci, 48 (1), 63-6
    DOI 10.1016/j.transci.2012.07.006, PubMed 22902604
  3. Bastani NE, Kostovski E, Sakhi AK, Karlsen A, Carlsen MH, Hjeltnes N, Blomhoff R, Iversen PO (2012)
    Reduced antioxidant defense and increased oxidative stress in spinal cord injured patients
    Arch Phys Med Rehabil, 93 (12), 2223-8.e2
    DOI 10.1016/j.apmr.2012.06.021, PubMed 22772083
  4. Batorova A, Holme P, Gringeri A, Richards M, Hermans C, Altisent C, Lopez-Fernández M, Fijnvandraat K, European Haemophilia Treatment Standardisation Board (2012)
    Continuous infusion in haemophilia: current practice in Europe
    Haemophilia, 18 (5), 753-9
    DOI 10.1111/j.1365-2516.2012.02810.x, PubMed 22530687
  5. Berentsen S, Tjønnfjord GE (2012)
    Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia
    Blood Rev, 26 (3), 107-15
    DOI 10.1016/j.blre.2012.01.002, PubMed 22330255
  6. Bergrem A, Dahm AE, Jacobsen AF, Sandvik L, Sandset PM (2012)
    Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study
    Thromb Haemost, 108 (6), 1165-71
    DOI 10.1160/TH12-05-0350, PubMed 23015030
  7. Boon H, Kostovski E, Pirkmajer S, Song M, Lubarski I, Iversen PO, Hjeltnes N, Widegren U, Chibalin AV (2012)
    Influence of chronic and acute spinal cord injury on skeletal muscle Na+-K+-ATPase and phospholemman expression in humans
    Am J Physiol Endocrinol Metab, 302 (7), E864-71
    DOI 10.1152/ajpendo.00625.2011, PubMed 22275761
  8. Bye A, Jordhøy MS, Skjegstad G, Ledsaak O, Iversen PO, Hjermstad MJ (2012)
    Symptoms in advanced pancreatic cancer are of importance for energy intake
    Support Care Cancer, 21 (1), 219-27
    DOI 10.1007/s00520-012-1514-8, PubMed 22684989
  9. Cesaro S, Pillon M, Tridello G, Aljurf M, Martino R, Schroyens W, Nozzoli C, Barba P, Faraci M, Fagioli F, Cappelli B, Cordonnier C, Al-Mohareb F, Floisand Y, Greil J, Panizzolo IS, Santarone S (2012)
    Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation
    Bone Marrow Transplant, 48 (6), 809-13
    DOI 10.1038/bmt.2012.247, PubMed 23222380
  10. Dahm AE, Bezemer ID, Bergrem A, Jacobsen AF, Jacobsen EM, Skretting G, Rosendaal FR, Sandset PM (2012)
    Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis
    Br J Haematol, 157 (6), 753-61
    DOI 10.1111/j.1365-2141.2012.09121.x, PubMed 22533697
  11. Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebø R, Kierulf P, Mowinckel MC, Skretting G, Sandset PM (2012)
    A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women
    Thromb Res, 130 (1), 45-51
    DOI 10.1016/j.thromres.2011.12.009, PubMed 22217510
  12. Einvik G, Flyvbjerg A, Hrubos-Strøm H, Randby A, Frystyk J, Bjerre M, Namtvedt SK, Kristiansen HA, Nordhus IH, Somers VK, Dammen T, Omland T (2012)
    Novel cardiovascular risk markers in depression: no association between depressive symptoms and osteoprotegerin or adiponectin in persons at high risk for sleep apnea
    J Affect Disord, 145 (3), 400-4
    DOI 10.1016/j.jad.2012.05.065, PubMed 22862888
  13. Enden T, Klow NE, Sandset PM (2012)
    Catheter-directed thrombolysis for acute deep vein thrombosis Reply
    Lancet, 379 (9828), 1786-1787
  14. Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE, Dybedal I, Holte H, Heldal D, Torfoss D, Aurlien E, Lauritzsen GF, Fosså A, Lehne G, Baggerød E, Kvalheim G, Egeland T, Bishop MR, Fowler DH, Kolstad A (2012)
    Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation
    Bone Marrow Transplant, 47 (12), 1552-7
    DOI 10.1038/bmt.2012.63, PubMed 22522568
  15. Fløisand Y, Tjønnfjord G, Beiske K (2012)
    [Invasive fungal infection]
    Tidsskr Nor Laegeforen, 132 (23-24), 2618
    DOI 10.4045/tidsskr.12.0603, PubMed 23338093
  16. Ghanima W, Lee SY, Barsam S, Miller A, Sandset PM, Bussel JB (2012)
    Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists
    Br J Haematol, 158 (6), 811-4
    DOI 10.1111/j.1365-2141.2012.09227.x, PubMed 22816787
  17. Gravensteen IK, Helgadottir LB, Jacobsen EM, Sandset PM, Ekeberg Ø (2012)
    Long-term impact of intrauterine fetal death on quality of life and depression: a case-control study
    BMC Pregnancy Childbirth, 12, 43
    DOI 10.1186/1471-2393-12-43, PubMed 22676992
  18. Haig Y, Enden T, Slagsvold CE, Sandvik L, Sandset PM, Kløw NE (2012)
    Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis
    J Vasc Interv Radiol, 24 (1), 17-24; quiz 26
    DOI 10.1016/j.jvir.2012.09.023, PubMed 23176966
  19. Hjorth M, Hjertner Ø, Knudsen LM, Gulbrandsen N, Holmberg E, Pedersen PT, Andersen NF, Andréasson B, Billström R, Carlson K, Carlsson MS, Flogegård M, Forsberg K, Gimsing P, Karlsson T, Linder O, Nahi H, Othzén A, Swedin A, Nordic Myeloma Study Group (NMSG) (2012)
    Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study
    Eur J Haematol, 88 (6), 485-96
    DOI 10.1111/j.1600-0609.2012.01775.x, PubMed 22404182
  20. Holm AM, Riise GC, Hansson L, Brinch L, Bjørtuft O, Iversen M, Simonsen S, Fløisand Y (2012)
    Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT
    Bone Marrow Transplant, 48 (5), 703-7
    DOI 10.1038/bmt.2012.197, PubMed 23064037
  21. Holmström M, Tran HT, Holme PA (2012)
    Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A--a two-centre experience
    Haemophilia, 18 (4), 544-9
    DOI 10.1111/j.1365-2516.2012.02748.x, PubMed 22348384
  22. IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A (2012)
    The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
    Lancet, 379 (9834), 2352-63
    DOI 10.1016/S0140-6736(12)60768-5, PubMed 22632908
  23. Jacobsen AF, Sandset PM (2012)
    Venous thromboembolism associated with pregnancy and hormonal therapy
    Best Pract Res Clin Haematol, 25 (3), 319-32
    DOI 10.1016/j.beha.2012.07.006, PubMed 22959548
  24. Moltu SJ, Strømmen K, Blakstad EW, Almaas AN, Westerberg AC, Brække K, Rønnestad A, Nakstad B, Berg JP, Veierød MB, Haaland K, Iversen PO, Drevon CA (2012)
    Enhanced feeding in very-low-birth-weight infants may cause electrolyte disturbances and septicemia--a randomized, controlled trial
    Clin Nutr, 32 (2), 207-12
    DOI 10.1016/j.clnu.2012.09.004, PubMed 23043722
  25. Narverud I, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Johansen SG, Nenseter MS, Sandset PM, Ulven SM, Ose L, Retterstøl K, Holven KB (2012)
    Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH
    Thromb Res, 131 (2), 178-82
    DOI 10.1016/j.thromres.2012.11.008, PubMed 23199546
  26. Nyquist KB, Panagopoulos I, Thorsen J, Roberto R, Wik HS, Tierens A, Heim S, Micci F (2012)
    t(12;13)(q14;q31) leading to HMGA2 upregulation in acute myeloid leukaemia
    Br J Haematol, 157 (6), 769-71
    DOI 10.1111/j.1365-2141.2012.09081.x, PubMed 22404713
  27. Ringdén O, Labopin M, Beelen DW, Volin L, Ehninger G, Finke J, Greinix HT, Kyrcz-Krzemien S, Bunjes D, Brinch L, Niederwieser D, Arnold R, Mohty M, Rocha V, Acute Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT) (2012)
    Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients
    J Intern Med, 272 (5), 472-83
    DOI 10.1111/j.1365-2796.2012.02547.x, PubMed 22519980
  28. Rossouw JE, Johnson KC, Pettinger M, Cushman M, Sandset PM, Kuller L, Rosendaal F, Rosing J, Wasserthal-Smoller S, Martin LW, Manson JE, Lakshminarayan K, Merino JG, Lynch J (2012)
    Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy
    Stroke, 43 (4), 952-7
    DOI 10.1161/STROKEAHA.111.643072, PubMed 22363056
  29. Ruud E, Kanellopoulos A, Zeller B, Widing E, Tjønnfjord GE, Fosså SD (2012)
    Patient knowledge of late effects of acute lymphoblastic leukaemia
    Tidsskr Nor Laegeforen, 132 (18), 2052-5
    DOI 10.4045/tidsskr.12.0153, PubMed 23038194
  30. Sandset EC, Murray GD, Bath PM, Kjeldsen SE, Berge E, Scandinavian Candesartan Acute Stroke Trial (SCAST) Study Group (2012)
    Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome
    Stroke, 43 (8), 2108-14
    DOI 10.1161/STROKEAHA.111.647362, PubMed 22627991
  31. Sandset PM (2012)
    CXCL4-platelet factor 4, heparin-induced thrombocytopenia and cancer
    Thromb Res, 129 Suppl 1, S97-100
    DOI 10.1016/S0049-3848(12)70026-9, PubMed 22682144
  32. Skretting G, Iversen N, Myklebust CF, Dahm AE, Sandset PM (2012)
    Overexpression of tissue factor pathway inhibitor in CHO-K1 cells results in increased activation of NF-κB and apoptosis mediated by a caspase-3 independent pathway
    Mol Biol Rep, 39 (12), 10089-96
    DOI 10.1007/s11033-012-1882-7, PubMed 22932941
  33. Stavik B, Skretting G, Olstad OK, Sletten M, Dehli Vigeland M, Sandset PM, Iversen N (2012)
    TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells
    PLoS One, 7 (10), e47184
    DOI 10.1371/journal.pone.0047184, PubMed 23071754
  34. Thorsen J, Aamot HV, Roberto R, Tjønnfjord GE, Micci F, Heim S (2012)
    Myelodysplastic syndrome with a t(2;11)(p21;q23-24) and translocation breakpoint close to miR-125b-1
    Cancer Genet, 205 (10), 528-32
    DOI 10.1016/j.cancergen.2012.06.003, PubMed 22944560
  35. Tjønnfjord GE, Jønsson V, Ly BE, Johannesen TB (2012)
    Familial occurrence of chronic lymphocytic leukaemia in Norway
    Tidsskr Nor Laegeforen, 132 (18), 2060-3
    DOI 10.4045/tidsskr.11.1350, PubMed 23038196
  36. Tjønnfjord GE, Ly BE, Johannesen TB, Tierens A, Beiske K, Heim S, Jønsson V (2012)
    Chronic lymphocytic leukaemia in Norway--incidence and prognostic markers at diagnosis
    Tidsskr Nor Laegeforen, 132 (18), 2056-9
    DOI 10.4045/tidsskr.11.1349, PubMed 23038195
  37. Turowski G, Berge LN, Helgadottir LB, Jacobsen EM, Roald B (2012)
    A new, clinically oriented, unifying and simple placental classification system
    Placenta, 33 (12), 1026-35
    DOI 10.1016/j.placenta.2012.10.002, PubMed 23110739
  38. Vandvik PO, Sandset PM (2012)
    [Confusion regarding evidence-based advice]
    Tidsskr Nor Laegeforen, 132 (10), 1204
    DOI 10.4045/tidsskr.12.0490, PubMed 22669369
  39. Whiteley WN, Slot KB, Fernandes P, Sandercock P, Wardlaw J (2012)
    Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies
    Stroke, 43 (11), 2904-9
    DOI 10.1161/STROKEAHA.112.665331, PubMed 22996959
  40. Wik HS, Jacobsen AF, Sandvik L, Sandset PM (2012)
    Prevalence and predictors for post-thrombotic syndrome 3 to 16 years after pregnancy-related venous thrombosis: a population-based, cross-sectional, case-control study
    J Thromb Haemost, 10 (5), 840-7
    DOI 10.1111/j.1538-7836.2012.04690.x, PubMed 22452811
  41. Wik HS, Jacobsen AF, Sandvik L, Sandset PM (2012)
    Long-term impact of pregnancy-related venous thrombosis on quality-of-life, general health and functioning: results of a cross-sectional, case-control study
    BMJ Open, 2 (6)
    DOI 10.1136/bmjopen-2012-002048, PubMed 23144263
  42. Woldt E, Terrand J, Mlih M, Matz RL, Bruban V, Coudane F, Foppolo S, El Asmar Z, Chollet ME, Ninio E, Bednarczyk A, Thiersé D, Schaeffer C, Van Dorsselaer A, Boudier C, Wahli W, Chambon P, Metzger D, Herz J, Boucher P (2012)
    The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells
    Nat Commun, 3, 1077
    DOI 10.1038/ncomms2087, PubMed 23011131

Publications 2011

  1. Abelsson J, Merup M, Birgegård G, WeisBjerrum O, Brinch L, Brune M, Johansson P, Kauppila M, Lenhoff S, Liljeholm M, Malm C, Remes K, Vindelöv L, Andréasson B, Nordic MPD Study Group (2011)
    The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries
    Bone Marrow Transplant, 47 (3), 380-6
    DOI 10.1038/bmt.2011.91, PubMed 21552298
  2. Alatri A, Armstrong AE, Greinacher A, Koster A, Kozek-Langenecker SA, Lancé MD, Link A, Nielsen JD, Sandset PM, Spanjersberg AJ, Spannagl M (2011)
    Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - a European Perspective
    Thromb Res, 129 (4), 426-33
    DOI 10.1016/j.thromres.2011.11.041, PubMed 22178575
  3. Andresen MS, Sandven I, Brunborg C, Njaastad AM, Strekerud F, Abdelnoor M, Smith P, Abildgaard U (2011)
    Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy
    Thromb Res, 127 (6), 540-6
    DOI 10.1016/j.thromres.2011.02.017, PubMed 21435698
  4. Bergrem A, Dahm AE, Jacobsen AF, Mowinckel MC, Sandvik L, Sandset PM (2011)
    Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism
    Br J Haematol, 154 (2), 241-7
    DOI 10.1111/j.1365-2141.2011.08712.x, PubMed 21564075
  5. Enden T, Haig Y, Kløw NE, Slagsvold CE, Sandvik L, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbæk G, Sandset PM, CaVenT Study Group (2011)
    Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial
    Lancet, 379 (9810), 31-8
    DOI 10.1016/S0140-6736(11)61753-4, PubMed 22172244
  6. Fløisand Y, Delabie J, Fosså A, Helseth E, Jacobsen EA, Rolke J, Tjønnfjord GE (2011)
    Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia
    Leuk Lymphoma, 52 (10), 2007-9
    DOI 10.3109/10428194.2011.580480, PubMed 21663503
  7. Frøyland M, Ruffini PA, Thompson KM, Gedde-Dahl T, Fredriksen AB, Bogen B (2011)
    Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing
    Eur J Haematol, 86 (5), 385-95
    DOI 10.1111/j.1600-0609.2011.01590.x, PubMed 21332794
  8. Ghanima W, Kleven IW, Enden T, Rosales A, Wik HS, Pederstad L, Holme PA, Sandset PM (2011)
    Recurrent venous thrombosis, post-thrombotic syndrome and quality of life after catheter-directed thrombolysis in severe proximal deep vein thrombosis
    J Thromb Haemost, 9 (6), 1261-3
    DOI 10.1111/j.1538-7836.2011.04298.x, PubMed 21489133
  9. Gruber FX, Lundán T, Goll R, Silye A, Mikkola I, Rekvig OP, Knuutila S, Remes K, Gedde-Dahl T, Porkka K, Hjorth-Hansen H (2011)
    BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?
    Med Oncol, 29 (1), 219-26
    DOI 10.1007/s12032-010-9781-z, PubMed 21221851
  10. Haugen F, Labori KJ, Noreng HJ, Buanes T, Iversen PO, Drevon CA (2011)
    Altered expression of genes in adipose tissues associated with reduced fat mass in patients with pancreatic cancer
    Arch Physiol Biochem, 117 (2), 78-87
    DOI 10.3109/13813455.2011.560609, PubMed 21457003
  11. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM (2011)
    The association of inherited thrombophilia and intrauterine fetal death: a case-control study
    Blood Coagul Fibrinolysis, 22 (8), 651-6
    DOI 10.1097/MBC.0b013e32834a614c, PubMed 22198364
  12. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM (2011)
    Incidence and risk factors of fetal death in Norway: a case-control study
    Acta Obstet Gynecol Scand, 90 (4), 390-7
    DOI 10.1111/j.1600-0412.2011.01079.x, PubMed 21306337
  13. Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM (2011)
    The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study
    Thromb Res, 130 (1), 32-7
    DOI 10.1016/j.thromres.2011.11.029, PubMed 22178574
  14. Jønsson V, Awan H, Nyquist E, Maisenhølder M, Johannesen TB, Ly B, Tjønnfjord GE (2011)
    Familial Hodgkin's lymphoma in Scandinavia
    In Vivo, 25 (3), 431-7
    PubMed 21576419
  15. Karlsen TA, Mirtaheri P, Shahdadfar A, Fløisand Y, Brinchmann JE (2011)
    Effect of three-dimensional culture and incubator gas concentration on phenotype and differentiation capability of human mesenchymal stem cells
    J Cell Biochem, 112 (2), 684-93
    DOI 10.1002/jcb.22978, PubMed 21268090
  16. Knudsen E, Iversen PO, Bøyum A, Seierstad T, Nicolaysen G, Benestad HB (2011)
    G-CSF enhances the proliferation and mobilization, but not the maturation rate, of murine myeloid cells
    Eur J Haematol, 87 (4), 302-11
    DOI 10.1111/j.1600-0609.2011.01658.x, PubMed 21623923
  17. Kostovski E, Dahm AE, Iversen N, Hjeltnes N, Østerud B, Sandset PM, Iversen PO (2011)
    Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium
    Blood Coagul Fibrinolysis, 22 (4), 254-9
    DOI 10.1097/MBC.0b013e3283442ce2, PubMed 21297449
  18. Kvam AK, Fayers PM, Wisloff F (2011)
    Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma
    Eur J Haematol, 87 (4), 330-7
    DOI 10.1111/j.1600-0609.2011.01665.x, PubMed 21668504
  19. Lassila R, Antovic JP, Armstrong E, Baghaei F, Dalsgaard-Nielsen J, Hillarp A, Holme PA, Holmström M, Johnsson H, Joutsi-Korhonen L, Sandset PM (2011)
    Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia
    Semin Thromb Hemost, 37 (3), 328-36
    DOI 10.1055/s-0031-1274516, PubMed 21455867
  20. Lassila R, Holme PA, Landorph A, Petrini P, Onundarson PT, Hillarp A (2011)
    Nordic Haemophilia Council's practical guidelines on diagnosis and management of von Willebrand disease
    Semin Thromb Hemost, 37 (5), 495-502
    DOI 10.1055/s-0031-1281034, PubMed 22102192
  21. Ljungman P, Locasciulli A, de Soria VG, Békássy AN, Brinch L, Espigado I, Ferrant A, Franklin IM, O'Riordan J, Rovira M, Shaw P, Einsele H, Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (2011)
    Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy
    Bone Marrow Transplant, 47 (9), 1217-21
    DOI 10.1038/bmt.2011.238, PubMed 22158388
  22. Mead GE, Graham C, Dorman P, Bruins SK, Lewis SC, Dennis MS, Sandercock PA, UK Collaborators of IST (2011)
    Fatigue after stroke: baseline predictors and influence on survival. Analysis of data from UK patients recruited in the International Stroke Trial
    PLoS One, 6 (3), e16988
    DOI 10.1371/journal.pone.0016988, PubMed 21445242
  23. Möllgård L, Saft L, Treppendahl MB, Dybedal I, Nørgaard JM, Astermark J, Ejerblad E, Garelius H, Dufva IH, Jansson M, Jädersten M, Kjeldsen L, Linder O, Nilsson L, Vestergaard H, Porwit A, Grønbæk K, Hellström-Lindberg E (2011)
    Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
    Haematologica, 96 (7), 963-71
    DOI 10.3324/haematol.2010.039669, PubMed 21719884
  24. Negaard HF, Sandset PM, Kolset SO, Svennevig K, Østenstad B, Iversen PO (2011)
    Associations between regulators of extracellular matrix and hemostatic factors in hematologic neoplasias
    Leuk Lymphoma, 52 (6), 1157-9
    DOI 10.3109/10428194.2011.563886, PubMed 21463121
  25. Nilsson-Ehle H, Birgegård G, Samuelsson J, Antunovic P, Astermark J, Garelius H, Engström LM, Kjeldsen L, Nilsson L, Olsson A, Skov-Holm M, Wallvik J, Gulbrandsen N, Hellström-Lindberg E (2011)
    Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions
    Eur J Haematol, 87 (3), 244-52
    DOI 10.1111/j.1600-0609.2011.01654.x, PubMed 21623919
  26. Nyquist KB, Thorsen J, Zeller B, Haaland A, Trøen G, Heim S, Micci F (2011)
    Identification of the TAF15-ZNF384 fusion gene in two new cases of acute lymphoblastic leukemia with a t(12;17)(p13;q12)
    Cancer Genet, 204 (3), 147-52
    DOI 10.1016/j.cancergen.2011.01.003, PubMed 21504714
  27. Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011)
    An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
    J Virol, 85 (13), 6557-66
    DOI 10.1128/JVI.00073-11, PubMed 21490090
  28. Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Antonio A et al. (2011)
    Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
    Trials, 12, 252
    DOI 10.1186/1745-6215-12-252, PubMed 22129158
  29. Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, Thijs V, Berge E, SCAST Study Group (2011)
    The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
    Lancet, 377 (9767), 741-50
    DOI 10.1016/S0140-6736(11)60104-9, PubMed 21316752
  30. Simonsson B, Gedde-Dahl T, Markevärn B, Remes K, Stentoft J, Almqvist A, Björeman M, Flogegård M, Koskenvesa P, Lindblom A, Malm C, Mustjoki S, Myhr-Eriksson K, Ohm L, Räsänen A, Sinisalo M, Själander A, Strömberg U, Bjerrum OW, Ehrencrona H, Gruber F, Kairisto V, Olsson K, Sandin F, Nagler A et al. (2011)
    Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
    Blood, 118 (12), 3228-35
    DOI 10.1182/blood-2011-02-336685, PubMed 21685374
  31. Slaastad H, Wu W, Goullart L, Kanderova V, Tjønnfjord G, Stuchly J, Kalina T, Holm A, Lund-Johansen F (2011)
    Multiplexed immuno-precipitation with 1725 commercially available antibodies to cellular proteins
    Proteomics, 11 (23), 4578-82
    DOI 10.1002/pmic.201000744, PubMed 21956872
  32. Stavik B, Skretting G, Aasheim HC, Tinholt M, Zernichow L, Sletten M, Sandset PM, Iversen N (2011)
    Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility
    BMC Cancer, 11, 357
    DOI 10.1186/1471-2407-11-357, PubMed 21849050
  33. Tangen JM, Jaworska A, Mattsson H (2011)
    The Fukushima accident--health consequences
    Tidsskr Nor Laegeforen, 131 (23), 2342-3
    DOI 10.4045/tidsskr.11.0957, PubMed 22139113
  34. Tjeldhorn L, Iversen N, Sandvig K, Bergan J, Sandset PM, Skretting G (2011)
    Protein C mutation (A267T) results in ER retention and unfolded protein response activation
    PLoS One, 6 (8), e24009
    DOI 10.1371/journal.pone.0024009, PubMed 21901152
  35. Tran HT, Tjønnfjord GE, Paus A, Holme PA (2011)
    rFVIIa administered by continuous infusion during surgery in patients with severe congenital FVII deficiency
    Haemophilia, 17 (5), 764-70
    DOI 10.1111/j.1365-2516.2011.02596.x, PubMed 21707871
  36. Vetlesen A, Holme PA, Lyberg T, Kjeldsen-Kragh J (2011)
    Recovery, survival, and function of transfused platelets and detection of platelet engraftment after allogeneic stem cell transplantation
    Transfusion, 52 (6), 1321-32
    DOI 10.1111/j.1537-2995.2011.03442.x, PubMed 22084943
  37. Wang Y, Brinch L, Jebsen P, Tanbo T, Kirschner R (2011)
    A clinical study of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation
    Biol Blood Marrow Transplant, 18 (5), 747-53
    DOI 10.1016/j.bbmt.2011.09.012, PubMed 21963879
  38. Westerberg AC, Schei R, Henriksen C, Smith L, Veierød MB, Drevon CA, Iversen PO (2011)
    Attention among very low birth weight infants following early supplementation with docosahexaenoic and arachidonic acid
    Acta Paediatr, 100 (1), 47-52
    DOI 10.1111/j.1651-2227.2010.01946.x, PubMed 20624152
  39. Wik HS, Enden TR, Jacobsen AF, Sandset PM (2011)
    Long-term quality of life after pregnancy-related deep vein thrombosis and the influence of socioeconomic factors and comorbidity
    J Thromb Haemost, 9 (10), 1931-6
    DOI 10.1111/j.1538-7836.2011.04468.x, PubMed 21848904
  40. Wiktor-Jedrzejczak W, Dearden C, de Wreede L, van Biezen A, Brinch L, Leblond V, Brune M, Volin L, Kazmi M, Nagler A, Schetelig J, de Witte T, Dreger P, EBMT Chronic Leukemia Working Party (2011)
    Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium
    Leukemia, 26 (5), 972-6
    DOI 10.1038/leu.2011.304, PubMed 22116553

Publications 2010

  1. Abrahamsen IW, Stronen E, Wälchli S, Johansen JN, Kjellevoll S, Kumari S, Komada M, Gaudernack G, Tjonnfjord G, Toebes M, Schumacher TN, Lund-Johansen F, Olweus J (2010)
    Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif
    Leukemia, 24 (11), 1901-9
    DOI 10.1038/leu.2010.186, PubMed 20844564
  2. Astermark J, Altisent C, Batorova A, Diniz MJ, Gringeri A, Holme PA, Karafoulidou A, Lopez-Fernández MF, Reipert BM, Rocino A, Schiavoni M, von Depka M, Windyga J, Fijnvandraat K, European Haemophilia Therapy Standardisation Board (2010)
    Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report
    Haemophilia, 16 (5), 747-66
    DOI 10.1111/j.1365-2516.2010.02231.x, PubMed 20398077
  3. Austbø L, Røed KH, Dolvik NI, Skretting G (2010)
    Identification of differentially expressed genes associated with osteochondrosis in standardbred horses using RNA arbitrarily primed PCR
    Anim Biotechnol, 21 (2), 135-9
    DOI 10.1080/10495391003608316, PubMed 20379890
  4. Awan H, Jønsson V, Johannesen TB, Ly B, Tjønnfjord GE (2010)
    Anticipation in families with chronic lymphocytic leukemia and other lymphoproliferative disorders
    Transl Oncogenomics, 4, 1-9
    PubMed 21566766
  5. Berentsen S, Randen U, Vågan AM, Hjorth-Hansen H, Vik A, Dalgaard J, Jacobsen EM, Thoresen AS, Beiske K, Tjønnfjord GE (2010)
    High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
    Blood, 116 (17), 3180-4
    DOI 10.1182/blood-2010-06-288647, PubMed 20634373
  6. Bergrem A, Jacobsen EM, Skjeldestad FE, Jacobsen AF, Skogstad M, Sandset PM (2010)
    The association of antiphospholipid antibodies with pregnancy-related first time venous thrombosis--a population-based case-control study
    Thromb Res, 125 (5), e222-7
    DOI 10.1016/j.thromres.2009.12.006, PubMed 20051285
  7. Bjornaas MA, Jacobsen EM, Jacobsen D (2010)
    Nonfatal self-poisoning with LMW heparin and the use of antidote
    Thromb Res, 126 (5), e403-5
    DOI 10.1016/j.thromres.2010.08.026, PubMed 20870279
  8. Dahm AE, Bezemer ID, Sandset PM, Rosendaal FR (2010)
    Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis
    J Thromb Haemost, 8 (5), 1130-2
    DOI 10.1111/j.1538-7836.2010.03805.x, PubMed 20149077
  9. Enden T, Storås TH, Negård A, Haig Y, Sandvik L, Gjesdal KI, Sandset PM, Kløw NE (2010)
    Visualization of deep veins and detection of deep vein thrombosis (DVT) with balanced turbo field echo (b-TFE) and contrast-enhanced T1 fast field echo (CE-FFE) using a blood pool agent (BPA)
    J Magn Reson Imaging, 31 (2), 416-24
    DOI 10.1002/jmri.22046, PubMed 20099355
  10. Fløisand Y, Sioud M (2010)
    Recent advances in hematopoietic stem cell transplantation and perspectives of RNAi applications
    Methods Mol Biol, 629, 507-23
    DOI 10.1007/978-1-60761-657-3_30, PubMed 20387168
  11. Ghanima W, Holme PA, Tjønnfjord GE (2010)
    [Immune thrombocytopenia--pathophysiology and treatment]
    Tidsskr Nor Laegeforen, 130 (21), 2120-3
    DOI 10.4045/tidsskr.09.1119, PubMed 21052113
  12. Gimsing P, Carlson K, Turesson I, Fayers P, Waage A, Vangsted A, Mylin A, Gluud C, Juliusson G, Gregersen H, Hjorth-Hansen H, Nesthus I, Dahl IM, Westin J, Nielsen JL, Knudsen LM, Ahlberg L, Hjorth M, Abildgaard N, Andersen NF, Linder O, Wisløff F (2010)
    Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
    Lancet Oncol, 11 (10), 973-82
    DOI 10.1016/S1470-2045(10)70198-4, PubMed 20863761
  13. Grövdal M, Karimi M, Khan R, Aggerholm A, Antunovic P, Astermark J, Bernell P, Engström LM, Kjeldsen L, Linder O, Nilsson L, Olsson A, Holm MS, Tangen JM, Wallvik J, Oberg G, Hokland P, Jacobsen SE, Porwit A, Hellström-Lindberg E (2010)
    Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy
    Br J Haematol, 150 (3), 293-302
    DOI 10.1111/j.1365-2141.2010.08235.x, PubMed 20497178
  14. Ha L, Hauge T, Iversen PO (2010)
    Body composition in older acute stroke patients after treatment with individualized, nutritional supplementation while in hospital
    BMC Geriatr, 10, 75
    DOI 10.1186/1471-2318-10-75, PubMed 20955603
  15. Ha L, Hauge T, Spenning AB, Iversen PO (2010)
    Individual, nutritional support prevents undernutrition, increases muscle strength and improves QoL among elderly at nutritional risk hospitalized for acute stroke: a randomized, controlled trial
    Clin Nutr, 29 (5), 567-73
    DOI 10.1016/j.clnu.2010.01.011, PubMed 20176418
  16. Iversen PO, Sørensen DR, Sioud M (2010)
    A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia
    Thromb Haemost, 104 (2), 350-4
    DOI 10.1160/TH09-12-0816, PubMed 20539915
  17. Jacobsen AF, Dahm A, Bergrem A, Jacobsen EM, Sandset PM (2010)
    Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms
    J Thromb Haemost, 8 (11), 2443-9
    DOI 10.1111/j.1538-7836.2010.04038.x, PubMed 20735725
  18. Jensen K, Schaffer L, Olstad OK, Bechensteen AG, Hellebostad M, Tjønnfjord GE, Kierulf P, Gautvik KM, Osnes LT (2010)
    Striking decrease in the total precursor B-cell compartment during early childhood as evidenced by flow cytometry and gene expression changes
    Pediatr Hematol Oncol, 27 (1), 31-45
    DOI 10.3109/08880010903420687, PubMed 20121553
  19. Johnsen HE, Klausen TW, Boegsted M, Lenhoff S, Gimsing P, Christiansen I, Gedde-Dahl T, Lindås R, Mellqvist UH, Nordic Myeloma Study Group (2010)
    Improved survival for multiple myeloma in denmark based on autologous stem cell transplantation and novel drug therapy in collaborative trials: analysis of accrual, prognostic variables, selection bias, and clinical behavior on survival in more than 1200 patients in trials of the nordic myeloma study group
    Clin Lymphoma Myeloma Leuk, 10 (4), 290-6
    DOI 10.3816/CLML.2010.n.060, PubMed 20709667
  20. Jønsson V, Tjønnfjord GE, Johannesen TB, Ly B, Olsen JH, Yuille M (2010)
    Familial chronic lymphocytic leukemia in Norway and Denmark. Comments on pleiotropy and birth order
    In Vivo, 24 (1), 85-95
    PubMed 20133982
  21. Kostovski E, Iversen PO, Hjeltnes N (2010)
    [Complications of chronic spinal cord injury]
    Tidsskr Nor Laegeforen, 130 (12), 1242-5
    DOI 10.4045/tidsskr.09.0055, PubMed 20567276
  22. Krarup LH, Sandset EC, Sandset PM, Berge E (2010)
    D-dimer levels and stroke progression in patients with acute ischemic stroke and atrial fibrillation
    Acta Neurol Scand, 124 (1), 40-4
    DOI 10.1111/j.1600-0404.2010.01409.x, PubMed 20726843
  23. Kringen MK, Narum S, Lygren I, Seljeflot I, Sandset PM, Trøseid AM, Johansen PW, Brørs O, Holthe MR (2010)
    Reduced platelet function and role of drugs in acute gastrointestinal bleeding
    Basic Clin Pharmacol Toxicol, 108 (3), 194-201
    DOI 10.1111/j.1742-7843.2010.00643.x, PubMed 21118353
  24. Krishnan B, Else M, Tjonnfjord GE, Cazin B, Carney D, Carter J, Ketterer N, Catovsky D, Ethell M, Matutes E, Dearden CE (2010)
    Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study
    Br J Haematol, 149 (6), 907-10
    DOI 10.1111/j.1365-2141.2010.08134.x, PubMed 20201944
  25. Kvam AK, Wisløff F, Fayers PM (2010)
    Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma
    Health Qual Life Outcomes, 8, 79
    DOI 10.1186/1477-7525-8-79, PubMed 20678240
  26. Opstad TB, Eilertsen AL, Høibraaten E, Skretting G, Sandset PM (2010)
    Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy
    Blood Coagul Fibrinolysis, 21 (6), 516-21
    DOI 10.1097/MBC.0b013e32833a06cd, PubMed 20453636
  27. Ruland CM, Holte HH, Røislien J, Heaven C, Hamilton GA, Kristiansen J, Sandbaek H, Kvaløy SO, Hasund L, Ellison MC (2010)
    Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trial
    J Am Med Inform Assoc, 17 (4), 403-10
    DOI 10.1136/jamia.2010.005660, PubMed 20595307
  28. Sandset EC, Murray G, Boysen G, Jatuzis D, Kõrv J, Lüders S, Richter PS, Roine RO, Terént A, Thijs V, Berge E, SCAST Study Group (2010)
    Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003)
    Int J Stroke, 5 (5), 423-7
    DOI 10.1111/j.1747-4949.2010.00473.x, PubMed 20854630
  29. Sandset PM (2010)
    Immunobiology of heparin-induced thrombocytopenia
    Curr Top Microbiol Immunol, 341, 193-202
    DOI 10.1007/82_2010_17, PubMed 20369319
  30. Sandset PM, Arnesen H, Jacobsen AF, Wergeland H (2010)
    Prophylaxis against prosthetic mitral valve thrombosis with unfractionated heparin administered by an elastometric infusion pump
    Thromb Res, 126 (3), e232-4
    DOI 10.1016/j.thromres.2010.05.005, PubMed 20553950
  31. Sandset PM, Francis C (2010)
    Thrombosis Research--affiliation with the European Thrombosis Research Organization (ETRO)
    Thromb Res, 125 (1), 1
    DOI 10.1016/j.thromres.2010.01.008, PubMed 20171348
  32. Semaeva E, Tenstad O, Skavland J, Enger M, Iversen PO, Gjertsen BT, Wiig H (2010)
    Access to the spleen microenvironment through lymph shows local cytokine production, increased cell flux, and altered signaling of immune cells during lipopolysaccharide-induced acute inflammation
    J Immunol, 184 (8), 4547-56
    DOI 10.4049/jimmunol.0902049, PubMed 20237290
  33. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
    Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation
    Scand J Immunol, 71 (4), 267-74
    DOI 10.1111/j.1365-3083.2010.02378.x, PubMed 20384870
  34. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
    Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins
    Int J Oncol, 38 (2), 385-90
    DOI 10.3892/ijo.2010.869, PubMed 21165555
  35. Skretting G, Stavik B, Landvik NE, Myklebust CF, Iversen N, Zienolddiny S, Sandset PM (2010)
    Functional characterization of polymorphisms in the human TFPI gene
    Biochem Biophys Res Commun, 397 (1), 106-11
    DOI 10.1016/j.bbrc.2010.05.078, PubMed 20519147
  36. Smeland EB, Vartdal F, Wisløff F (2010)
    [Close cooperation, but not oversteering]
    Tidsskr Nor Laegeforen, 130 (6), 590-1
    DOI 10.4045/tidsskr.10.0153, PubMed 20348990
  37. Smeland EB, Vartdal F, Wisløff F (2010)
    [Leadership and academic competence]
    Tidsskr Nor Laegeforen, 130 (6), 591
    DOI 10.4045/tidsskr.10.0217, PubMed 20348994
  38. Stavik B, Skretting G, Sletten M, Sandset PM, Iversen N (2010)
    Overexpression of both TFPIα and TFPIβ induces apoptosis and expression of genes involved in the death receptor pathway in breast cancer cells
    Mol Carcinog, 49 (11), 951-63
    DOI 10.1002/mc.20679, PubMed 20886581
  39. Tangen JM, Fløisand Y, Haukås E, Naess IA, Skjelbakken T, Stapnes C, Tjønnfjord GE (2010)
    [Survival in adults with acute lymphoblastic leukaemia]
    Tidsskr Nor Laegeforen, 130 (17), 1710-3
    DOI 10.4045/tidsskr.09.1293, PubMed 20835280
  40. Tjeldhorn L, Iversen N, Sandvig K, Bergan J, Sandset PM, Skretting G (2010)
    Functional characterization of the protein C A267T mutation: evidence for impaired secretion due to defective intracellular transport
    BMC Cell Biol, 11, 67
    DOI 10.1186/1471-2121-11-67, PubMed 20815936
  41. Westerberg AC, Henriksen C, Ellingvåg A, Veierød MB, Júlíusson PB, Nakstad B, Aurvåg AK, Rønnestad A, Grønn M, Iversen PO, Drevon CA (2010)
    First year growth among very low birth weight infants
    Acta Paediatr, 99 (4), 556-62
    DOI 10.1111/j.1651-2227.2009.01667.x, PubMed 20096031
  42. Wiig H, Tenstad O, Iversen PO, Kalluri R, Bjerkvig R (2010)
    Interstitial fluid: the overlooked component of the tumor microenvironment?
    Fibrogenesis Tissue Repair, 3, 12
    DOI 10.1186/1755-1536-3-12, PubMed 20653943
  43. Waage A, Gimsing P, Fayers P, Abildgaard N, Ahlberg L, Björkstrand B, Carlson K, Dahl IM, Forsberg K, Gulbrandsen N, Haukås E, Hjertner O, Hjorth M, Karlsson T, Knudsen LM, Nielsen JL, Linder O, Mellqvist UH, Nesthus I, Rolke J, Strandberg M, Sørbø JH, Wisløff F, Juliusson G, Turesson I et al. (2010)
    Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
    Blood, 116 (9), 1405-12
    DOI 10.1182/blood-2009-08-237974, PubMed 20448107

Publications 2009

  1. Abildgaard U, Sandset PM, Hammerstrøm J, Gjestvang FT, Tveit A (2009)
    Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin
    Thromb Res, 124 (3), 262-7
    DOI 10.1016/j.thromres.2008.12.005, PubMed 19162303
  2. Andresen PA, Heimdal K, Aaberg K, Eklo K, Ariansen S, Silye A, Fausa O, Aabakken L, Aretz S, Eide TJ, Gedde-Dahl T (2009)
    APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations
    J Cancer Res Clin Oncol, 135 (10), 1463-70
    DOI 10.1007/s00432-009-0594-4, PubMed 19444466
  3. Astermark J, Negrier C, Hermans C, Holme PA, Klamroth R, Kotsi P, de Moerloose P, Pasi J, Rocino A, von Depka M, Windyga J, Ludlam CA, Interdisciplinary Working Group IDWG (2009)
    European curriculum for thrombosis and haemostasis
    Haemophilia, 15 (1), 337-44
    DOI 10.1111/j.1365-2516.2008.01836.x, PubMed 19149857
  4. Berentsen S, Sundic T, Hervig T, Tjønnfjord GE (2009)
    [Autoimmune hemolytic anemia]
    Tidsskr Nor Laegeforen, 129 (21), 2226-31
    DOI 10.4045/tidsskr.09.0161, PubMed 19898570
  5. Bird J, Behrens J, Westin J, Turesson I, Drayson M, Beetham R, D'Sa S, Soutar R, Waage A, Gulbrandsen N, Gregersen H, Low E, Haemato-oncology Task Force of the British Committee for Standards in Haematology, UK Myeloma Forum and Nordic Myeloma Study Group (2009)
    UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)
    Br J Haematol, 147 (1), 22-42
    DOI 10.1111/j.1365-2141.2009.07807.x, PubMed 19673884
  6. Damås JK, Landrø L, Fevang B, Heggelund L, Tjønnfjord GE, Fløisand Y, Halvorsen B, Frøland SS, Aukrust P (2009)
    Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication
    Clin Exp Immunol, 157 (3), 400-7
    DOI 10.1111/j.1365-2249.2009.03976.x, PubMed 19664149
  7. Enden T, Kløw NE, Sandvik L, Slagsvold CE, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbaek G, Sandset PM, CaVenT study group (2009)
    Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency
    J Thromb Haemost, 7 (8), 1268-75
    DOI 10.1111/j.1538-7836.2009.03464.x, PubMed 19422443
  8. Haram K, Svendsen E, Abildgaard U (2009)
    The HELLP syndrome: clinical issues and management. A Review
    BMC Pregnancy Childbirth, 9, 8
    DOI 10.1186/1471-2393-9-8, PubMed 19245695
  9. Henriksen C, Westerberg AC, Rønnestad A, Nakstad B, Veierød MB, Drevon CA, Iversen PO (2009)
    Growth and nutrient intake among very-low-birth-weight infants fed fortified human milk during hospitalisation
    Br J Nutr, 102 (8), 1179-86
    DOI 10.1017/S0007114509371755, PubMed 19445820
  10. Holme PA, Glomstein A, Grønhaug S, Tjønnfjord GE (2009)
    Home treatment with bypassing products in inhibitor patients: a 7.5-year experience
    Haemophilia, 15 (3), 727-32
    DOI 10.1111/j.1365-2516.2009.02017.x, PubMed 19320748
  11. Iversen PO, Andersson KB, Finsen AV, Sjaastad I, von Lueder TG, Sejersted OM, Attramadal H, Christensen G (2009)
    Separate mechanisms cause anemia in ischemic vs. nonischemic murine heart failure
    Am J Physiol Regul Integr Comp Physiol, 298 (3), R808-14
    DOI 10.1152/ajpregu.00250.2009, PubMed 20032264
  12. Iversen PO, Semaeva E, Sorensen DR, Wiig H, Sioud M (2009)
    Dendritic Cells Loaded with Tumor Antigens and a Dual Immunostimulatory and Anti-Interleukin 10-Specific Small Interference RNA Prime T Lymphocytes against Leukemic Cells
    Transl Oncol, 2 (4), 242-6
    DOI 10.1593/tlo.09154, PubMed 19956385
  13. Iversen PO, Wisløff F, Gulbrandsen N (2009)
    Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support
    Clin Nutr, 29 (4), 488-91
    DOI 10.1016/j.clnu.2009.12.002, PubMed 20044183
  14. Kardel KR, Johansen B, Voldner N, Iversen PO, Henriksen T (2009)
    Association between aerobic fitness in late pregnancy and duration of labor in nulliparous women
    Acta Obstet Gynecol Scand, 88 (8), 948-52
    DOI 10.1080/00016340903093583, PubMed 19562561
  15. Kvam AK, Fayers P, Hjermstad M, Gulbrandsen N, Wisloff F (2009)
    Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations
    Eur J Haematol, 83 (4), 279-89
    DOI 10.1111/j.1600-0609.2009.01303.x, PubMed 19558508
  16. Kvam AK, Fayers P, Wisloff F (2009)
    What changes in health-related quality of life matter to multiple myeloma patients? A prospective study
    Eur J Haematol, 84 (4), 345-53
    DOI 10.1111/j.1600-0609.2009.01404.x, PubMed 20041946
  17. Micci F, Panagopoulos I, Haugom L, Andersen HK, Tjønnfjord GE, Beiske K, Heim S (2009)
    t(3;21)(q22;q22) leading to truncation of the RYK gene in atypical chronic myeloid leukemia
    Cancer Lett, 277 (2), 205-11
    DOI 10.1016/j.canlet.2008.12.016, PubMed 19168282
  18. Michalsen S, Schrumpf E, Beiske K, Tierens A, Stenberg V, Tjønnfjord GE (2009)
    [Large granular lymphocytic leukaemia]
    Tidsskr Nor Laegeforen, 129 (11), 1098-102
    DOI 10.4045/tidsskr.09.0152, PubMed 19488091
  19. Mustjoki S, Ekblom M, Arstila TP, Dybedal I, Epling-Burnette PK, Guilhot F, Hjorth-Hansen H, Höglund M, Kovanen P, Laurinolli T, Liesveld J, Paquette R, Pinilla-Ibarz J, Rauhala A, Shah N, Simonsson B, Sinisalo M, Steegmann JL, Stenke L, Porkka K (2009)
    Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy
    Leukemia, 23 (8), 1398-405
    DOI 10.1038/leu.2009.46, PubMed 19295545
  20. Negaard HF, Svennevig K, Kolset SO, Iversen N, Lothe IM, Østenstad B, Sandset PM, Iversen PO (2009)
    Alterations in regulators of the extracellular matrix in non-Hodgkin lymphomas
    Leuk Lymphoma, 50 (6), 998-1004
    DOI 10.1080/10428190902889270, PubMed 19373600
  21. Perry D, Berntorp E, Tait C, Dolan G, Holme PA, Laffan M, Lassila R, Mumford A, Pasi J, Wilde J, Will A, Yee TT (2009)
    FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations
    Haemophilia, 16 (1), 80-9
    DOI 10.1111/j.1365-2516.2009.02104.x, PubMed 19780845
  22. Rehn TA, Borge BA, Lunde PK, Munkvik M, Sneve ML, Grøndahl F, Aronsen JM, Sjaastad I, Prydz K, Kolset SO, Wiig H, Sejersted OM, Iversen PO (2009)
    Temporary fatigue and altered extracellular matrix in skeletal muscle during progression of heart failure in rats
    Am J Physiol Regul Integr Comp Physiol, 297 (1), R26-33
    DOI 10.1152/ajpregu.90617.2008, PubMed 19339678
  23. Reseland JE, Reppe S, Olstad OK, Hjorth-Hansen H, Brenne AT, Syversen U, Waage A, Iversen PO (2009)
    Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma
    Eur J Haematol, 83 (5), 460-70
    DOI 10.1111/j.1600-0609.2009.01311.x, PubMed 19572994
  24. Sandset PM, Francis C (2009)
    Thrombosis Research: Introduction of e-pages
    Thromb Res, 124 (3), 251
    DOI 10.1016/j.thromres.2009.06.001, PubMed 19596224
  25. Sandset PM, Francis C, Key N (2009)
    Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)
    Thromb Res, 124 (5), 515
    DOI 10.1016/j.thromres.2009.09.021, PubMed 19837232
  26. Sandset PM, Høibraaten E, Eilertsen AL, Dahm A (2009)
    Mechanisms of thrombosis related to hormone therapy
    Thromb Res, 123 Suppl 2, S70-3
    DOI 10.1016/S0049-3848(09)70015-5, PubMed 19217481
  27. Schjesvold FH (2009)
    [Erythrocytosis as a problem]
    Tidsskr Nor Laegeforen, 129 (22), 2387; author reply 2387
    DOI 10.4045/tidsskr.09.1196, PubMed 19935946
  28. Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J (2009)
    Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells
    Scand J Immunol, 69 (4), 319-28
    DOI 10.1111/j.1365-3083.2008.02223.x, PubMed 19284496
  29. Sørby R, Austbø L, Press CM, Skretting G, Landsverk T, Espenes A (2009)
    PrP expression, PrPSc accumulation and innervation of splenic compartments in sheep experimentally infected with scrapie
    PLoS One, 4 (9), e6885
    DOI 10.1371/journal.pone.0006885, PubMed 19727393
  30. Taraldsrud E, Grøgaard HK, Solheim S, Lunde K, Fløisand Y, Arnesen H, Seljeflot I, Egeland T (2009)
    Age and stress related phenotypical changes in bone marrow CD34+ cells
    Scand J Clin Lab Invest, 69 (1), 79-84
    DOI 10.1080/00365510802419447, PubMed 18836945
  31. Tjeldhorn L, Sandset PM, Haugbro K, Skretting G (2009)
    Hereditary protein C deficiency caused by the Ala267Thr mutation in the protein C gene is associated with symptomatic and asymptomatic venous thrombosis
    Thromb Res, 125 (3), 230-4
    DOI 10.1016/j.thromres.2009.05.013, PubMed 19535131
  32. Vefring HK, Gruber FX, Wee L, Hovland R, Hjorth-Hansen H, Gedde Dahl T, Meyer P (2009)
    Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases
    Acta Haematol, 122 (1), 11-6
    DOI 10.1159/000230037, PubMed 19641300
  33. Vik A, Holme PA, Singh K, Dorenberg E, Nordhus KC, Kumar S, Hansen JB (2009)
    Catheter-directed thrombolysis for treatment of deep venous thrombosis in the upper extremities
    Cardiovasc Intervent Radiol, 32 (5), 980-7
    DOI 10.1007/s00270-009-9655-y, PubMed 19641959

Publications 2008

  1. Akkök CA, Holte MR, Tangen JM, Ostenstad B, Bruserud O (2008)
    Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells
    Transfusion, 49 (2), 354-61
    DOI 10.1111/j.1537-2995.2008.01949.x, PubMed 18980622
  2. Austbø L, Kampmann A, Müller-Ladner U, Neumann E, Olsaker I, Skretting G (2008)
    Identification of differentially expressed genes in ileal Peyer's patch of scrapie-infected sheep using RNA arbitrarily primed PCR
    BMC Vet Res, 4, 12
    DOI 10.1186/1746-6148-4-12, PubMed 18373840
  3. Benestad HB, Wisløff F (2008)
    [Research ethics and University of Oslo]
    Tidsskr Nor Laegeforen, 128 (15), 1683-4
    PubMed 18704143
  4. Brinch L, Tjønnfjord G, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I (2008)
    [Allogeneic stem cell transplantation in acute myelogenous leukemia]
    Tidsskr Nor Laegeforen, 128 (15), 1681-2; author reply 1682
    PubMed 18704137
  5. Crowther-Swanepoel D, Wild R, Sellick G, Dyer MJ, Mauro FR, Cuthbert RJ, Jonsson V, Matutes E, Dearden C, Wiley J, Fuller S, Catovsky D, Houlston RS (2008)
    Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL
    Blood, 111 (12), 5691-3
    DOI 10.1182/blood-2008-03-142349, PubMed 18424666
  6. Eilertsen AL, Karssemeijer N, Skaane P, Qvigstad E, Sandset PM (2008)
    Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method
    BJOG, 115 (6), 773-9
    DOI 10.1111/j.1471-0528.2008.01690.x, PubMed 18355366
  7. Eilertsen AL, Sandvik L, Steinsvik B, Sandset PM (2008)
    Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers
    J Thromb Haemost, 6 (6), 928-34
    DOI 10.1111/j.1538-7836.2008.02970.x, PubMed 18394014
  8. Enden T, Garratt AM, Kløw NE, Sandset PM (2008)
    Assessing burden of illness following acute deep vein thrombosis: data quality, reliability and validity of the Norwegian version of VEINES-QOL/Sym, a disease-specific questionnaire
    Scand J Caring Sci, 23 (2), 369-74
    DOI 10.1111/j.1471-6712.2008.00618.x, PubMed 19068041
  9. Fløisand Y, Brinch L, Dybedal I, Gedde-Dahl T, Heldal D, Holme PA, Egeland T, Tjønnfjord GE (2008)
    [Allogeneic stem cell transplantation in adults with acute lymphoblastic leukaemia]
    Tidsskr Nor Laegeforen, 128 (22), 2563-6
    PubMed 19023351
  10. Ha L, Iversen PO, Hauge T (2008)
    [Nutrition for elderly acute stroke patients]
    Tidsskr Nor Laegeforen, 128 (17), 1946-50
    PubMed 18787570
  11. Haga HJ, Jacobsen EM, Peen E (2008)
    Incidence of thromboembolic events in patients with primary Sjögren's syndrome
    Scand J Rheumatol, 37 (2), 127-9
    DOI 10.1080/03009740701716843, PubMed 18415770
  12. Hofstad B, Nesbakken A, Eritsland J, Brørs O, Sandset PM (2008)
    [Should platelet inhibitors be discontinued before gastrointestinal endoscopy?]
    Tidsskr Nor Laegeforen, 128 (21), 2440-2
    PubMed 19096466
  13. Holme PA, Michelsen AE (2008)
    [A 40-year old woman with dizziness and vomiting]
    Tidsskr Nor Laegeforen, 128 (12), 1413-5
    PubMed 18584769
  14. Iversen PO, Ukrainchenko E, Afanasyev B, Hulbekkmo K, Choukah A, Gulbrandsen N, Wisløff F, Tangen JM (2008)
    Impaired nutritional status during intensive chemotherapy in Russian and Norwegian cohorts with acute myeloid leukemia
    Leuk Lymphoma, 49 (10), 1916-24
    DOI 10.1080/10428190802339723, PubMed 18949615
  15. Jacobsen AF, Skjeldestad FE, Sandset PM (2008)
    Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study
    J Thromb Haemost, 6 (6), 905-12
    DOI 10.1111/j.1538-7836.2008.02961.x, PubMed 18363820
  16. Johannesen TB, Ly B, Samuelsen SO, Tjønnfjord GE, Jønsson V (2008)
    [A new study of chronic lymphatic leukemia in Norway]
    Tidsskr Nor Laegeforen, 128 (6), 713
    PubMed 18337855
  17. Jädersten M, Malcovati L, Dybedal I, Della Porta MG, Invernizzi R, Montgomery SM, Pascutto C, Porwit A, Cazzola M, Hellström-Lindberg E (2008)
    Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome
    J Clin Oncol, 26 (21), 3607-13
    DOI 10.1200/JCO.2007.15.4906, PubMed 18559873
  18. Jønsson V, Samuelsen SO, Tjønnfjord G, Johannesen T (2008)
    Looking for CLL genes
    Leuk Lymphoma, 49 (1), 10-1
    DOI 10.1080/10428190701713705, PubMed 18203003
  19. Jønsson V, Tjønnfjord GE, Johannesen TB, Samuelsen SO, Ly B (2008)
    Possible imprinting and microchimerism in chronic lymphocytic leukemia and related lymphoproliferative disorders
    Transl Oncogenomics, 3, 15-20
    PubMed 21566740
  20. Kolstad A, Tjønnfjord G, Jønsson V (2008)
    High frequency of unrecognized indolent hematological disorders among HLA-matched siblings of patients with lymphoproliferative malignancies eligible for allo-SCT
    Bone Marrow Transplant, 42 (6), 427-8
    DOI 10.1038/bmt.2008.183, PubMed 18587433
  21. Landrø L, Damås JK, Flo TH, Heggelund L, Ueland T, Tjønnfjord GE, Espevik T, Aukrust P, Frøland SS (2008)
    Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy
    Clin Exp Immunol, 152 (1), 57-63
    DOI 10.1111/j.1365-2249.2008.03592.x, PubMed 18241231
  22. Larson RA, Druker BJ, Guilhot F, O'Brien SG, Riviere GJ, Krahnke T, Gathmann I, Wang Y, IRIS (International Randomized Interferon vs STI571) Study Group (2008)
    Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
    Blood, 111 (8), 4022-8
    DOI 10.1182/blood-2007-10-116475, PubMed 18256322
  23. Lunde K, Solheim S, Forfang K, Arnesen H, Brinch L, Bjørnerheim R, Ragnarsson A, Egeland T, Endresen K, Ilebekk A, Mangschau A, Aakhus S (2008)
    Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up
    J Am Coll Cardiol, 51 (6), 674-6
    DOI 10.1016/j.jacc.2007.10.032, PubMed 18261689
  24. Mellqvist UH, Lenhoff S, Johnsen HE, Hjorth M, Holmberg E, Juliusson G, Tangen JM, Westin J, Nordic Myeloma Study Group (2008)
    Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone
    Cancer, 112 (1), 129-35
    DOI 10.1002/cncr.23145, PubMed 17973267
  25. Negaard HF, Iversen N, Bowitz-Lothe IM, Sandset PM, Steinsvik B, Ostenstad B, Iversen PO (2008)
    Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors
    Leukemia, 23 (1), 162-9
    DOI 10.1038/leu.2008.255, PubMed 18800145
  26. Negaard HF, Iversen PO, Ostenstad B, Mowinckel MC, Sandset PM (2008)
    Increased acquired activated protein C resistance in unselected patients with hematological malignancies
    J Thromb Haemost, 6 (9), 1482-7
    DOI 10.1111/j.1538-7836.2008.03060.x, PubMed 18573186
  27. Negaard HF, Iversen PO, Østenstad B, Iversen N, Holme PA, Sandset PM (2008)
    Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor
    Thromb Haemost, 99 (6), 1040-8
    DOI 10.1160/TH07-09-0541, PubMed 18521506
  28. Olsen AL, Johannesen TB, Ly B, Samuelsen SO, Tjonnfjord G, Jonsson V (2008)
    Pleiotropy in families with chronic lymphocytic leukemia
    Salud Cienc., 15 (8), 1236-+
  29. Piehler AP, Gulbrandsen N, Kierulf P, Urdal P (2008)
    Quantitation of serum free light chains in combination with protein electrophoresis and clinical information for diagnosing multiple myeloma in a general hospital population
    Clin Chem, 54 (11), 1823-30
    DOI 10.1373/clinchem.2008.106153, PubMed 18801937
  30. Sandercock P, Lindley R, Wardlaw J, Dennis M, Lewis S, Venables G, Kobayashi A, Czlonkowska A, Berge E, Slot KB, Murray V, Peeters A, Hankey G, Matz K, Brainin M, Ricci S, Celani MG, Righetti E, Cantisani T, Gubitz G, Phillips S, Arauz A, Prasad K, Correia M, Lyrer P et al. (2008)
    Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke
    Trials, 9, 37
    DOI 10.1186/1745-6215-9-37, PubMed 18559104
  31. Sandercock P, Wardlaw J, Dennis M, Lindley R, Hankey G, Matz K, Peeters A, Phillips S, Gubitz G, Prasad K, Ricci S, Celani MG, Righetti E, Cantisani T, Arauz A, Berge E, Slot KB, Kobayashi A, Czlonkowska A, Correia M, Murray V, Lyrer P, Venables G, IST-3 Collaborative Group (2008)
    EPITHET--where next?
    Lancet Neurol, 7 (7), 570-1; author reply 571-3
    DOI 10.1016/S1474-4422(08)70123-6, PubMed 18565447
  32. Schjesvold FH, Sjo M, Tangen JM, Hammerstrøm J, Brinch L (2008)
    [High-dose treatment of systemic AL-amyloidosis with autologous stem cell support]
    Tidsskr Nor Laegeforen, 128 (12), 1392-6
    PubMed 18552900
  33. Skretting G, Lien T, Sandset PM, Iversen N (2008)
    Expression of the V264M TFPI mutant in endothelial cell cultures may involve mRNA stability
    Thromb Res, 123 (6), 851-5
    DOI 10.1016/j.thromres.2008.09.003, PubMed 19007969
  34. Stelljes M, van Biezen A, Slavin S, Olavarria E, Clark RE, Nagler A, Koza V, Kienast J, Niederwieser D, de Witte T, Ruutu T, complications subcommittee of the Chronic Leukemia Working Party (2008)
    The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation
    Bone Marrow Transplant, 42 (11), 739-42
    DOI 10.1038/bmt.2008.254, PubMed 18724394
  35. Tangen JM, Fløisand Y, Foss-Abrahamsen J, Haukås E, Naess IA, Skjelbakken T (2008)
    [Survival in adults with acute myelogenous leukemia]
    Tidsskr Nor Laegeforen, 128 (10), 1164-7
    PubMed 18480864
  36. Aasbrenn M, Langmark F, Wisløff F (2008)
    [Is registration of multiple myeloma in the Norwegian Cancer Registry good enough?]
    Tidsskr Nor Laegeforen, 128 (23), 2712-4
    PubMed 19079417

Publications 2007

  1. Abildgaard U (2007)
    Antithrombin--early prophecies and present challenges
    Thromb Haemost, 98 (1), 97-104
    DOI 10.1160/Th07-040277, PubMed 17597998
  2. Akkök CA, Brinch L, Lauritzsen GF, Solheim BG, Kjeldsen-Kragh J (2007)
    Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy
    Vox Sang, 93 (1), 42-8
    DOI 10.1111/j.1423-0410.2007.00917.x, PubMed 17547564
  3. Andresen MS, Eilertsen AL, Abildgaard U, Sandset PM (2007)
    Hormone therapy and raloxifene reduce the coagulation inhibitor potential
    Blood Coagul Fibrinolysis, 18 (5), 455-60
    DOI 10.1097/MBC.0b013e32813a2de7, PubMed 17581320
  4. Andresen PA, Johansen T, Eide TJ, Gedde-Dahl T (2007)
    Gene symbol: APC
    Hum Genet, 121 (2), 288
    PubMed 17598199
  5. Austbø L, Espenes A, Olsaker I, Press CM, Skretting G (2007)
    Increased PrP mRNA expression in lymphoid follicles of the ileal Peyer's patch of sheep experimentally exposed to the scrapie agent
    J Gen Virol, 88 (Pt 7), 2083-90
    DOI 10.1099/vir.0.82791-0, PubMed 17554044
  6. Berentsen S, Beiske K, Tjønnfjord GE (2007)
    Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy
    Hematology, 12 (5), 361-70
    DOI 10.1080/10245330701445392, PubMed 17891600
  7. Berentsen S, Ulvestad E, Tjønnfjord GE (2007)
    B-lymphocytes as targets for therapy in chronic cold agglutinin disease
    Cardiovasc Hematol Disord Drug Targets, 7 (3), 219-27
    PubMed 17896962
  8. Berge E, Haug KB, Sandset EC, Haugbro KK, Turkovic M, Sandset PM (2007)
    The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation
    Stroke, 38 (3), 1069-71
    DOI 10.1161/01.STR.0000258076.04860.8e, PubMed 17290027
  9. Cocks K, Cohen D, Wisløff F, Sezer O, Lee S, Hippe E, Gimsing P, Turesson I, Hajek R, Smith A, Graham L, Phillips A, Stead M, Velikova G, Brown J, EORTC Quality of Life Group (2007)
    An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma
    Eur J Cancer, 43 (11), 1670-8
    DOI 10.1016/j.ejca.2007.04.022, PubMed 17574838
  10. Dahlqvist J, Klar J, Hausser I, Anton-Lamprecht I, Pigg MH, Gedde-Dahl T, Gånemo A, Vahlquist A, Dahl N (2007)
    Congenital ichthyosis: mutations in ichthyin are associated with specific structural abnormalities in the granular layer of epidermis
    J Med Genet, 44 (10), 615-20
    DOI 10.1136/jmg.2007.050542, PubMed 17557927
  11. Dahm AE, Sandset PM, Rosendaal FR (2007)
    The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1
    J Thromb Haemost, 6 (2), 393-5
    DOI 10.1111/j.1538-7836.2007.02859.x, PubMed 18045239
  12. Dalgaard J, Fløisand Y, Stenersen M, Egeland T, Brinch L (2007)
    [Non-myeloablative allogeneic stem cell transplantation]
    Tidsskr Nor Laegeforen, 127 (6), 721-4
    PubMed 17363982
  13. Eilertsen AL, Liestøl S, Mowinckel MC, Hemker HC, Sandset PM (2007)
    Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system
    Thromb Haemost, 97 (6), 938-43
    DOI 10.1160/TH06-11-0632, PubMed 17549295
  14. Enden T, Sandvik L, Kløw NE, Hafsahl G, Holme PA, Holmen LO, Ghanima W, Njaastad AM, Sandbaek G, Slagsvold CE, Sandset PM (2007)
    Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis--the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771)
    Am Heart J, 154 (5), 808-14
    DOI 10.1016/j.ahj.2007.07.010, PubMed 17967583
  15. Fløisand Y, Normann AP, Heim S, Lund-Johansen F, Tjønnfjord GE (2007)
    High expression of CD7 on CD34+ cells is not linked to deletion of derivative chromosome 9 or lack of dendritic cells in chronic myeloid leukaemia
    Scand J Clin Lab Invest, 68 (2), 93-8
    DOI 10.1080/00365510701558477, PubMed 17852828
  16. Frøyland M, Thompson KM, Thorpe SJ, Sahota SS, Gedde-Dahl T, Bogen B (2007)
    A VH4-34+ myeloma protein with weak autoreactivity
    Haematologica, 92 (5), 690-3
    DOI 10.3324/haematol.10850, PubMed 17488696
  17. Galli M, Borrelli G, Jacobsen EM, Marfisi RM, Finazzi G, Marchioli R, Wisloff F, Marziali S, Morboeuf O, Barbui T (2007)
    Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study
    Blood, 110 (4), 1178-83
    DOI 10.1182/blood-2007-01-066043, PubMed 17440049
  18. Ghanima W, Abdelnoor M, Holmen LO, Nielssen BE, Sandset PM (2007)
    The association between the proximal extension of the clot and the severity of pulmonary embolism (PE): a proposal for a new radiological score for PE
    J Intern Med, 261 (1), 74-81
    DOI 10.1111/j.1365-2796.2006.01733.x, PubMed 17222170
  19. Ghanima W, Nielssen BE, Holmen LO, Witwit A, Al-Ashtari A, Sandset PM (2007)
    Multidetector computed tomography (MDCT) in the diagnosis of pulmonary embolism: interobserver agreement among radiologists with varied levels of experience
    Acta Radiol, 48 (2), 165-70
    DOI 10.1080/02841850601100859, PubMed 17354136
  20. Ghanima W, Sandset PM (2007)
    Risk stratification of pulmonary embolism by computed tomography
    J Intern Med, 262 (6), 702
    DOI 10.1111/j.1365-2796.2007.1858.x, PubMed 17944881
  21. Grövdal M, Khan R, Aggerholm A, Antunovic P, Astermark J, Bernell P, Engström LM, Kjeldsen L, Linder O, Nilsson L, Olsson A, Wallvik J, Tangen JM, Oberg G, Jacobsen SE, Hokland P, Porwit A, Hellström-Lindberg E (2007)
    Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome
    Clin Cancer Res, 13 (23), 7107-12
    DOI 10.1158/1078-0432.CCR-07-1193, PubMed 18056190
  22. Holme PA (2007)
    [Deficient thrombosis prophylaxis]
    Tidsskr Nor Laegeforen, 127 (9), 1176
    PubMed 17479132
  23. Jacobsen AF, Skjeldestad FE, Sandset PM (2007)
    Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study
    Am J Obstet Gynecol, 198 (2), 233.e1-7
    DOI 10.1016/j.ajog.2007.08.041, PubMed 17997389
  24. Jensen T, Kierulf P, Sandset PM, Klingenberg O, Joø GB, Godal HC, Skjønsberg OH (2007)
    Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells
    Thromb Haemost, 97 (5), 822-9
    DOI 10.1160/TH07-01-0039, PubMed 17479194
  25. Johannessen MK, Skretting G, Ytrehus B, Røed KH (2007)
    Neonatal growth cartilage: equine tissue specific gene expression
    Biochem Biophys Res Commun, 354 (4), 975-80
    DOI 10.1016/j.bbrc.2007.01.074, PubMed 17276390
  26. Jønsson V, Tjønnfjord G, Samuelsen SO, Johannesen T, Olsen J, Sellick G, Houlston R, Yuille M, Catovsky D (2007)
    Birth order pattern in the inheritance of chronic lymphocytic leukaemia and related lymphoproliferative disease
    Leuk Lymphoma, 48 (12), 2387-96
    DOI 10.1080/10428190701686273, PubMed 18067015
  27. Liestøl S, Sandset PM, Mowinckel MC, Wisløff F (2007)
    Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants
    J Thromb Haemost, 5 (11), 2204-10
    DOI 10.1111/j.1538-7836.2007.02734.x, PubMed 17958739
  28. Micci F, Panagopoulos I, Tjønnfjord GE, Kolstad A, Delabie J, Beiske K, Heim S (2007)
    Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies
    Virchows Arch, 450 (5), 559-65
    DOI 10.1007/s00428-007-0407-6, PubMed 17406891
  29. Nicolaysen A, Gammelsaeter R, Storm-Mathisen J, Gundersen V, Iversen PO (2007)
    The components required for amino acid neurotransmitter signaling are present in adipose tissues
    J Lipid Res, 48 (10), 2123-32
    DOI 10.1194/jlr.M700021-JLR200, PubMed 17600303
  30. Osuji N, Beiske K, Randen U, Matutes E, Tjonnfjord G, Catovsky D, Wotherspoon A (2007)
    Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia
    Histopathology, 50 (5), 547-54
    DOI 10.1111/j.1365-2559.2007.02656.x, PubMed 17394489
  31. Rand-Hendriksen S, Tjeldhorn L, Lundby R, Semb SO, Offstad J, Andersen K, Geiran O, Paus B (2007)
    Search for correlations between FBN1 genotype and complete Ghent phenotype in 44 unrelated Norwegian patients with Marfan syndrome
    Am J Med Genet A, 143A (17), 1968-77
    DOI 10.1002/ajmg.a.31759, PubMed 17663468
  32. Sioud M, Fløisand Y (2007)
    TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response
    Eur J Immunol, 37 (10), 2834-46
    DOI 10.1002/eji.200737112, PubMed 17853407
  33. Tchaikovski SN, van Vliet HA, Thomassen MC, Bertina RM, Rosendaal FR, Sandset PM, Helmerhorst FM, Tans G, Rosing J (2007)
    Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography
    Thromb Haemost, 98 (6), 1350-6
    DOI 10.1160/TH07-07-0439, PubMed 18064335
  34. Tjønnfjord GE, Gedde-Dahl T, Heldal D, Brinch L (2007)
    Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival
    Leukemia, 21 (10), 2203-4
    DOI 10.1038/sj.leu.2404751, PubMed 17525727
  35. Tjønnfjord GE, Holme PA (2007)
    Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors
    Vasc Health Risk Manag, 3 (4), 527-31
    PubMed 17969383
  36. Torfoss D, Høiby EA, Tangen JM, Holte H, Bø K, Meyer P, Grøttum K, Weyde K, Lauritzsen GF, Sandstad B, Jacobsen AB, Olsen H, Kvaløy S (2007)
    Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial
    J Antimicrob Chemother, 59 (4), 711-7
    DOI 10.1093/jac/dkm003, PubMed 17327294
  37. van Vliet HA, Bertina RM, Dahm AE, Rosendaal FR, Rosing J, Sandset PM, Helmerhorst FM (2007)
    Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor
    J Thromb Haemost, 6 (2), 346-51
    DOI 10.1111/j.1538-7836.2007.02863.x, PubMed 18067603
  38. Villa I, Kvale EO, Lund-Johansen F, Olweus J (2007)
    Assay for monitoring in vitro selective depletion strategies in allogeneic stem cell transplantation
    Cytotherapy, 9 (6), 600-10
    DOI 10.1080/14653240701510573, PubMed 17882725
  39. Wisløff F (2007)
    [Epoetin in cancer treatment--the end of the game?]
    Tidsskr Nor Laegeforen, 127 (18), 2359
    PubMed 17895937

Publications 2006

  1. Amundsen AL, Khoury J, Sandset PM, Seljeflot I, Ose L, Tonstad S, Henriksen T, Retterstøl K, Iversen PO (2006)
    Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
    Thromb Res, 120 (1), 21-7
    DOI 10.1016/j.thromres.2006.07.001, PubMed 16914186
  2. Austbø L, Espenes A, Olsaker I, Press CM, Skretting G (2006)
    Lymphoid follicles of the ileal Peyer's patch of lambs express low levels of PrP, as demonstrated by quantitative real-time RT-PCR on microdissected tissue compartments, in situ hybridization and immunohistochemistry
    J Gen Virol, 87 (Pt 11), 3463-71
    DOI 10.1099/vir.0.82008-0, PubMed 17030883
  3. Berentsen S, Ulvestad E, Langholm R, Beiske K, Hjorth-Hansen H, Ghanima W, Sørbø JH, Tjønnfjord GE (2006)
    Primary chronic cold agglutinin disease: a population based clinical study of 86 patients
    Haematologica, 91 (4), 460-6
    PubMed 16585012
  4. Broliden PA, Dahl IM, Hast R, Johansson B, Juvonen E, Kjeldsen L, Porwit-MacDonald A, Sjoo M, Tangen JM, Uggla B, Oberg G, Hellstrom-Lindberg E (2006)
    Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes
    Haematologica, 91 (5), 667-70
    PubMed 16670072
  5. Dahm A, Osterud B, Hjeltnes N, Sandset PM, Iversen PO (2006)
    Opposite circadian rhythms in melatonin and tissue factor pathway inhibitor type 1: does daylight affect coagulation?
    J Thromb Haemost, 4 (8), 1840-2
    DOI 10.1111/j.1538-7836.2006.02048.x, PubMed 16879232
  6. Dahm A, Rosendaal FR, Andersen TO, Sandset PM (2006)
    Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state
    Br J Haematol, 132 (3), 333-8
    DOI 10.1111/j.1365-2141.2005.05876.x, PubMed 16409298
  7. Dahm AE, Iversen N, Birkenes B, Ree AH, Sandset PM (2006)
    Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1
    BMC Cardiovasc Disord, 6, 40
    DOI 10.1186/1471-2261-6-40, PubMed 17029634
  8. Eilertsen AL, Qvigstad E, Andersen TO, Sandvik L, Sandset PM (2006)
    Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation
    Maturitas, 55 (3), 278-87
    DOI 10.1016/j.maturitas.2006.04.012, PubMed 16713143
  9. Eilertsen AL, Sandvik L, Mowinckel MC, Andersen TO, Qvigstad E, Sandset PM (2006)
    Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis
    Thromb Res, 120 (3), 371-9
    DOI 10.1016/j.thromres.2006.10.013, PubMed 17156824
  10. Enden T, Kløw NE, Sandset PM (2006)
    [Catheter-directed thrombolysis in acute deep venous thrombosis]
    Tidsskr Nor Laegeforen, 126 (13), 1765
    PubMed 16794675
  11. Farkas L, Kvale EO, Lund-Johansen F, Jahnsen FL (2006)
    Plasmacytoid dendritic cells induce a distinct cytokine pattern in virus-specific CD4+ memory T cells that is modulated by CpG oligodeoxynucleotides
    Scand J Immunol, 64 (4), 404-11
    DOI 10.1111/j.1365-3083.2006.01792.x, PubMed 16970682
  12. Frangu M, Gedde-Dahl T, Verder H (2006)
    [Epidermolysis bullosa simplex Dowling-Meara]
    Ugeskr Laeger, 168 (48), 4222-4
    PubMed 17147951
  13. Ghanima W, Abdelnoor M, Holmen LO, Nielssen BE, Ross S, Sandset PM (2006)
    D-dimer level is associated with the extent of pulmonary embolism
    Thromb Res, 120 (2), 281-8
    DOI 10.1016/j.thromres.2006.08.006, PubMed 17030057
  14. Ghanima W, Abdelnoor M, Mowinckel MC, Sandset PM (2006)
    The performance of STA-Liatest D-dimer assay in out-patients with suspected pulmonary embolism
    Br J Haematol, 132 (2), 210-5
    DOI 10.1111/j.1365-2141.2005.05859.x, PubMed 16398655
  15. Ghanima W, Sandset PM (2006)
    Validation of a new D-dimer microparticle enzyme immunoassay (AxSYM D-Dimer) in patients with suspected pulmonary embolism (PE)
    Thromb Res, 120 (4), 471-6
    DOI 10.1016/j.thromres.2006.11.005, PubMed 17161451
  16. Holm AM, Tjønnfjord G, Yndestad A, Beiske K, Müller F, Aukrust P, Frøland SS (2006)
    Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia
    Clin Exp Immunol, 144 (3), 418-24
    DOI 10.1111/j.1365-2249.2006.03086.x, PubMed 16734610
  17. Husted S, Emanuelsson H, Heptinstall S, Sandset PM, Wickens M, Peters G (2006)
    Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin
    Eur Heart J, 27 (9), 1038-47
    DOI 10.1093/eurheartj/ehi754, PubMed 16476694
  18. Jacobsen EM, Trettenes EJ, Wisløff F, Abildgaard U (2006)
    Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene
    Thromb J, 4, 3
    DOI 10.1186/1477-9560-4-3, PubMed 16436199
  19. Jensen T, Retterstøl LJ, Sandset PM, Godal HC, Skjønsberg OH (2006)
    A daily glass of red wine induces a prolonged reduction in plasma viscosity: a randomized controlled trial
    Blood Coagul Fibrinolysis, 17 (6), 471-6
    DOI 10.1097/01.mbc.0000240920.72930.63, PubMed 16905951
  20. Jønsson V (2006)
    [Inheritance and cancer]
    Ugeskr Laeger, 168 (24), 2327
    PubMed 16822411
  21. Jønsson V, Johannesen TB (2006)
    Anticipation in lymphoproliferative disorders
    Leuk Lymphoma, 47 (10), 2015-6
    DOI 10.1080/10428190600774857, PubMed 17071471
  22. Kildahl-Andersen O, Thorstensen K, Sagen E, Dahl IM, Tjønnfjord G (2006)
    [A 40-year-old woman with anemia]
    Tidsskr Nor Laegeforen, 126 (22), 2958-9
    PubMed 17144048
  23. Kvale EO, Fløisand Y, Lund-Johansen F, Rollag H, Farkas L, Ghanekar S, Brandtzaeg P, Jahnsen FL, Olweus J (2006)
    Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells
    Blood, 109 (8), 3369-76
    DOI 10.1182/blood-2006-06-031484, PubMed 17158235
  24. Lenhoff S, Hjorth M, Turesson I, Westin J, Gimsing P, Wislöff F, Ahlberg L, Carlson K, Christiansen I, Dahl IM, Forsberg K, Brinch L, Hammerström J, Johnsen HE, Knudsen LM, Linder O, Mellqvist UH, Nesthus I, Nielsen JL, Nordic Myeloma Study Group (2006)
    Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation
    Haematologica, 91 (9), 1228-33
    PubMed 16956822
  25. Lenhoff S, Hjorth M, Westin J, Brinch L, Bäckström B, Carlson K, Christiansen I, Dahl IM, Gimsing P, Hammerström J, Johnsen HE, Juliusson G, Linder O, Mellqvist UH, Nesthus I, Nielsen JL, Tangen JM, Turesson I, Nordic Myeloma Study Group (2006)
    Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group
    Br J Haematol, 133 (4), 389-96
    DOI 10.1111/j.1365-2141.2006.06042.x, PubMed 16643445
  26. Liestøl S, Sandset PM, Jacobsen EM, Mowinckel MC, Wisløff F (2006)
    Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants
    Br J Haematol, 136 (1), 131-7
    DOI 10.1111/j.1365-2141.2006.06385.x, PubMed 17092306
  27. Lotfi K, Karlsson K, Fyrberg A, Juliusson G, Jonsson V, Peterson C, Eriksson S, Albertioni F (2006)
    The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia
    Biochem Pharmacol, 71 (6), 882-90
    DOI 10.1016/j.bcp.2005.12.007, PubMed 16436271
  28. Negaard HF, Eilertsen AL, Dahm A, Iversen PO, Østenstad B, Sandset PM (2006)
    Decreased lung cancer survival with hormone-replacement therapy: caused by a decreased tissue factor pathway inhibitor level?
    J Clin Oncol, 24 (17), 2683-4; author reply 2684
    DOI 10.1200/JCO.2006.06.4345, PubMed 16763285
  29. Njaastad AM, Abildgaard U (2006)
    Bleeding in patients with mechanical heart valves on warfarin: impact of target INR and of comorbidity
    J Intern Med, 260 (6), 596
    DOI 10.1111/j.1365-2796.2006.01721.x, PubMed 17116014
  30. Njaastad AM, Abildgaard U, Lassen JF (2006)
    Gains and losses of warfarin therapy as performed in an anticoagulation clinic
    J Intern Med, 259 (3), 296-304
    DOI 10.1111/j.1365-2796.2005.01605.x, PubMed 16476107
  31. O'Donnell MJ, Berge E, Sandset PM (2006)
    Are there patients with acute ischemic stroke and atrial fibrillation that benefit from low molecular weight heparin?
    Stroke, 37 (2), 452-5
    DOI 10.1161/01.STR.0000198887.81948.74, PubMed 16410483
  32. Osuji N, Matutes E, Tjonnfjord G, Grech H, Del Giudice I, Wotherspoon A, Swansbury JG, Catovsky D (2006)
    T-cell large granular lymphocyte leukemia: A report on the treatment of 29 patients and a review of the literature
    Cancer, 107 (3), 570-8
    DOI 10.1002/cncr.22032, PubMed 16795070
  33. Roed KH, Hasle G, Midthjell V, Skretting G, Leinaas HP (2006)
    Identification and characterization of 17 microsatellite primers for the tick, Ixodes ricinus, using enriched genomic libraries
    Mol. Ecol. Notes, 6 (4), 1165-1167
  34. Ruland C, Røslien J, Bakken S, Kristiansen J (2006)
    Comparing tailored computerized symptom assessments to interviews and questionnaires
    AMIA Annu Symp Proc, 1081
    PubMed 17238700
  35. Sandset PM (2006)
    Hormone replacement therapy and risk of venous thromboembolism--still unresolved questions
    J Thromb Haemost, 4 (1), 68-9
    DOI 10.1111/j.1538-7836.2005.01750.x, PubMed 16409452
  36. Schneppenheim R, Kremer Hovinga JA, Becker T, Budde U, Karpman D, Brockhaus W, Hrachovinová I, Korczowski B, Oyen F, Rittich S, von Rosen J, Tjønnfjord GE, Pimanda JE, Wienker TF, Lämmle B (2006)
    A common origin of the 4143insA ADAMTS13 mutation
    Thromb Haemost, 96 (1), 3-6
    DOI 10.1160/TH05-12-0817, PubMed 16807643
  37. Sioud M, Fløisand Y, Forfang L, Lund-Johansen F (2006)
    Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage
    J Mol Biol, 364 (5), 945-54
    DOI 10.1016/j.jmb.2006.09.054, PubMed 17049554
  38. Smith A, Wisloff F, Samson D, UK Myeloma Forum, Nordic Myeloma Study Group, British Committee for Standards in Haematology (2006)
    Guidelines on the diagnosis and management of multiple myeloma 2005
    Br J Haematol, 132 (4), 410-51
    DOI 10.1111/j.1365-2141.2005.05867.x, PubMed 16412016
  39. Strauss G, Osen W, Knape I, Jacobsen EM, Müller SM, Debatin KM (2006)
    Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity
    Cell Death Differ, 14 (3), 480-8
    DOI 10.1038/sj.cdd.4402019, PubMed 16902496
  40. Tjønnfjord GE (2006)
    Surgery in patients with hemophilia and inhibitors: a review of the Norwegian experience with FEIBA
    Semin Hematol, 43 (2 Suppl 4), S18-21
    DOI 10.1053/j.seminhematol.2006.03.003, PubMed 16690372
  41. Wisløff F, Kvam AK, Hjorth M, Lenhoff S (2006)
    Serum calcium is an independent predictor of quality of life in multiple myeloma
    Eur J Haematol, 78 (1), 29-34
    DOI 10.1111/j.0902-4441.2006.t01-1-EJH2887.x, PubMed 17038019
  42. Aamot HV, Tjønnfjord GE, Delabie J, Heim S (2006)
    Molecular cytogenetic analysis of leukemic mantle cell lymphoma with a cryptic t(11;14)
    Cancer Genet Cytogenet, 165 (2), 172-5
    DOI 10.1016/j.cancergencyto.2005.08.012, PubMed 16527613

Publications 2005

  1. Abrahamsen IW, Sømme S, Heldal D, Egeland T, Kvale D, Tjønnfjord GE (2005)
    Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease
    Haematologica, 90 (1), 86-93
    PubMed 15642674
  2. Crowther MA, Wisloff F (2005)
    Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis
    Thromb Res, 115 (1-2), 3-8
    DOI 10.1016/j.thromres.2004.06.041, PubMed 15567446
  3. Dahm AE, Andersen TO, Rosendaal F, Sandset PM (2005)
    A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)
    J Thromb Haemost, 3 (4), 651-8
    DOI 10.1111/j.1538-7836.2005.01237.x, PubMed 15842349
  4. Dahm AE, Iversen PO, Hjeltnes N, Sandset PM (2005)
    Differences in circadian variations of tissue factor pathway inhibitor type 1 between able-bodied and spinal cord injured
    Thromb Res, 118 (2), 281-7
    DOI 10.1016/j.thromres.2005.07.021, PubMed 16139333
  5. de Visser MC, van Hylckama Vlieg A, Tans G, Rosing J, Dahm AE, Sandset PM, Rosendaal FR, Bertina RM (2005)
    Determinants of the APTT- and ETP-based APC sensitivity tests
    J Thromb Haemost, 3 (7), 1488-94
    DOI 10.1111/j.1538-7836.2005.01430.x, PubMed 15978106
  6. Eilertsen AL, Høibraaten E, Os I, Andersen TO, Sandvik L, Sandset PM (2005)
    The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis
    Maturitas, 52 (2), 111-8
    DOI 10.1016/j.maturitas.2005.01.004, PubMed 16186073
  7. Finazzi G, Marchioli R, Brancaccio V, Schinco P, Wisloff F, Musial J, Baudo F, Berrettini M, Testa S, D'Angelo A, Tognoni G, Barbui T (2005)
    A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)
    J Thromb Haemost, 3 (5), 848-53
    DOI 10.1111/j.1538-7836.2005.01340.x, PubMed 15869575
  8. Ghanima W, Almaas V, Aballi S, Dörje C, Nielssen BE, Holmen LO, Almaas R, Abdelnoor M, Sandset PM (2005)
    Management of suspected pulmonary embolism (PE) by D-dimer and multi-slice computed tomography in outpatients: an outcome study
    J Thromb Haemost, 3 (9), 1926-32
    DOI 10.1111/j.1538-7836.2005.01544.x, PubMed 16102097
  9. Gruber FX, Lamark T, Anonli A, Sovershaev MA, Olsen M, Gedde-Dahl T, Hjort-Hansen H, Skogen B (2005)
    Selecting and deselecting imatinib-resistant clones: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL
    Leukemia, 19 (12), 2159-65
    DOI 10.1038/sj.leu.2403983, PubMed 16224487
  10. Guren TK, Christoffersen T, Thoresen GH, Wisløff F, Dajani O, Tveit KM (2005)
    [Antineoplastic agents targeting tyrosine kinases]
    Tidsskr Nor Laegeforen, 125 (22), 3115-9
    PubMed 16299568
  11. Haram K, Björge L, Sandset PM (2005)
    Successful preconceptional prophylactic treatment with combined acetyl salicylic acid and low-molecular heparin (Fragmin) in a case of antiphospholipid-antibody syndrome with prior life-threatening hemolysis, elevated liver enzymes and low-platelet syndrome: a case report
    Acta Obstet Gynecol Scand, 84 (12), 1213-4
    DOI 10.1111/j.0001-6349.2005.0070e.x, PubMed 16305714
  12. Hippe E, Westin J, Wislöff F (2005)
    Nordic Myeloma Study Group, the first 15 years: scientific collaboration and improvement of patient care
    Eur J Haematol, 74 (3), 185-93
    DOI 10.1111/j.1600-0609.2004.00379.x, PubMed 15693787
  13. Holme PA, Brosstad F, Tjønnfjord GE (2005)
    Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies
    Haemophilia, 11 (5), 510-5
    DOI 10.1111/j.1365-2516.2005.01136.x, PubMed 16128896
  14. Iversen PO, Wiig H (2005)
    Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis
    Clin Cancer Res, 11 (19 Pt 1), 6793-9
    DOI 10.1158/1078-0432.CCR-05-1033, PubMed 16203766
  15. Jädersten M, Montgomery SM, Dybedal I, Porwit-MacDonald A, Hellström-Lindberg E (2005)
    Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF
    Blood, 106 (3), 803-11
    DOI 10.1182/blood-2004-10-3872, PubMed 15840690
  16. Kvale EØ, Dalgaard J, Lund-Johansen F, Rollag H, Farkas L, Midtvedt K, Jahnsen FL, Brinchmann JE, Olweus J (2005)
    CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection
    Blood, 107 (5), 2022-9
    DOI 10.1182/blood-2005-05-2016, PubMed 16269620
  17. Mathisen B, Loennechen T, Gedde-Dahl T, Winberg JO (2005)
    Fibroblast heterogeneity in collagenolytic response to colchicine
    Biochem Pharmacol, 71 (5), 574-83
    DOI 10.1016/j.bcp.2005.11.018, PubMed 16378602
  18. Mishra V, Andresen S, Brinch L, Kvaløy S, Ernst P, Lønset MK, Tangen JM, Wikelund J, Flatum C, Baggerød E, Helle B, Vaaler S, Hagen TP (2005)
    Cost of autologous peripheral blood stem cell transplantation: the Norwegian experience from a multicenter cost study
    Bone Marrow Transplant, 35 (12), 1149-53
    DOI 10.1038/sj.bmt.1704988, PubMed 15880133
  19. Mishra V, Paus AC, Tjønnfjord GE (2005)
    [Surgery in patients with bleeding disorders--expensive treatment for a small group of patients]
    Tidsskr Nor Laegeforen, 125 (7), 883-5
    PubMed 15815735
  20. Negaard H, Dahm A, Sandset PM, Iversen PO, Ostenstad B (2005)
    Angiogenesis and hemostasis in hematological neoplasias
    Curr. Drug Targets, 6 (6), 681-699
  21. Negaard H, Dahm A, Sandset PM, Iversen PO, Østenstad B (2005)
    Angiogenesis and hemostasis in hematological neoplasias
    Curr Drug Targets, 6 (6), 683-99
    PubMed 16178801
  22. Sandset PM, Francis C, Ginsberg J (2005)
    Thrombosis Research Anno 2005
    Thromb. Res., 115 (1-2), 1
  23. Schulman S, Tjønnfjord GE, Wallensten R, Martinowitz U, Kenet G (2005)
    Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII
    Thromb Haemost, 94 (6), 1177-80
    DOI 10.1160/TH05-05-0342, PubMed 16411390
  24. Sellick GS, Webb EL, Allinson R, Matutes E, Dyer MJ, Jonsson V, Langerak AW, Mauro FR, Fuller S, Wiley J, Lyttelton M, Callea V, Yuille M, Catovsky D, Houlston RS (2005)
    A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci
    Am J Hum Genet, 77 (3), 420-9
    DOI 10.1086/444472, PubMed 16080117
  25. Sigurdardottir K, Digranes A, Harthug S, Nesthus I, Tangen JM, Dybdahl B, Meyer P, Hopen G, Løkeland T, Grøttum K, Vie W, Langeland N (2005)
    A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility
    Scand J Infect Dis, 37 (6-7), 455-64
    DOI 10.1080/00365540510038497, PubMed 16012006
  26. Sioud M, Iversen PO (2005)
    Ribozymes, DNAzymes and small interfering RNAs as therapeutics
    Curr Drug Targets, 6 (6), 647-53
    DOI 10.2174/1389450054863653, PubMed 16178798
  27. Tjønnfjord GE (2005)
    [Anticoagulation therapy and oral surgery]
    Tidsskr Nor Laegeforen, 125 (21), 2999; author reply 2999
    PubMed 16276400
  28. Tjønnfjord GE (2005)
    [Polycythemia vera]
    Tidsskr Nor Laegeforen, 125 (19), 2649
    PubMed 16273739
  29. Trydal T, Bolann B, Brosstad F, Sandberg S, Sandset PM, Stavelin A, Steensland H, Thue G, Ødegaard OR (2005)
    [Analysis of prothrombin time in primary health care]
    Tidsskr Nor Laegeforen, 125 (15), 2048-9
    PubMed 16100552
  30. Wisløff F, Gulbrandsen N, Hjorth M, Lenhoff S, Fayers P (2005)
    Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes
    Eur J Haematol, 75 (4), 293-8
    DOI 10.1111/j.1600-0609.2005.00509.x, PubMed 16146535
  31. Yang L, Dybedal I, Bryder D, Nilsson L, Sitnicka E, Sasaki Y, Jacobsen SE (2005)
    IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells
    J Immunol, 174 (2), 752-7
    DOI 10.4049/jimmunol.174.2.752, PubMed 15634895

Publications 2004

  1. Andresen MS, Abildgaard U (2004)
    Coagulation Inhibitor Potential: a study of assay variables
    Thromb Res, 115 (6), 519-26
    DOI 10.1016/j.thromres.2004.11.018, PubMed 15792684
  2. Andresen MS, Abildgaard U, Liestøl S, Sandset PM, Mowinckel MC, Ødegaard OR, Larsen ML, Diep LM (2004)
    The ability of three global plasma assays to recognize thrombophilia
    Thromb Res, 113 (6), 411-7
    DOI 10.1016/j.thromres.2004.05.002, PubMed 15226097
  3. Brodin E, Børvik T, Sandset PM, Bønaa KH, Nordøy A, Hansen JB (2004)
    Coagulation activation in young survivors of myocardial infarction (MI)--a population-based case-control study
    Thromb Haemost, 92 (1), 178-84
    DOI 10.1160/TH03-11-0674, PubMed 15213859
  4. Corthay A, Lundin KU, Munthe LA, Frøyland M, Gedde-Dahl T, Dembic Z, Bogen B (2004)
    Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models
    Cancer Immunol Immunother, 53 (9), 759-69
    DOI 10.1007/s00262-004-0504-1, PubMed 15088126
  5. Farkas L, Kvale EO, Johansen FE, Jahnsen FL, Lund-Johansen F (2004)
    Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides
    J Allergy Clin Immunol, 114 (2), 436-43
    DOI 10.1016/j.jaci.2004.04.035, PubMed 15316529
  6. Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE (2004)
    [Treatment of T-cell prolymphocytic leukemia with monoclonal anti- CD52 antibody (alemtuzumab]
    Tidsskr Nor Laegeforen, 124 (6), 768-70
    PubMed 15039804
  7. Ghanima W, Kahrs J, Dahl TG, Tjonnfjord GE (2004)
    Sustained cytogenetic response after discontinuation of imatinib mesylate in a patient with chronic myeloid leukaemia
    Eur J Haematol, 72 (6), 441-3
    DOI 10.1111/j.1600-0609.2004.00257.x, PubMed 15128424
  8. Gniadecki R, Rossen K, Ralfkier E, Thomsen K, Skovgaard GL, Jønsson V (2004)
    CD56+ lymphoma with skin involvement: clinicopathologic features and classification
    Arch Dermatol, 140 (4), 427-36
    DOI 10.1001/archderm.140.4.427, PubMed 15096371
  9. Gulbrandsen N, Hjermstad MJ, Wisløff F, Nordic Myeloma Study Group (2004)
    Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences
    Eur J Haematol, 72 (3), 172-80
    DOI 10.1046/j.0902-4441.2003.00195.x, PubMed 14962235
  10. Heldal D, Brinch L, Evensen SA, Tjønnfjord GE, Aamodt G, Elgjo K, Sviland L (2004)
    Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow
    Bone Marrow Transplant, 34 (4), 345-50
    DOI 10.1038/sj.bmt.1704568, PubMed 15170163
  11. Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, Kaasa S (2004)
    A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation
    Bone Marrow Transplant, 34 (3), 257-66
    DOI 10.1038/sj.bmt.1704561, PubMed 15170167
  12. Hjort PF, Sandset PM, Abildgaard U, Rao LV, Mast A, Ott I, Bajaj SP (2004)
    Tissue factor pathway inhibitor revisited
    J Thromb Haemost, 2 (12), 2241-9
    DOI 10.1111/j.1538-7836.2004.01058.x, PubMed 15613032
  13. Jacobsen AF, Drolsum A, Klow NE, Dahl GF, Qvigstad E, Sandset PM (2004)
    Deep vein thrombosis after elective cesarean section
    Thromb Res, 113 (5), 283-8
    DOI 10.1016/j.thromres.2004.03.008, PubMed 15183039
  14. Jensen T, Halvorsen S, Godal HC, Sandset PM, Skjønsberg OH (2004)
    The viscosity of fibrinogen subfractions and of EDTA denatured fibrinogen do not differ from that of native fibrinogen
    Thromb Res, 113 (1), 51-6
    DOI 10.1016/j.thromres.2004.01.010, PubMed 15081565
  15. Klar J, Gedde-Dahl T, Larsson M, Pigg M, Carlsson B, Tentler D, Vahlquist A, Dahl N (2004)
    Assignment of the locus for ichthyosis prematurity syndrome to chromosome 9q33.3-34.13
    J Med Genet, 41 (3), 208-12
    DOI 10.1136/jmg.2003.012567, PubMed 14985385
  16. Koss-Harnes D, Høyheim B, Jonkman MF, de Groot WP, de Weerdt CJ, Nikolic B, Wiche G, Gedde-Dahl T (2004)
    Life-long course and molecular characterization of the original Dutch family with epidermolysis bullosa simplex with muscular dystrophy due to a homozygous novel plectin point mutation
    Acta Derm Venereol, 84 (2), 124-31
    DOI 10.1080/00015550310007094, PubMed 15206692
  17. Liestøl S, Wisløff F (2004)
    Effect of subcutaneous administration of dalteparin on lupus anticoagulant assays
    Thromb Res, 115 (6), 509-17
    DOI 10.1016/j.thromres.2004.11.013, PubMed 15792683
  18. Lindahl TL, Egberg N, Hillarp A, Ødegaard OR, Edlund B, Svensson J, Sandset PM, Rånby M (2004)
    INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples
    Thromb Haemost, 91 (6), 1223-31
    DOI 10.1160/TH03-07-0456, PubMed 15175811
  19. Lund MB, Brinch L, Kongerud J, Boe J (2004)
    Lung function 5 yrs after allogeneic bone marrow transplantation conditioned with busulphan and cyclophosphamide
    Eur Respir J, 23 (6), 901-5
    DOI 10.1183/09031936.04.00084804, PubMed 15219005
  20. Ly B, Njaastad AM, Sandbaek G, Solstrand R, Rosales A, Slagsvold CE (2004)
    [Catheter-directed thrombolysis of iliofemoral venous thrombosis]
    Tidsskr Nor Laegeforen, 124 (4), 478-80
    PubMed 14983192
  21. Lyngstadaas A, Husebekk A, Funderud S, Brinch L (2004)
    [Clinical use of haematopoietic stem cells from cord blood]
    Tidsskr Nor Laegeforen, 124 (22), 2928-31
    PubMed 15550970
  22. Rodriguez-Merchan EC, Rocino A, Ewenstein B, Bartha L, Batorova A, Goudemand J, Gringeri A, Joao-Diniz M, Lopaciuk S, Negrier C, Quintana M, Tagariello G, Tjonnfjord GE, Villar VA, Vorlova Z (2004)
    Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement
    Haemophilia, 10 Suppl 2, 50-2
    DOI 10.1111/j.1365-2516.2004.00941.x, PubMed 15385047
  23. Russell D, Thomassen L, Indredavik B, Sandset PM, Joakimsen O, Berge E (2004)
    [Patients with acute brain infarction should receive thrombolytic therapy]
    Tidsskr Nor Laegeforen, 124 (12), 1666-7
    PubMed 15229721
  24. Sandset PM, Abildgaard U (2004)
    Tissue factor pathway inhibitor revisited
    J. Thromb. Haemost., 2 (12), 2242-2243
  25. Solberg EE, Ekeberg O, Holen A, Ingjer F, Sandvik L, Standal PA, Vikman A (2004)
    Hemodynamic changes during long meditation
    Appl Psychophysiol Biofeedback, 29 (3), 213-21
    DOI 10.1023/B:APBI.0000039059.20738.39, PubMed 15497620
  26. Tiercy JM, Passweg J, van Biezen A, Zander A, Kröger N, Gratwohl A, Chapuis B, Helg C, Brinch L, Cornelissen J, Oudshoorn M, Ruutu T, Volin L, Niederwieser D, Roosnek E, Chronic Leukemia Working Party of the European Blood and Marrow Transplant Group (EBMT) (2004)
    Isolated HLA-C mismatches in unrelated donor transplantation for CML
    Bone Marrow Transplant, 34 (3), 249-55
    DOI 10.1038/sj.bmt.1704569, PubMed 15195077
  27. Tjønnfjord GE (2004)
    Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience
    Haemophilia, 10 Suppl 2, 41-5
    DOI 10.1111/j.1365-2516.2004.00939.x, PubMed 15385045
  28. Tjønnfjord GE, Brinch L, Gedde-Dahl T, Brosstad FR (2004)
    Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX
    Haemophilia, 10 (2), 174-8
    DOI 10.1046/j.1365-2516.2003.00857.x, PubMed 14962207
  29. Wisløff F (2004)
    [Total survival as quality indicator]
    Tidsskr Nor Laegeforen, 124 (23), 3096; author reply 3096
    PubMed 15586201
  30. Wisløff F, Crowther M (2004)
    Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failure
    Thromb Res, 114 (2), 75-81
    DOI 10.1016/j.thromres.2004.05.006, PubMed 15306148
  31. Waage A, Gimsing P, Juliusson G, Turesson I, Gulbrandsen N, Eriksson T, Hjorth M, Nielsen JL, Lenhoff S, Westin J, Wislöff F, Nordic Myeloma Study Group (2004)
    Early response predicts thalidomide efficiency in patients with advanced multiple myeloma
    Br J Haematol, 125 (2), 149-55
    DOI 10.1111/j.1365-2141.2004.04879.x, PubMed 15059136

Publications 2003

  1. Amundsen HF, Stray-Pedersen A, Tjønnfjord GE, Abrahamsen TG (2003)
    [Chronic neutropenia--subtypes and treatment]
    Tidsskr Nor Laegeforen, 123 (5), 624-6
    PubMed 12683188
  2. Amundsen HF, Stray-Pedersen A, Tjønnfjord GE, Abrahamsen TG (2003)
    [Patients with severe chronic neutropenia]
    Tidsskr Nor Laegeforen, 123 (5), 621-3
    PubMed 12683187
  3. Astermark J, Voorberg J, Lenk H, DiMichele D, Shapiro A, Tjönnfjord G, Berntorp E (2003)
    Impact of inhibitor epitope profile on the neutralizing effect against plasma-derived and recombinant factor VIII concentrates in vitro
    Haemophilia, 9 (5), 567-72
    DOI 10.1046/j.1365-2516.2003.00802.x, PubMed 14511295
  4. Bendz B, Sandset PM (2003)
    Acute hypoxia and activation of coagulation
    Lancet, 362 (9388), 997-8
    DOI 10.1016/S0140-6736(03)14378-4, PubMed 14511938
  5. Berentsen S, Ulvestad E, Gjertsen BT, Hjorth-Hansen H, Langholm R, Knutsen H, Ghanima W, Shammas FV, Tjønnfjord GE (2003)
    Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients
    Blood, 103 (8), 2925-8
    DOI 10.1182/blood-2003-10-3597, PubMed 15070665
  6. Bergheim J, Ernst P, Brinch L, Gore DM, Chetty MC, Stewart GW (2003)
    Allogeneic bone marrow transplantation for severe post-splenectomy thrombophilic state in leaky red cell membrane haemolytic anaemia of the stomatocytosis class
    Br J Haematol, 121 (1), 119-22
    DOI 10.1046/j.1365-2141.2003.04262.x, PubMed 12670341
  7. Dahm A, Van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM (2003)
    Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis
    Blood, 101 (11), 4387-92
    DOI 10.1182/blood-2002-10-3188, PubMed 12560220
  8. Dueland S, Sauer T, Lund-Johansen F, Ostenstad B, Tveit KM (2003)
    Epidermal growth factor receptor inhibition induces trichomegaly
    Acta Oncol, 42 (4), 345-6
    DOI 10.1080/02841860310006038, PubMed 12899508
  9. Gruber A, Bjorkholm M, Brinch L, Evensen S, Gustavsson B, Hedenus M, Juliusson G, Lofvenberg E, Nesthus I, Simonsson B, Sjo M, Stenke L, Tangen JM, Tidefelt U, Uden AM, Paul C, Liliemark J (2003)
    A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia
    Leuk. Res., 27 (4), PII S0145-2126(02)00181-9-328
  10. Gruber A, Björkholm M, Brinch L, Evensen S, Gustavsson B, Hedenus M, Juliusson G, Löfvenberg E, Nesthus I, Simonsson B, Sjo M, Stenke L, Tangen JM, Tidefelt U, Udén AM, Paul C, Liliemark J (2003)
    A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia
    Leuk Res, 27 (4), 323-8
    PubMed 12531223
  11. Haram K, Trovik J, Sandset PM, Hordnes K (2003)
    Severe syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP) in the 18th week of pregnancy associated with the antiphospholipid-antibody syndrome
    Acta Obstet Gynecol Scand, 82 (7), 679-80
    DOI 10.1034/j.1600-0412.2003.00181.x, PubMed 12790854
  12. Hast R, Hellström-Lindberg E, Ohm L, Björkholm M, Celsing F, Dahl IM, Dybedal I, Gahrton G, Lindberg G, Lerner R, Linder O, Löfvenberg E, Nilsson-Ehle H, Paul C, Samuelsson J, Tangen JM, Tidefelt U, Turesson I, Wahlin A, Wallvik J, Winquist I, Oberg G, Bernell P (2003)
    No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease
    Leukemia, 17 (9), 1827-33
    DOI 10.1038/sj.leu.2403035, PubMed 12970783
  13. Heldal D, Brinch L, Tjønnfjord G, Solheim BG, Egeland T, Albrechtsen D, Aamodt G, Evensen SA (2003)
    Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study
    Bone Marrow Transplant, 32 (3), 257-64
    DOI 10.1038/sj.bmt.1704127, PubMed 12858196
  14. Hellström-Lindberg E, Gulbrandsen N, Lindberg G, Ahlgren T, Dahl IM, Dybedal I, Grimfors G, Hesse-Sundin E, Hjorth M, Kanter-Lewensohn L, Linder O, Luthman M, Löfvenberg E, Oberg G, Porwit-MacDonald A, Rådlund A, Samuelsson J, Tangen JM, Winquist I, Wisloff F, Scandinavian MDS Group (2003)
    A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life
    Br J Haematol, 120 (6), 1037-46
    DOI 10.1046/j.1365-2141.2003.04153.x, PubMed 12648074
  15. Hjermstad MJ, Evensen SA, Kvaløy SO, Loge JH, Fayers PM, Kaasa S (2003)
    The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation
    Psychooncology, 12 (8), 803-13
    DOI 10.1002/pon.708, PubMed 14681953
  16. Iversen PO, Wisløff F (2003)
    [Gaucher disease]
    Tidsskr Nor Laegeforen, 123 (3), 304-7
    PubMed 12640894
  17. Jacobsen AF, Qvigstad E, Sandset PM (2003)
    Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy
    BJOG, 110 (2), PII S1470-0328(02)02182-1-144
  18. Jacobsen AF, Qvigstad E, Sandset PM (2003)
    Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy
    BJOG, 110 (2), 139-44
    PubMed 12618157
  19. Lundin J, Hagberg H, Repp R, Cavallin-Ståhl E, Fredén S, Juliusson G, Rosenblad E, Tjønnfjord G, Wiklund T, Osterborg A (2003)
    Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome
    Blood, 101 (11), 4267-72
    DOI 10.1182/blood-2002-09-2802, PubMed 12543862
  20. Mishra V, Vaaler S, Brinch L (2003)
    Cost analysis of autologous peripheral blood stem cell transplantation for multiple myeloma
    Clin Lab Haematol, 25 (3), 179-84
    DOI 10.1046/j.1365-2257.2003.00512.x, PubMed 12755795
  21. Nazir M, Stien R, Carlsen E, Jacobsen AF, Nesheim BI (2003)
    Early evaluation of bowel symptoms after primary repair of obstetric perineal rupture is misleading: an observational cohort study
    Dis Colon Rectum, 46 (9), 1245-50
    DOI 10.1097/01.DCR.0000084340.44237.3B, PubMed 12972970
  22. Normann AP, Egeland T, Madshus IH, Heim S, Tjønnfjord GE (2003)
    CD7 expression by CD34+ cells in CML patients, of prognostic significance?
    Eur J Haematol, 71 (4), 266-75
    DOI 10.1034/j.1600-0609.2003.00133.x, PubMed 12950236
  23. Os I, Høieggen A, Larsen A, Sandset PM, Djurovic S, Berg K, Os A, Birkeland K, Westheim A (2003)
    Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and beta-cell function
    J Intern Med, 253 (2), 232-9
    DOI 10.1046/j.1365-2796.2003.01110.x, PubMed 12542565
  24. Schaadt BK, Hendel HW, Gimsing P, Jønsson V, Pedersen H, Hesse B (2003)
    99mTc-aprotinin scintigraphy in amyloidosis
    J Nucl Med, 44 (2), 177-83
    PubMed 12571206
  25. Thomassen L, Sandset PM, Joakimsen O, Indredavik B, Russell D (2003)
    [Intravenous thrombolytic therapy of patients with acute cerebral infarction]
    Tidsskr Nor Laegeforen, 123 (5), 638-9
    PubMed 12683192
  26. Virtanen M, Smith SK, Gedde-Dahl T, Vahlquist A, Bowden PE (2003)
    Splice site and deletion mutations in keratin (KRT1 and KRT10) genes: unusual phenotypic alterations in Scandinavian patients with epidermolytic hyperkeratosis
    J Invest Dermatol, 121 (5), 1013-20
    DOI 10.1046/j.1523-1747.2003.12534.x, PubMed 14708600
  27. Wisløff F (2003)
    [Financing of enzyme treatment in Gaucher disease]
    Tidsskr Nor Laegeforen, 123 (3), 364
    PubMed 12640908
  28. Wisløff F, Brinch L, Hammerstrøm J (2003)
    [National guidelines for treatment of chronic myelogenous leukemia]
    Tidsskr Nor Laegeforen, 123 (2), 157-9
    PubMed 12607495

Publications 2002

  1. Andresen MS, Iversen N, Abildgaard U (2002)
    Overall haemostasis potential assays performed in thrombophilic plasma: the effect of preactivating protein C and antithrombin
    Thromb Res, 108 (5-6), 323-8
    DOI 10.1016/S0049-3848(03)00067-7, PubMed 12676193
  2. Bendz B, Sandset PM (2002)
    [Air travel and venous thrombosis]
    Tidsskr Nor Laegeforen, 122 (16), 1579-81
    PubMed 12119787
  3. Bendz B, Sandset PM (2002)
    Air travel and risk of venous thromboembolism
    Thromb Res, 108 (1), 15-7
    DOI 10.1016/S0049-3848(02)00389-4, PubMed 12586126
  4. Dalgaard J, Brinch L, Tjønnfjord GE (2002)
    [Paroxysmal nocturnal hemoglobinuria--a rare disease with many faces]
    Tidsskr Nor Laegeforen, 122 (4), 374-8
    PubMed 11915665
  5. Ghanima W, Heldal D, Tjønnfjord GE (2002)
    [Hairy cell leukemia treated with cladribine]
    Tidsskr Nor Laegeforen, 122 (11), 1094-7
    PubMed 12043051
  6. Heldal D, Brinch L, Tjønnfjord G, Solheim BG, Egeland T, Gadeholt G, Albrechtsen D, Aamodt G, Evensen SA (2002)
    Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints
    Bone Marrow Transplant, 29 (6), 479-86
    DOI 10.1038/sj.bmt.1703418, PubMed 11960266
  7. Holte H, Smeland S, Blystad AK, Kvaløy S, Hammerstrøm J, Tjønnfjord GE (2002)
    [Intensive chemotherapy in Burkitt's lymphoma and aggressive non-Hodgkin's lymphoma]
    Tidsskr Nor Laegeforen, 122 (4), 364-9
    PubMed 11915663
  8. Itälä M, Geisler CH, Kimby E, Juvonen E, Tjonnfjord G, Karlsson K, Remes K (2002)
    Standard-dose anti-CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia: results from a Nordic multicentre study
    Eur J Haematol, 69 (3), 129-34
    DOI 10.1034/j.1600-0609.2002.02786.x, PubMed 12406005
  9. Iversen N, Brandtzaeg P, Sandset PM, Kierulf P, Abildgaard U (2002)
    TFPI fractions in plasma from patients with systemic meningococcal disease
    Thromb Res, 108 (5-6), 347-53
    DOI 10.1016/S0049-3848(03)00065-3, PubMed 12676197
  10. Iversen N, Lindahl AK, Abildgaard U (2002)
    Elevated plasma levels of the factor Xa-TFPI complex in cancer patients
    Thromb. Res., 105 (1), PII S0049-3848(01)00404-2-36
  11. Iversen PO, De Groot P, Hjeltnes N, Andersen TO, Mowinckel MC, Sandset PM (2002)
    Attenuated diurnal oscillations of pro-thrombotic markers in tetraplegia
    REPORTS FROM THE 17TH INTERNATIONAL CONGRESS ON THROMBOSIS, 59-62
  12. Iversen PO, Groot PD, Hjeltnes N, Andersen TO, Mowinckel MC, Sandset PM (2002)
    Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia
    Br J Haematol, 119 (4), 1011-6
    DOI 10.1046/j.1365-2141.2002.03953.x, PubMed 12472582
  13. Jahnsen FL, Farkas L, Lund-Johansen F, Brandtzaeg P (2002)
    Involvement of plasmacytoid dendritic cells in human diseases
    Hum. Immunol., 63 (12), PII S0198-8859(02)00759-0-1205
  14. Jahnsen FL, Farkas L, Lund-Johansen F, Brandtzaeg P (2002)
    Involvement of plasmacytoid dendritic cells in human diseases
    Hum Immunol, 63 (12), 1201-5
    PubMed 12480264
  15. Jensen T, Halvorsen S, Godal HC, Skjonsberg OH (2002)
    Influence of freeze-drying on the clotting properties of fibrinogen in plasma
    Thromb. Res., 105 (6), PII S0049-3848(02)00057-9-502
  16. Keating MJ, Cazin B, Coutré S, Birhiray R, Kovacsovics T, Langer W, Leber B, Maughan T, Rai K, Tjønnfjord G, Bekradda M, Itzhaki M, Hérait P (2002)
    Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed
    J Clin Oncol, 20 (1), 205-13
    DOI 10.1200/JCO.2002.20.1.205, PubMed 11773171
  17. Koss-Harnes D, Høyheim B, Anton-Lamprecht I, Gjesti A, Jørgensen RS, Jahnsen FL, Olaisen B, Wiche G, Gedde-Dahl T (2002)
    A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations
    J Invest Dermatol, 118 (1), 87-93
    DOI 10.1046/j.0022-202x.2001.01591.x, PubMed 11851880
  18. Lehne G, Sørensen DR, Tjønnfjord GE, Beiske C, Hagve TA, Rugstad HE, Clausen OP (2002)
    The cyclosporin PSC 833 increases survival and delays engraftment of human multidrug-resistant leukemia cells in xenotransplanted NOD-SCID mice
    Leukemia, 16 (12), 2388-94
    DOI 10.1038/sj.leu.2402663, PubMed 12454743
  19. Liestol S, Jacobsen EM, Wisloff F (2002)
    Dilute prothrombin time-based lupus ratio test - Integrated LA testing with recombinant tissue thromboplastin
    Thromb. Res., 105 (2), PII S0049-3848(01)00420-0-182
  20. Liestøl S, Jacobsen EM, Wisløff F (2002)
    Dilute prothrombin time-based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastin
    Thromb Res, 105 (2), 177-82
    PubMed 11958810
  21. Lind B, Gedde-Dahl T, Tjønnfjord G, Villoutreix BO, Brosstad F (2002)
    Protein C deficiency caused by homozygosity for a novel PROC D180G mutation--in vitro expression and structural analysis of the mutation
    Thromb Haemost, 88 (4), 632-8
    PubMed 12362235
  22. Mishra V, Tjønnfjord GE, Paus AC, Vaaler S (2002)
    Orthopaedic surgery in severe bleeding disorders: a low-volume, high-cost procedure
    Haemophilia, 8 (6), 809-14
    DOI 10.1046/j.1365-2516.2002.00691.x, PubMed 12410652
  23. Mortensen TB, Jønsson V, Wiik A, Bock JE (2002)
    [Forty four pregnancies with idiopathic thrombocytopenic purpura]
    Ugeskr Laeger, 164 (34), 3968-72
    PubMed 12212479
  24. Müller F, Tjønnfjord GE, Nordøy I, Kvale D, Mellbye OJ, Aukrust P, Frøland SS (2002)
    Immunophenotypic analyses of CD34(+) cell subsets in bone marrow from HIV-infected patients during highly- active antiretroviral therapy
    Eur J Clin Invest, 32 (7), 535-40
    DOI 10.1046/j.1365-2362.2002.00995.x, PubMed 12153555
  25. Nazir M, Carlsen E, Jacobsen AF, Nesheim BI (2002)
    Is there any correlation between objective anal testing, rupture grade, and bowel symptoms after primary repair of obstetric anal sphincter rupture?: an observational cohort study
    Dis Colon Rectum, 45 (10), 1325-31
    DOI 10.1097/01.DCR.0000027035.77948.18, PubMed 12394430
  26. Os I, Os A, Sandset PM, Bølling S, Seljeflot I, Djurovic S, Westheim A (2002)
    Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine
    Cardiology, 98 (1-2), 6-12
    DOI 10.1159/000064667, PubMed 12373040
  27. Ruutu T, Hermans J, Niederwieser D, Gratwohl A, Kiehl M, Volin L, Bertz H, Ljungman P, Spence D, Verdonck LF, Prentice HG, Bosi A, Du Toit CE, Brinch L, Apperley JF, EBMT Chronic Leukaemia Working Party (2002)
    Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT)
    Br J Haematol, 118 (4), 1112-9
    DOI 10.1046/j.1365-2141.2002.03721.x, PubMed 12199793
  28. Sandset PM (2002)
    [Anticoagulant therapy with warfarin--still difficult]
    Tidsskr Nor Laegeforen, 122 (10), 992
    PubMed 12082707
  29. Sandset PM, Abildgaard U (2002)
    Perioperative management of oral anticoagulant therapy
    Thromb Res, 108 (1), 1-2
    DOI 10.1016/S0049-3848(02)00388-2, PubMed 12586124
  30. Standal T, Borset M, Lenhoff S, Wisloff F, Stordal B, Sundan A, Waage A, Seidel C (2002)
    Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor
    Blood, 100 (12), 3925-9
    DOI 10.1182/blood-2002-05-1406, PubMed 12393395
  31. Van Maldergem L, Magré J, Khallouf TE, Gedde-Dahl T, Delépine M, Trygstad O, Seemanova E, Stephenson T, Albott CS, Bonnici F, Panz VR, Medina JL, Bogalho P, Huet F, Savasta S, Verloes A, Robert JJ, Loret H, De Kerdanet M, Tubiana-Rufi N, Mégarbané A, Maassen J, Polak M, Lacombe D, Kahn CR et al. (2002)
    Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy
    J Med Genet, 39 (10), 722-33
    DOI 10.1136/jmg.39.10.722, PubMed 12362029
  32. Wisløff F, Jacobsen EM, Liestøl S (2002)
    Laboratory diagnosis of the antiphospholipid syndrome
    Thromb Res, 108 (5-6), 263-71
    DOI 10.1016/S0049-3848(02)00400-0, PubMed 12676184

Publications 2001

  1. Andresen PA, Gedde-Dahl T, Fausa O, Eide TJ, Heiberg A (2001)
    [Genetic analysis in familial adenomatous polyposis]
    Tidsskr Nor Laegeforen, 121 (1), 64-8
    PubMed 12013617
  2. Bendz B, Rostrup M, Sevre K, Andersen TO, Sandset PM (2001)
    Hypobaric hypoxia - Reply
    Lancet, 357 (9260), 955-956
  3. Bendz B, Sandset PM (2001)
    Deep-vein thrombosis in long-haul flights
    Lancet, 358 (9284), 837-8; author reply 839
    DOI 10.1016/S0140-6736(01)05978-5, PubMed 11570398
  4. Bendz B, Sevre K, Andersen TO, Sandset PM (2001)
    Low molecular weight heparin prevents activation of coagulation in a hypobaric environment
    Blood Coagul Fibrinolysis, 12 (5), 371-4
    DOI 10.1097/00001721-200107000-00006, PubMed 11505080
  5. Berentsen S, Tjønnfjord GE, Brudevold R, Gjertsen BT, Langholm R, Løkkevik E, Sørbø JH, Ulvestad E (2001)
    Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease
    Br J Haematol, 115 (1), 79-83
    DOI 10.1046/j.1365-2141.2001.03078.x, PubMed 11722415
  6. Berge E, Fjaertoft H, Indredavik B, Sandset PM (2001)
    Validity and reliability of simple questions in assessing short- and long-term outcome in Norwegian stroke patients
    Cerebrovasc Dis, 11 (4), 305-10
    DOI 10.1159/000047658, PubMed 11385209
  7. Berge E, Friis P, Sandset PM (2001)
    Hemostatic activation in acute ischemic stroke
    Thromb Res, 101 (2), 13-21
    DOI 10.1016/S0049-3848(00)00380-7, PubMed 11342202
  8. Berge E, Nakstad PH, Sandset PM, HAEST Study Group (2001)
    Large middle cerebral artery infarctions and the hyperdense middle cerebral artery sign in patients with atrial fibrillation
    Acta Radiol, 42 (3), 261-8
    DOI 10.1034/j.1600-0455.2001.042003261.x, PubMed 11350283
  9. Berge E, Sandset PM (2001)
    Heparin and aspirin in stroke
    Lancet, 357 (9261), 1044-5
    DOI 10.1016/S0140-6736(05)71619-6, PubMed 11293624
  10. Bryder D, Ramsfjell V, Dybedal I, Theilgaard-Mönch K, Högerkorp CM, Adolfsson J, Borge OJ, Jacobsen SE (2001)
    Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation
    J Exp Med, 194 (7), 941-52
    DOI 10.1084/jem.194.7.941, PubMed 11581316
  11. Dearden CE, Matutes E, Cazin B, Tjønnfjord GE, Parreira A, Nomdedeu B, Leoni P, Clark FJ, Radia D, Rassam SM, Roques T, Ketterer N, Brito-Babapulle V, Dyer MJ, Catovsky D (2001)
    High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H
    Blood, 98 (6), 1721-6
    DOI 10.1182/blood.v98.6.1721, PubMed 11535503
  12. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL (2001)
    Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions
    Am J Pathol, 159 (1), 237-43
    DOI 10.1016/s0002-9440(10)61689-6, PubMed 11438470
  13. Gulbrandsen N, Wisløff F, Brinch L, Carlson K, Dahl IM, Gimsing P, Hippe E, Hjorth M, Knudsen LM, Lamvik J, Lenhoff S, Løfvenberg E, Nesthus I, Nielsen JL, Turesson I, Westin J, Nordic Myeloma Study Group (2001)
    Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support
    Med Oncol, 18 (1), 65-77
    DOI 10.1385/MO:18:1:65, PubMed 11778972
  14. Gulbrandsen N, Wisløff F, Nord E, Lenhoff S, Hjorth M, Westin J, Nordic Myeloma Study Group (2001)
    Cost-utility analysis of high-dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myeloma
    Eur J Haematol, 66 (5), 328-36
    DOI 10.1034/j.1600-0609.2001.066005328.x, PubMed 11422413
  15. Hansen JB, Grimsgaard S, Huseby N, Sandset PM, Bønaa KH (2001)
    Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men
    Thromb Res, 102 (1), 3-13
    DOI 10.1016/S0049-3848(01)00215-8, PubMed 11323009
  16. Høibraaten E, Mowinckel MC, de Ronde H, Bertina RM, Sandset PM (2001)
    Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial
    Br J Haematol, 115 (2), 415-20
    DOI 10.1046/j.1365-2141.2001.03111.x, PubMed 11703344
  17. Høibraaten E, Qvigstad E, Andersen TO, Mowinckel MC, Sandset PM (2001)
    The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial
    Thromb Haemost, 85 (5), 775-81
    PubMed 11372667
  18. Jacobsen EM, Barna-Cler L, Taylor JM, Triplett DA, Wisløff F (2001)
    The evaluation of clotting times in the laboratory detection of lupus anticoagulants
    Thromb Res, 104 (4), 275-82
    DOI 10.1016/S0049-3848(01)00365-6, PubMed 11728529
  19. Jonkers IJ, de Man FH, van Tilburg NH, van der Laarse A, Sandset PM, Smelt AH, Bertina RM (2001)
    Alterations in the extrinsic pathway in hypertriglyceridemia do not cause a 'procoagulant state': effects of bezafibrate therapy
    Blood Coagul Fibrinolysis, 12 (8), 705-12
    DOI 10.1097/00001721-200112000-00013, PubMed 11734672
  20. Jorulf H, Finnbogason T, Jönsson V, Ringertz H (2001)
    Pediatric PACS, Astrid Lindgren Children's Hospital at Karolinska Hospital, Stockholm, technical and practical aspects
    Comput Methods Programs Biomed, 66 (1), 25-30
    PubMed 11378218
  21. Ljungman P, Ward KN, Crooks BN, Parker A, Martino R, Shaw PJ, Brinch L, Brune M, De La Camara R, Dekker A, Pauksen K, Russell N, Schwarer AP, Cordonnier C (2001)
    Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
    Bone Marrow Transplant, 28 (5), 479-84
    DOI 10.1038/sj.bmt.1703139, PubMed 11593321
  22. Magré J, Delépine M, Khallouf E, Gedde-Dahl T, Van Maldergem L, Sobel E, Papp J, Meier M, Mégarbané A, Bachy A, Verloes A, d'Abronzo FH, Seemanova E, Assan R, Baudic N, Bourut C, Czernichow P, Huet F, Grigorescu F, de Kerdanet M, Lacombe D, Labrune P, Lanza M, Loret H, Matsuda F et al. (2001)
    Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13
    Nat Genet, 28 (4), 365-70
    DOI 10.1038/ng585, PubMed 11479539
  23. Melsom T, Brinch L, Hessen JO, Schei MA, Kolstrup N, Jacobsen BK, Svanes C, Pandey MR (2001)
    Asthma and indoor environment in Nepal
    Thorax, 56 (6), 477-81
    DOI 10.1136/thorax.56.6.477, PubMed 11359965
  24. Mishra V, Vaaler S, Brinch L (2001)
    A prospective cost evaluation related to allogeneic haemopoietic stem cell transplantation including pretransplant procedures, transplantation and 1 year follow-up procedures
    Bone Marrow Transplant, 28 (12), 1111-6
    DOI 10.1038/sj.bmt.1703310, PubMed 11803351
  25. Ringsted C, Schroeder TV, Henriksen J, Ramsing B, Lyngdorf P, Jønsson V, Scherpbier A (2001)
    Medical students' experience in practical skills is far from stakeholders' expectations
    Med Teach, 23 (4), 412-416
    DOI 10.1080/01421590120043017, PubMed 12098390
  26. Virtanen M, Gedde-Dahl T, Mörk NJ, Leigh I, Bowden PE, Vahlquist A (2001)
    Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression
    Acta Derm Venereol, 81 (3), 163-70
    DOI 10.1080/000155501750376221, PubMed 11558869
  27. Wisløff F (2001)
    [Should iron preparations be available only on prescription?]
    Tidsskr Nor Laegeforen, 121 (9), 1155-6
    PubMed 11354901
  28. Wisløff F (2001)
    [Use of blood from patients with hemochromatosis]
    Tidsskr Nor Laegeforen, 121 (12), 1448
    PubMed 11449762
  29. Wisløff F, Tangen JM, Brinch L, Dahl IM, Gruber FX, Hammerstrøm J, Waage A, Nesthus I, Ernst P (2001)
    [High dose therapy with autologous stem cell support--finally a progress in myelomatosis]
    Tidsskr Nor Laegeforen, 121 (20), 2402-6
    PubMed 11603051

Publications 2000

  1. Bendz B, Andersen TO, Sandset PM (2000)
    Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins
    Blood Coagul Fibrinolysis, 11 (4), 343-8
    DOI 10.1097/00001721-200006000-00005, PubMed 10847421
  2. Bendz B, Andersen TO, Sandset PM (2000)
    A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1
    Thromb Res, 97 (6), 463-72
    DOI 10.1016/S0049-3848(99)00183-8, PubMed 10704656
  3. Bendz B, Rostrup M, Sevre K, Andersen TO, Sandset PM (2000)
    Association between acute hypobaric hypoxia and activation of coagulation in human beings
    Lancet, 356 (9242), 1657-8
    DOI 10.1016/S0140-6736(00)03165-2, PubMed 11089830
  4. Berentsen S, Tjønnfjord GE, Shammas FV, Bergheim J, Hammerstrøm J, Langholm R, Ulvestad E (2000)
    No response to cladribine in five patients with chronic cold agglutinin disease
    Eur J Haematol, 65 (1), 88-90
    DOI 10.1034/j.1600-0609.2000.9l201.x, PubMed 10914950
  5. Berge E, Abdelnoor M, Nakstad PH, Sandset PM (2000)
    Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial
    Lancet, 355 (9211), 1205-10
    DOI 10.1016/s0140-6736(00)02085-7, PubMed 10770301
  6. Berge E, Sandset PM (2000)
    Heparin versus aspirin in ischaemic stroke - Reply
    Lancet, 356 (9228), 505
  7. Bock JE, Jønsson V (2000)
    [Innate mechanisms during pregnancy]
    Ugeskr Laeger, 162 (3), 366-8
    PubMed 10680480
  8. Bruserud O, Tjønnfjord G, Gjertsen BT, Foss B, Ernst P (2000)
    New strategies in the treatment of acute myelogenous leukemia: mobilization and transplantation of autologous peripheral blood stem cells in adult patients
    Stem Cells, 18 (5), 343-51
    DOI 10.1634/stemcells.19-1-1, PubMed 11007918
  9. Clausen OP, Olsen G, Tjønnfjord GE (2000)
    [Flow cytometry--use in cell biology and benefits in clinical medicine]
    Tidsskr Nor Laegeforen, 120 (4), 489-95
    PubMed 10833942
  10. Dalgaard J, Ritland S, Brinch L, Ikonomou IM (2000)
    [Mastocytosis--a review illustrated by two case reports]
    Tidsskr Nor Laegeforen, 120 (11), 1312-5
    PubMed 10868093
  11. Dupuy BM, Gedde-Dahl T, Olaisen B (2000)
    DYS393 and its X chromosome counterpart
    INT CONGR SER (1193), 67-70
  12. Dupuy BM, Gedde-Dahl T, Olaisen B (2000)
    DXYS267: DYS393 and its X chromosome counterpart
    Forensic Sci Int, 112 (2-3), 111-21
    DOI 10.1016/S0379-0738(00)00170-5, PubMed 10940596
  13. Gudmundsdottir E, Jonasson F, Jonsson V, Stefánsson E, Sasaki H, Sasaki K (2000)
    "With the rule" astigmatism is not the rule in the elderly. Reykjavik Eye Study: a population based study of refraction and visual acuity in citizens of Reykjavik 50 years and older. Iceland-Japan Co-Working Study Groups
    Acta Ophthalmol Scand, 78 (6), 642-6
    PubMed 11167223
  14. Hansen JB, Naalsund T, Sandset PM, Svensson B (2000)
    Rebound activation of coagulation after treatment with unfractionated heparin and not with low molecular weight heparin is associated with partial depletion of tissue factor pathway inhibitor and antithrombin
    Thromb Res, 100 (5), 413-7
    DOI 10.1016/S0049-3848(00)00351-0, PubMed 11150584
  15. Hansen JB, Svensson B, Sandset PM, Thijssen F (2000)
    Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin
    Thromb Res, 100 (5), 389-96
    DOI 10.1016/S0049-3848(00)00343-1, PubMed 11150580
  16. Heldal D, Tjønnfjord G, Brinch L, Albrechtsen D, Egeland T, Steen R, Solheim BG, Evensen SA (2000)
    A randomised study of allogeneic transplantation with stem cells from blood or bone marrow
    Bone Marrow Transplant, 25 (11), 1129-36
    DOI 10.1038/sj.bmt.1702422, PubMed 10849524
  17. Hoibraaten E, Os I, Seljeflot I, Andersen TO, Hofstad A, Sandset PM (2000)
    The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study
    Thromb Res, 98 (1), 19-27
    DOI 10.1016/S0049-3848(99)00233-9, PubMed 10706930
  18. Høibraaten E, Qvigstad E, Arnesen H, Larsen S, Wickstrøm E, Sandset PM (2000)
    Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET)
    Thromb Haemost, 84 (6), 961-7
    PubMed 11154141
  19. Iversen N, Strekerud FG, Abildgaard U (2000)
    Tissue factor pathway inhibitor (TFPI) in disseminated intravascular coagulation: low levels of the activated factor X-TFPI complex
    Blood Coagul Fibrinolysis, 11 (7), 591-8
    DOI 10.1097/00001721-200010000-00002, PubMed 11085278
  20. Jacobsen AF, Qvigstad E, Sandset PM (2000)
    [Treatment of venous thromboembolism in pregnancy with low molecular weight heparin]
    Tidsskr Nor Laegeforen, 120 (20), 2448-9
    PubMed 11475236
  21. Jacobsen EM, Barna-Cler L, Taylor JM, Triplett DA, Wisløff F (2000)
    The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5
    Thromb Haemost, 83 (5), 704-8
    PubMed 10823266
  22. Jahnsen FL, Lund-Johansen F, Dunne JF, Farkas L, Haye R, Brandtzaeg P (2000)
    Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy
    J Immunol, 165 (7), 4062-8
    DOI 10.4049/jimmunol.165.7.4062, PubMed 11034417
  23. Jensen T, Halvorsen S, Godal HC, Sandset PM, Skjøonsberg OH (2000)
    Discrepancy between fibrinogen concentrations determined by clotting rate and clottability assays during the acute-phase reaction
    Thromb Res, 100 (5), 397-403
    DOI 10.1016/S0049-3848(00)00344-3, PubMed 11150581
  24. Lenhoff S, Hjorth M, Holmberg E, Turesson I, Westin J, Nielsen JL, Wislöff F, Brinch L, Carlson K, Carlsson M, Dahl IM, Gimsing P, Hippe E, Johnsen HE, Lamvik J, Löfvenberg E, Nesthus I, Rödjer S (2000)
    Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group
    Blood, 95 (1), 7-11
    PubMed 10607678
  25. Lund C, Rygh J, Stensrød B, Sandset PM, Brucher R, Russell D (2000)
    Cerebral microembolus detection in an unselected acute ischemic stroke population
    Cerebrovasc Dis, 10 (5), 403-8
    DOI 10.1159/000016097, PubMed 10971027
  26. Molander S, Jønsson V, Andersen LP, Bennedsen M, Christiansen M, Hou-Jensen K, Madsen HO, Ryder LP, Permin H, Wiik A (2000)
    [Pseudolymphoma and ventricular maltoma in patients with chronic gastritis, ulcer and Helicobacter pylori infection]
    Ugeskr Laeger, 162 (6), 791-5
    PubMed 10689954
  27. Nordbø SA, Skaug K, Holter E, Waage A, Brinch L (2000)
    Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation
    Eur J Haematol, 65 (1), 86-7
    DOI 10.1034/j.1600-0609.2000.9l228.x, PubMed 10914949
  28. Nordoy A, Bonaa KH, Sandset PM, Hansen JB, Nilsen H (2000)
    Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia
    Arterioscler Thromb Vasc Biol, 20 (1), 259-65
    DOI 10.1161/01.ATV.20.1.259, PubMed 10634827
  29. Nordøy A, Bønaa KH, Sandset PM, Hansen JB, Nilsen H (2000)
    Relationship between apolipoprotein E polymorphism, postprandial hyperlipemia and hemostatic variables in patients with combined hyperlipemia
    Nutr Metab Cardiovasc Dis, 10 (1), 15-23
    PubMed 10812583
  30. Os I, Hofstad AE, Brekke M, Abdelnoor M, Nesheim BI, Jacobsen AF, Birkeland K, Larsen A, Midtbo K, Westheim A (2000)
    The EWA (estrogen in women with atherosclerosis) study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins
    J Intern Med, 247 (4), 433-41
    DOI 10.1046/j.1365-2796.2000.00675.x, PubMed 10792556
  31. Pigg M, Gedde-Dahl T, Cox DW, Haugen G, Dahl N (2000)
    Haplotype association and mutation analysis of the transglutaminase 1 gene for prenatal exclusion of lamellar ichthyosis
    Prenat Diagn, 20 (2), 132-7
    DOI 10.1002/(SICI)1097-0223(200002)20:2<132::AID-PD765>3.0.CO;2-0, PubMed 10694685
  32. Sandset PM, Bendz B, Hansen JB (2000)
    Physiological function of tissue factor pathway inhibitor and interaction with heparins
    Haemostasis, 30 Suppl 2, 48-56
    DOI 10.1159/000054163, PubMed 11251341
  33. Steen R, Tjønnfjord GE, Grøseth LA, Egeland T (2000)
    Characteristics of haemopoietic progenitor cells related to CD34 epitope class expression
    Eur J Haematol, 64 (4), 245-51
    DOI 10.1034/j.1600-0609.2000.90050.x, PubMed 10776696
  34. Tangen JM (2000)
    [Alexander Pushkin's duel--biographic and medical aspects]
    Tidsskr Nor Laegeforen, 120 (10), 1170-2
    PubMed 10863347
  35. Wisløff F, Gulbrandsen N (2000)
    Health-related quality of life and patients' perceptions in interferon-treated multiple myeloma patients. Nordic Myeloma Study Group
    Acta Oncol, 39 (7), 809-13
    PubMed 11145438
 
Page visits: 8454